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Abstract  
In this research project we investigated the feasibility of incorporating organic solvent nanofiltration 
techniques with peptide synthesis and developed the Membrane Enhanced Peptide Synthesis process 
– the MEPS process. Two membranes had been identified to be applicable for the MEPS process to 
separate the peptide building block from post reaction waste. These are the commercially available 
Inopor ZrO2/Al2O3 hydrophobic membrane and the cross-linked polyimide membrane that had been 
fabricated in our laboratory. Two penta-peptides were synthesized on a soluble polymeric support to 
demonstrate the principle of MEPS process. The purity and yields of these penta-peptides were 
excellent when compared with one synthesized using the Liquid Phase Peptide Synthesis (LPPS) and 
Solid Phase Peptide Synthesis (SPPS) processes. 
To improve the quality and supply of membrane for the MEPS process a number of membrane 
fabrication parameters were investigated. This investigation demonstrated ways of manipulating the 
performance of the cross-linked polyimide membrane which gives engineers the opportunity to tailor 
make polymeric membrane to meet the requirement of the MEPS process. This membrane 
optimisation provides the MEPS process with a constant supply of reproducible membrane and 
allows this process to be further developed into a highly repeatable process. 
Other soluble polymeric support products were also been investigated in an attempt to avoid product 
contamination by PEGylated waste. Peptide chains were built onto a degradable polymeric support 
and once the desired peptide sequence had completed, the polymeric support was then completely 
hydrolysed in acid to obtain a high purity peptide product. Results showed this simple idea was not as 
straight forward to perform as expected. It demonstrated that the idea was possible and has great 
potential but further development is required.  
A number of recommendations have been suggested for further improvement and optimisation of this 
newly developed MEPS process. Not only these are related to the enhancement of the membrane 
stability, improvement in peptide crude purity and product yield, but also other potential applications 
of the MEPS principle.  
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Chapter 1.  
 
Introduction 
Peptides are small versions of protein molecules with a high level of bioactivity and specificity, but 
with a low toxicity. Many people believe peptides and oligonucleotides will be the next generation of 
therapeutic drugs and health care active pharmaceutical ingredients (API). There are currently a 
number of peptide products available. Such as: Vaccine IC41, for immunity against chronic Hepatitis 
C virus [1]; Fuzeon, the anti-HIV agent; Exenatide, for diabetes; Palmitoyl Penta-peptide, which is 
the key ingredient in modern anti-wrinkle cream [2] and many more. There were 43 peptide products 
reported in 1999, with annual sales of over US$ 4 billion. More than 100 companies are in 
competition to develop new peptide products and production pipe-lines, giving an annual growth rate 
of 10% - 15% [3]. With more peptide projects entered into preclinical or Phase I stage clinical trials, 
there is a clear need for development of a better and more efficient peptide production method to 
support such a fast growing market and to meet the up-coming global demand for peptide products 
[4].  
Common peptide synthesis routes can be classified into biosynthesis and chemical synthesis. In 
biosynthesis, a host is genetically modified to produce the target peptide; followed by multiplication 
of the host population; allowing these hosts to grow in a bio-medium for mass production of the 
target peptide. The advantage of synthesizing peptides via biosynthesis is that the purity of the 
peptide product is excellent and very rarely gives any wrong sequencing [5]. Nevertheless, the 
downside of biosynthesis includes the complexity in the genetic modification (compared to chemical 
synthesis) and that a long culturing period is required that causes inflexibility when it comes to 
business production strategies. The production is also generally done in a very diluted bio-broth 
giving low product/volume ratios which increases post synthesis waste. Furthermore, bio-synthesis 
rarely accepts non-natural amino acids. Recent research has suggested there are many advantages of 
synthesizing peptides that contain unnatural amino acids [6]. Examples of peptides containing 
unnatural amino acids include the hormone regulator, Abarelix [7] and Ganirelix [8]. 
Chemical synthesis is divided into solution phase peptide synthesis (SolPS), solid phase peptide 
synthesis (SPPS), liquid phase peptide synthesis (LPPS) and recombinant technology which 
combines SPPS with SolPS. Solid phase peptide synthesis is currently the most popular production 
method due to its easy separation procedure compared to liquid phase synthesis, and unlike 
biosynthesis, it allows reactions to be performed in concentrated solutions under simple operating 
conditions. Liquid phase synthesis on the other hand is also an attractive production strategy. It has 
many advantages such as having faster reaction rates, being less affected by mass transfer phenomena, 
and not requiring the use of an expensive solid resin as a support, etc. The main problem associated 
with liquid phase synthesis is its separation strategy, due to the chemical and physical similarity 
between peptide reactants and product, e.g. between bi-peptide and tri-peptide, which makes 
separation difficult. The challenges of peptide production generally rest in the formulation, the 
production scale-up, the final purification and the intermediate step separation methods. This 
research concentrated on improving the intermediate step separation procedure for LPPS by applying 
an organic solvent nanofiltration, (OSN) separation technique called Membrane Enhanced Peptide 
Synthesis (MEPS), Figure 1. The success of the MEPS process will bring an alternative peptide 
production method that benefits from the high performance of peptide synthesis in the homogenous 
reaction, while achieving simple intermediate step separation as in the heterogeneous recation. The 
potential gain of this research will be a unique process that has great flexibility and adaptation, as 
well as providing a fast, simple and robust peptide production method. 
 
Figure 1: Schematic representation of the membrane enhanced peptide synthesis (MEPS) process. A protected 
amino acid is assembled onto the peptide building block during coupling step and deprotected during deprotection 
step with membrane purification between each reaction. 
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2.2 Organic Solvent Nanofiltration (OSN) 
Membrane Processes 
OSN membranes are semi-permeable barriers that have different selectivity between molecules and 
are stable in a wide range of organic solvents. This technology has caught an increasing amount of 
attention, especially in the areas of organometallic catalyst recovery [9], [10] and pharmaceuticals 
and fine chemical separation. There are many advantages of using OSN over conventional separation 
systems, including no azeotropic limitation, enabling separation of mixtures containing similar 
volatility, separation of heat-sensitive or fragile products, providing large surface area per unit 
volume [11], [12], simple process procedure and easy scale-up. There are two classes of OSN 
membranes – organic and inorganic membranes. A brief summary of these membranes is a good 
starting point for this project and will help facilitate the understanding of how these membranes are 
formed, the fabrication of new membrane and  membrane modification if necessary.  
More detailed background information on OSN membranes and its technology can be found in 
review by Vandezande [13] or in a book by Baker [14]. 
2.2.1 Organic Membranes 
The use of organic membranes has several advantages over inorganic membranes, such as: 
- Easy handling and installation,  
- polymeric membranes are highly flexible and generally sealing is not an issue; 
- They are usually cheaper and easier to synthesize even in large quantity, which allows lower 
process capital cost; 
- Replacing fouled organic membrane is more economical than replacing inorganic membrane; 
- Polymeric NF membranes can operate at high pressure, which allows a higher permeation 
flux; 
- High membrane area per volume is achievable without problems of mechanical stability. 
Conventional nanofiltration (NF) membranes are synthesized from polymers that dissolve in most 
common organic solvents and so are only applicable in aqueous separation systems. OSN membranes 
are made from polymers that only dissolve in specific solvents, with or without post-treatment for 
further stabilisation. Hence these membranes are stable in a wide range of organic solvents. The 
structure of the membrane is often asymmetric and consists of two to three layers. The top layer, 
which performs the separation, is called the “active layer”. It is often made from an organic polymer 
such as polyamide, polyimide or silicon rubber and is where most of the mass-transport resistance 
occurs. Generally, the active layer can be classified as dense membrane in which the transport 
mechanism is believed to be the absorption-diffusion-desorption of molecules on and off the 
membrane; while porous membranes have a pore distribution with a mean diameter of a few 
nanometres. Here the key separation mechanism is based on the sieving of molecules with different 
molecular sizes. The retention of solute by NF or OSN membranes depends on; the type of polymers 
used for the active layer, the membrane-solute-solvent interaction and the membrane structure. The 
permeation flux through the membrane predominantly depends on the thickness of this active layer, 
which is typically only a few microns thick. The membrane “backing layer” is placed below the 
active layer to provide the mechanical strength required for the membrane so it can withstand the 
high operational pressure used during filtration. This layer often has a thickness of > 100 microns 
with channels much larger than those on the active layer. This minimises the mass transport 
resistance through the backing layer. An asymmetric “support layer” is sometimes placed or formed 
in between the active layer and backing layer. This layer is often used to control the flux across the 
membrane or for the modification of membrane properties.  
There are many ways to form polymeric membranes, including controlled stretching, extrusion, 
track-etching, etc. and each provides unique membrane properties. The phase inversion technique is 
the most common method used for the fabraication of membrane with a low molecular size range of 
MWCO of < 1,000 g.mol-1. The types of membrane in this category include; NF, reverse osmosis 
(RO) and gas separation (GS). During the phase inversion process, a polymer solution is cast on a 
suitable support followed by transformation of this liquid polymer into solid state in a controlled 
environment. The transformations are classified into the following methods; “precipitation by solvent 
evaporation”, “precipitation from vapour phase”, “precipitation by controlled evaporation”, 
“thermal precipitation” and “immersion precipitation”. Depending on the process requirements and 
on the different transformation methods used, different types of membranes can be formed. In the 
precipitation by solvent method, the solvent is evaporated from the cast polymer film to an inert 
atmosphere and the membranes produced by this method are dense and homogenous in structure. In 
the precipitation from vapour phase method, the cast polymer film is placed in a chamber filled with 
a non-solvent that is saturated with solvent. This prevents the solvent from evaporating but allows the 
non-solvent to diffuse into the film, solidifying the polymer and giving a homogenous porous 
structure. For the rest of the methods, precipitation by controlled evaporation, thermal precipitation 
and immersion precipitation all produce asymmetric membranes. In precipitation by controlled 
evaporation the polymer is dissolved in a mixture of volatile solvent and less volatile non-solvent. As 
the solvent evaporates, the membrane begins solidifying as the composition of the solution changes 
and passes the spinodal curve. Thermal precipitation uses either a single solvent or a mixture of 
solvents to dissolve the polymer, and the cast film is cooled until phase separation occurs followed by 
evaporation of the solvent. Finally, immersion precipitation is the most common and popular method 
for the preparation of polymer membranes. The polymer film is fully immersed in a coagulation bath 
after being cast and the membrane film solidifies as the solvent disperses and non-solvent intrudes 
into the cast film. The structure of this asymmetric membrane, however, can be modified to be 
symmetric by the addition of organic or inorganic chemicals into the coagulation bath or the polymer 
solution. As reported by Yang and Liu [16], phase inversion of polyacrylonitrile (PAN) membranes 
in a demineralised (DI) water bath with controlled addition of NaCl salt can change morphology of 
the membrane structure from traditional asymmetric membranes to symmetric membranes. With the 
addition of Na2CO3 salt into the DI water bath, the membrane thickness was seen to reduce as the salt 
content increased while the membrane structure remained asymmetric. Furthermore, the membrane 
performance such as permeation flux can also be modified in the same way with the addition of salt 
to the coagulation bath.  
A classic property of polymeric membranes is that they tend to swell differently in various solvent 
systems hence variation in membrane performance is expected between different solvents. Polymeric 
membranes also have a lower and narrower range of operating temperatures compared to inorganic 
membranes. Normally, thermo-stability is closely related to chemical stability. However, there are 
several factors that can promote both stabilities in polymeric membranes,  
1) using polymers containing aromatic or heterocyclic backbone structures promotes resonance 
structures and stabilises polymer molecules; 
2) polymeric backbones made from strong bonds such as C-Si, C-O, etc. which is more resistant to 
chemical attack from solute; 
3) cross-linking post-treatment, inter-locks polymer chains together preventing dissolution of the 
membrane and reducing swelling, which improves stability but also increases brittleness;  
4) absence of reactive groups such as –OH, -NH2, etc. (although this is debatable since their presence 
may cause instability on neighbouring group by inductive effect or reaction with solute during 
recovery or separation but it would also allowing cross-linking to be achieved).  
There are only a few commercial polymeric OSN membranes currently on the market. These include 
the StarMem™ series from W.R. Grace co. (USA), MP™ series from Koch Membrane Systems Ltd. 
(Germany), BV™ series from Solsep Ltd. (Netherland) and the newly developed DuraMem™ from 
Membrane Extraction Technology (MET) Ltd. (UK). This limited choice of membranes for the 
process means that membrane development may be necessary for this project.  
2.2.2 Inorganic membranes 
Inorganic membranes are usually made from ceramics or metal oxides or a combination of both. 
There are varieties of methods in synthesizing these inorganic membranes, including “phase 
separation”, “leaching”, “sol-gel technique”, “anodic oxidation”, “etching” and “sintering”. The 
main advantages of these inorganic membranes are their excellent thermo- and chemical stability. 
Application of inorganic membranes at high temperature up to hundreds of degrees centigrade has 
been well reported, especially in fuel-cell technology [17]. Their stability in concentrated acid or base 
gives them a non-replaceable position in the membrane market. The membrane performance is less 
affected by the different solvent media since inorganic membranes are generally considered not to 
swell. However, they are often brittle (low mechanical strength) and difficult to seal onto the 
filtration rig or cell due to this brittleness, as well as a swelling issue of the polymeric o-ring or epoxy 
glue, hence their application is still limited.  
Out of all the synthesis methods, the most popular preparation methods are sintering and sol-gel 
technique. The sintering method involves compressing a fine powder of a given particle size into the 
shape of the membrane followed by sintering it at an elevated temperature, until these particles are 
partially fused together leaving small channels/pores between the fused particles, Figure 2. In some 
cases an organic “binder” is added into the inorganic casting solution. The binder helps to keep the 
inorganic particles together during and after the casting. This improves the flexibility of the cast pre-
membrane structure, increasing its durability. The organic binder is then incinerated during the 
sintering process, leaving a porous structure for filtration. The sintering temperature required depends 
on the type of material used. The pore sizes formed during the process depend on the size distribution 
and average diameter of the particles and on the sintering temperature and duration of sintering.  
 Figure 2: Inorganic membrane synthesized by the sintering technique 
The Sol-gel technique [18] is a more advanced process compared to the traditional sintering 
technique. Generally, the sol-gel process involves an organometallic liquid such as metal alkoxide 
solution, known as “sol”, which undergoes a reaction in which it turns into a solid “gel”, as 
represented in Figure 3. The gel is applied in casting (on a suitable support giving a filtration 
membrane); or coating (to form a dense membrane); or drying (to form a porous structure) before 
sintering and fusing the particles together. The sol-gel technique either generates ultra-fine/nano-fine 
spherical particles or forms a colloidal suspension, which normal sintering techniques cannot achieve. 
Sintering these ultra-fine particles together forms an ultra-/nano- porous membrane structure that can 
be used for separation. Using this method also allows for the formation of an ultra-thin separation 
layer that reduces mass transfer resistance hence giving the membrane a higher permeation flux. 
However, one major set-back with this method is the “shrinkage” of gel during sintering which 
results in poor adhesion between active layer and support layer. 
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Figure 3: General formula for Sol-Gel process, i) hydrolysis of metal alkoxide, M(OR)2 follow by ii) polymerisation 
of metal alkoxide 
The two main transport mechanisms for inorganic membranes are adsorption (dense membrane) and 
Knudsen diffusion (porous membrane) [19]. With dense membranes such as Pd or LaxCoOySrz, 
atomic or ionic species are transported by diffusion through interstitial vacancies or charge carriers 
by multivalent sites on the membrane. Porous membranes such as zeolites, carbon, etc. contain inter-
connected pores that act as channels for solutes to diffuse through the membrane by Knudsen 
diffusion.  
As for polymeric OSN membranes, ceramic NF membranes are limited due to the fact that both are 
newly emerging membrane technologies. Commercially available ceramic membranes include a 
Heat 
Pore Particles of 
known sizes Compress 
 
or Cast 
ZrO2/TiO2 ceramic membrane supplied by Sterlitech Corp. (USA), a series of metal oxide 
membranes from Inocermic and Inopor GmbH (Germany) and TiO2 ceramic membrane from TAMI 
industries (France). 
2.2.3 Membrane Characterisation Methods and the 
Membrane Selection  
Membrane characterisation is essential for both polymeric and ceramic membranes, as it gives 
prediction and comparison of physical properties and performance of the fabricated membrane. It is 
generally divided into membrane morphology and membrane performance. Characterisation by 
membrane morphology involves detailed examination of the membrane structure and membrane 
composition. This is commonly achieved by using techniques such as scanning electron microscopy 
(SEM), atomic force microscopy (AFM), Fourier transform infrared – attenuated total reflectance 
(FTIR-ATR), liquid–liquid displacement porosimetry (LLDP) and recently Positron Annihilation 
Lifetime Spectroscopy (PALS).  
SEM is a great tool for investigating the structure of the membrane, as it gives a photographic 
presentation of the area of interest. The basic principle of SEM works by scanning a solid surface 
with an accelerated electron beam. As these high-energy electrons interact with atoms within the 
solid it gives out a variety of signals, including secondary electrons, back scattered electrons, X-rays, 
etc. Different detectors are required to detect each signal hence multiple detectors are sometimes 
installed in the SEM machine.  
FTIR-ATR on the other hand is often used to analyse the functional groups on the membrane and for 
monitoring surface modification or degradation. Groups on a molecule are constantly rotating and 
vibrating at their specific frequency which corresponds to an individual energy level. Exciting these 
groups using infrared radiation and measuring the amount of energy being absorbed by the bond 
oscillation allows for the identification of specific groups being formed, or reacted, during 
modification or degradation. Traditional FTIR is measured by transmission of infrared through the 
samples. For solid samples it often requires complex preparation procedures and suffers from 
inevitable reproducibility. In ATR, the infrared beam is passing through an optically dense crystal 
with high a refractive index and generates an infrared probe of 0.5 – 5 µm above the surface of the 
crystal and into the contacting sample. This allows surface scanning of the solid sample, avoids 
complex sample preparation and makes analysis more reproducible. Researchers have not come to a 
conclusion on whether polymeric NF membranes contain pores or not, but some have tried to 
estimate pore diameters and pore distribution using a number of methods including AFM, LLDP [20] 
and PALS.  
Characterisation by membrane performance is more relevant for process development and membrane 
application. The permeation flux is calculated from Equation 1. One of the factors determining the 
feasibility of a membrane process is the permeation flux. A high permeation flux is always preferable 
since it gives faster separation per membrane area hence is more economically efficient.  
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The rejection of a molecule during filtration is calculated according to Equation 2. It is commonly 
accepted that high molecular weight molecule are more retained by the membrane hence have a 
higher rejection, while the opposite is true for lower molecular weight molecules. However, this isn’t 
always the case since the retention of a molecule depends on its shape and charge as well as its 
molecular weight. 
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Where CiP is the concentration of solute i in the permeate side of the membrane and C
i
R is the 
concentration of solute i in the retentate side of the membrane. 
Over the past decades, a number of researchers have come up with different ways to characterise 
membrane performance. A standardised point known as the “molecular weight cut-off” (MWCO) is 
generally used, which is defined as “the molecular weight at which 90% rejection is reached”. 
However, this isn’t particularly useful since in real-life applications 90% rejection of valuable 
product is not acceptable. A more appropriate approach is a rejection curve, Figure 4 where the 
rejections of a series of solutes with different molecular weight are plotted against their molecular 
weight. This gives a complete rejection profile of the membrane and indicates the molecular weight 
at which the membrane will give 100% rejection. Referring the molecular weight of solute to the 
rejection profile allows for prediction of the feasibility of applying such a membrane before an 
experiment and eases the membrane selection procedure. Different solutes have been reported for 
determining the MWCO and rejection curves. These include a series of alkanes, dyes with various 
molecular weights, organic/organometallic salts with different sizes, polymers of different lengths, 
etc. With advantages and disadvantages of their own, it is difficult to compare MWCO determination 
method. A Summary of these methods can be found in a number of publications such as See-Toh et 
al. and Boussu et al. [21], [22]. However, the most ideal solute for MWCO determination would be a 
molecule such as aromatic dendrimer, since aromatic systems can be easily detected by a UV 
detector, and a dendritic molecule has a defined shape that can be calibrated to the “pore size” on the 
membrane. The solute molecular diameter and molecular weight solely depend on the generation of 
the dendrimer.  
 
Figure 4: The theoretical rejection curve of solutes with different molecular weights 
2.2.4 Membrane Fouling and Concentration Polarisation 
Concentration polarisation phenomenon [23] can occur for both inorganic and organic membrane 
processes. This occurs when the smaller solvent molecules pass through the membrane at a greater 
rate than the larger retained solute molecules can diffuse back into the bulk. This results in an 
accumulation of solute molecules at the interface, forming a higher concentration layer above the 
membrane surface. The negative effects resulting from concentration polarisation include: 
1) An increase in osmotic pressure which reduces permeation flux 
2) An increase in mass transfer resistance, leading to an increase in rejection for the less rejected 
molecules and a decrease in solvent flux through the membrane 
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3) Generating additional concentration gradient adjacent to the membrane surface, lowering the 
actual rejection of the more rejected molecules 
4) Changing the membrane properties, i.e. changing the surface charges or hydrophobicity of the 
membrane surface 
5) In extreme cases, it fouls the membrane, if the concentration of solute adjacent to the membrane 
surface reaches its solubility limit 
The combined overall effect leads to a decrease in solute recovery or poorer selectivity between two 
solutes and a reduction of overall permeation flux, hence lowering efficiency of the membrane 
process. Unlike in micro-filtration (MF) and some ultra-filtration (UF) where fouling is reversible by 
back-flow (applying pressure from the permeate side) or chemical removal (by soaking in solvent) 
[24], these cleaning techniques cannot be applied to NF. Nevertheless it is possible to minimise 
concentration polarisation by either improving mixing within the filtration cell, (which reduces the 
thickness of the rejected solute layer), or by using a cross-flow system with high feed flow rate to 
enhance axial velocity and sweep away the solute layer.  
2.1 Peptide Chemistry 
There are many reviews in the field of peptide chemistry and its production, from the simplest [25] to 
some more detailed overview of the community [26] - [28]. This started as an engineering project 
therefore it was decided to begin the literature review on peptide chemistry from the simplest point 
and gradually building-up the foundation of the chemistry.  
Peptides are poly(amino acids), usually synthesized from α-L-amino acids, as for proteins, but 
typically containing less than 50 residues. The simplest synthesis method is a dehydration reaction 
between two amino acids Figure 5. A similar procedure is used in human metabolism and the 
resulting peptides are used on a daily basis, from growth to fighting diseases. The specific function of 
a peptide mainly depends on the side-chain, R, of the amino acid, the sequence of the peptide 
synthesized, and any inter- or intra-chain connections, for example any number of disulphide bridges 
within the peptide.  
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Figure 5: Coupling of two α-amino acids 
There are 20 naturally occurring amino acids (ref. chapter 8.2) together with the modern non-natural 
amino acids which can generate an infinite number of peptide and protein combinations. Each 
combination could be a potential “active pharmaceutical ingredient” (API). Enabling efficient 
processes for manufacturing of these peptides will create an enormous advantage in the drug market 
and benefits to society. Each amino acid contains an amino terminal, N-terminal, a carboxyl terminal, 
C-terminal and a side chain, R-terminal. Protonation of N- or C- terminal on the amino acid due to 
its surrounding environment will result in either the ionic or non-ionic form or the zwitterionic form. 
The unique characteristic of each amino acid comes from its R-terminal, and each amino acid can be 
classified as acidic, basic, neutral, hydrophobic or hydrophilic. It is commonly known that the side-
chain of the amino acid governs its behaviour and its separation potential.  
The synthesis of peptides can be divided into biosynthesis and chemical synthesis. Biosynthesis 
generally involves genetic modification of a host’s DNA, allowing these hosts to multiply in a 
controlled environment, followed by using them to synthesize the peptide in a bio-broth, and finally 
product recovery and separation. Biosynthesis of peptides is often considered as a racemisation free 
process, with no limitation on the length of the peptide synthesized. However, biosynthesis is 
constrained with the use of natural L-amino acids, low product per reaction volume which generates 
large amounts of bio-waste. Genetic modification is often not straightforward and the reproducibility 
and behaviour of the host varies from batch to batch. It is also inflexible in terms of production and 
marketing strategy, since genetic modification research is necessary for every new peptide sequence 
planned to be synthesized or any alteration on a peptide sequence.  
Chemical peptide synthesis in contrast is highly flexible since there is no constraint in the application 
of natural L- or D- amino acids or non-natural amino acids such as β-amino acids. The peptide 
sequence synthesis solely depends on the production strategy, no genetic modification or in depth 
initial-stage research is required before production. Synthesis is often performed in concentrated 
solutions giving high product per reaction volume ratio, and the synthesis protocol is also much 
simpler compared to biosynthesis. Therefore, chemical synthesis has been gaining an increasing 
amount of application in peptide industries.  
Understanding the basic peptide chemistry is the foundation of this project. As shown later in 
Chapter 5, the advance of the membrane-peptide synthesis process was developed based on an 
understanding of the key linkages between the soluble support and the peptide building blocks. 
Knowing how the coupling reaction was performed and protection works would give us some 
advantages when encountering difficulties or during process development and modification of the 
membrane-peptide synthesis process. 
2.1.1 Protection Methods 
Every pair of amino acids coupled together can generate many possible products through 
uncontrolled multiple coupling and coupling at the wrong terminals, and these undesired products 
will cause difficulty during separation and lowering product purity. Hence, during chemical synthesis 
it is important to protect the R-terminal at all times, and to protect either the N-terminal or the C-
terminal to avoid wrong sequencing attachment. For the past decades, many classes of protecting 
group had been introduced but many are for the protection of acidic functional groups that included 
the protection of the C-terminal and the acidic R-terminal; and for the protection of basic functional 
groups that included the protection of the N-terminal and the basic R-terminal. Other protecting 
groups had also been developed for other purposes such as the protection of the amide back-bone, 
while others are capable of deprotection in aqueous conditions or are photoliable. The main 
difference between these protecting groups lays in their ability to be selectively removed from the 
amino acid. Protection groups that can be remove by different deprotection conditions and allow 
deprotection to be performed in any order in the synthesis is known as orthogonal protection. This is 
important because a deprotection step is performed after each successive coupling step to regenerate 
an N-terminal or C-terminal for the next amino acid coupling, while the protection on the R-terminal 
must remain intact.  
An ideal protection group should be, 1) inert during the synthesis and not affect the peptide molecule 
while in position; 2) stay firmly at its post as long as required; 3) be easily removed when its purpose 
has been served, under conditions which will not affect the product. In general, a straightforward 
suppression of reactivity or mix strategies is used to protect the acidic or basic terminals. The 
reactivity of the amino group (basic terminus) arises from the lone pair of electrons on the nitrogen 
atom, allowing it to perform nucleophilic attacks to the surroundings for instance the carbonyl centre 
of the carboxylic acid group. The most efficient way to protect the N-terminal is to suppress the 
nucleophilic reactivity of the α-amino group during the synthesis. This can be done by connecting an 
electron withdrawing group next to the nitrogen and drawing electron density away into an 
appropriate substituent; or by concealing the nitrogen behind a screen of steric hindrance. Whereas 
the reactivity of a carboxylic acid group arises from the highly electronegative oxygen atoms, 
displacing electrons from the carbonyl centre and leaving a slight positive charge on the carbon that 
is vulnerable to nucleophilic attack. The protection of this centre can be achieved by attaching an 
electron-donating group closely next to the carbonyl centre to reduce the positive charge and hence 
its reactivity or by steric hindrance.  
The type of protection and deprotection conditions required affects greatly the type of membrane that 
can be applied and the membrane performance. For instance, the size, shape, polarity or 
hydrophilicity of the protecting group affects the rejection of the amino acid, which leads to 
unfeasible process application or too harsh deprotection environment that damages the membrane 
during filtration. Therefore, some understanding of these protection groups is essential for this project.  
2.1.1.1 α-Amino Terminal Protection 
Many types of amino protecting group have been developed, but out of all N-terminal protection, the 
alkoxycarbonyl protection family is the most common because it meets most of the requirements 
mentioned above, it is free from racemisation and is often inexpensive. They are usually installed by 
Schotten-Baumann reaction, Figure 6 a), which was developed by Bermann and Zervas in 1932. By 
reacting the N-terminal of the amino acid with a chloroformate and substituting the chlorine atom. 
The resulting alkoxycarbonyl group suppresses the nucleophilicity of the nitrogen atom on the N-
terminal by attaching two more electronegative oxygen atoms to the neighbouring carbon and 
withdrawing electron density from the nitrogen via the induction effect, therefore deactivating the N-
terminal, Figure 6 b).  
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The most commonly used alkoxycarbonyl protecting groups are illustrated in Figure 7, they are: 
benzyloxycarbonyl (Z-group); t-butoxycarbonyl (Boc-group); 2-(4-biphenylyl)-isopropoxycarbonyl 
(Bpoc-group); and 9-fluorenylmethoxycarbonyl (Fmoc-group). Although they belong to the same 
family and have a common alkoxycarbonyl bond, but they have different characteristic behaviour 
which gives them orthogonal protection during the synthesis.  
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Figure 7: Alkoxycarbonyl N-terminal protection family a) Z-protection, b) Boc-protection, c) Bpoc-protection, d) 
Fmoc-protection and e) Trt-protection 
The deprotection of all alkoxycarbonyl protecting groups follows similar acid triggered 
decomposition mechanisms, except one – the Fmoc- protection. The lower reactivity of –OCO–NH– 
group favours alkyl-oxygen fission and degrades into the corresponding carbamic acid. The carbamic 
acid then decarboxylates spontaneously to regenerate back to the parent amino group, giving off 
carbon dioxide gas as shown in Figure 8. Such a deprotection method is simple, clean and highly 
immune from racemisation.  
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Figure 8: General mechanism for deprotection of Alkoxycarbonyl Protecting Group 
The Z group, Figure 7 a), is well known to be stable under mildly basic and nucleophilic conditions. 
However, under strong alkali conditions it could potentially lead to cyclicization of larger peptides 
during synthesis. The deprotection of the Z-group requires concentrated HBr/AcOH (or liquid HF or 
HBr/TFA) mixtures which are highly corrosive to the surrounding environment, therefore 
precautions must be taken during the deprotection process.  
The Boc group, Figure 7 b), is unreactive under catalytic hydrogenolysis, basic, nucleophilic and 
reducing conditions. However, it is more active under acidic conditions than the Z group. This allows 
the Boc group to be removed under milder acidic conditions such as TFA in DCM at ambient 
temperature and used orthogonally with the Z group.  
The Bpoc group, Figure 7 c), is a derivative from the Boc group with a highly electron-withdrawing 
bi-phenyl substituent attached. This helps to stabilise the carbocation generated during the 
deprotection process. This makes it even more reactive under acidic conditions and more stable in 
basic conditions when compared with other alkoxycarbonyl protecting groups. For instance, the Bpoc 
group can be removed with a mixture of chloro-acetic acid in DCM, while the Z or Boc group would 
remain intact. It also can be remove by catalytic hydrogenolysis, while the Boc group cannot. This 
allows the Bpoc group be used orthogonally with the Z or Boc groups.  
The Fmoc group [29], Figure 7 d), is also a member of the alkoxycarbonyl family but has a 
completely opposite behaviour in comparison to the other family members. It is stable under acidic 
conditions but can be cleaved under certain basic conditions. For instance, the deprotection is fast 
with the secondary amine, piperidine at 20% (v/v) in DMF but not with tertiary amine such as 
DIPEA. The Fmoc deprotection mechanism is shown in Figure 9. The secondary base acts as a 
nucleophile that initiates the E1cb elimination mechanism as well as acts as a scavenger to up-taking 
the dibenzofulvene that is released during deprotection. It is this unique nature of Fmoc protection 
which gives a prefect orthogonal protection with the Z or Boc protection, and is gaining more 
popularity within the community of peptide science. Furthermore, beside the standard 20% (v/v) 
piperidine deprotection method, other researchers also introduced milder ways of removing Fmoc-
protection, making this protection group even more selective [30] - [32].  
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Figure 9: Deprotection of Fmoc protection group with piperidine 
As modern peptide science becomes more advanced, there is an increasing demand for gentler and 
more selective N-terminal protecting groups. For example, the triphenylmethyl (Trt) group, Figure 7 
e), which protects by both steric hindrance and electron-withdrawing mechanism. It allows very 
gentle deprotection with acetic acid in 90% TFE mixtures or pH 4. Or the allyloxycarbonyl (Alloc) 
group [33] that can be remove by palladium catalytic reaction and the o-nitrobnzyloxycarbonyl (oNZ) 
group that can be remove by photolysis at wavelengths of >320 nm. 
2.1.1.2 α-Carboxyl Terminal Protection 
Although the C-terminal is less reactive when compared to the N-terminal, maximum protection is 
still applied. This is because the addition of protecting groups generally improves the solubility of the 
peptide in organic solvent and eases the product separation. Esterification is the most common 
method for the protection of the C-terminal. The parent carboxylic acid is regenerated from ester by 
acyl-oxygen or alkyl-oxygen fission. The deprotection can be triggered by acidic or basic conditions, 
depending on the synthesis requirement.  
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Figure 10: Ester C-terminal protection family a) methyl ester protection, b) ethyl ester protection, c) benzyl ester 
protection, d) t-butyl ester protection and e) phenyl ester protection 
Methyl and ethyl esters, Figure 10 a) & b), are very stable in most peptide synthesis coupling and N-
terminal deprotection conditions but are less preferable due to easy formation of diketopiperazine 
(DKP) during peptide synthesis through internal elimination, Ei mechanism. Both are also difficult to 
cleave due to their stable characteristics and therefore require harsh treatment. 
Benzyl (Bz) ester, Figure 10 c), however, is stable in TFA and cleavable under basic, hydrazineolysis, 
HBr/AcOH, HF and catalytic hydrogenolysis conditions. This allows it to be applied in orthogonal 
protection with other protecting groups. Unfortunately, there is a potential for DKP formation with 
Bz ester in basic conditions, hence care must be taken when using Bz ester protection.  
The development of t-butyl (tBu) ester, Figure 10 d), minimised the formation of DKP and is very 
stable under nucleophilic and basic conditions, but intra-molecular nucleophilic attacks can be 
triggered.  
Phenyl ester, Figure 10 e), was specifically developed to allow for the deprotection of carboxylic 
group in the presence of an acid sensitive side chain. It is completely stable under acidic and catalytic 
hydrogenolysis conditions, but rapidly cleaves under alkali and nucleophilic conditions, which is 
unique from the other C-terminal protecting groups. The use of equivalent amounts of hydrogen 
peroxide in DMF has become the standard deprotection procedure for this group, and has eliminated 
any problems associated with saponification cleavage. The deprotection mechanism is the same as 
other esters. The peracid generated from the treatment is unstable in alkaline conditions, therefore, it 
automatically broken down into corresponding carboxylic acid. An excess amount of DMS is 
required for the deprotection of peroxide sensitive side chain such as Met, Trp or Cys.  
A comprehensive review of the protection of amino acid was reported by Isidro-Llobet [34]. 
2.1.2 Coupling Activation and Activators 
Activation is essential for peptide synthesis, since most carboxylic acids would naturally form a salt 
with amines from an acid-base reaction at ambient temperature. Heating would promote these salts to 
couple and form a peptide, but would also cause damage to the functionalised side chain, structural 
transformation or enantiomeric racemisation. Activation of aminolysis to form an amide bond 
commonly involves the generation of a reactive acylating agent or an intermediate with the 
carboxylic terminal, result in –CO2X, where X = Cl or OAr (Ar = aromatic), which are generally 
good leaving groups. This is followed by a nucleophilic substitution reaction with the amine terminal 
of another protected amino acid. The common way of achieving this is by either addition reaction or 
substitution reaction with an electrophile. These electrophiles are known as the activating reagents. 
Ideally, the activated protected amino acids will couple rapidly under mild conditions and will not 
promote any side reactions or affect any chiral centres, and the by-products generated from the 
activations are easily removable.  
As the peptide chemistry community continues to expand and the demand for a better peptide 
synthesis reagent grows, many newly developed coupling and racemisation suppressing reagents 
have been developed [35] - [37]. Nevertheless, most of them are designed based on the principle of 
generating an active acyl-compound. A summary of these acyl-compounds would give an indication 
of the types of impurities that are required to be removed from the system by the MEPS process.  
Coupling through Acyl- compounds, such as acyl-chlorides/fluorides and acyl azides was introduced 
a hundred years ago. These are the most straightforward and traditional ways of chemical synthesis 
of peptides, following a simple addition reaction mechanism. Although the acyl-chloride family is 
extremely reactive towards coupling reactions, they are nowadays less popular due to the reactivity 
being too vigorous leading to incompatibility with sensitive substrates, introducing side-reaction and 
racemisation, etc. The handlings of certain acyl-chloride amino acids are also sometimes 
problematical, due to their unstable nature and high toxicity. Acyl-fluorides [38] in comparison are 
more stable toward hydrolysis and nucleophilic attacks than acid chlorides, while showed similar 
high reactivity toward coupling reactions, and it has been reported to give excellent purity. Amino 
acid fluorides is also compatible with the use of acid sensitive protection groups such as Boc or tBu, 
and it is suitable for the coupling of moderately hindered amino acids in peptide synthesis. Acyl-
azides also give high reactivity toward coupling reactions and are found to be almost free from 
racemisation (if reaction conditions are carefully controlled). But the generation of acyl-azides 
compounds are sometimes complex, using toxic reagents and the resulting azide compounds have to 
be subjected to aminolysis immediately without isolation or delay. Its usage is nowadays primarily 
for fragment condensation rather than stepwise synthesis.  
The anhydride is a large family of activated ester, from the original symmetric anhydrides, to the uses 
of a mixture of anhydrides with carboxylic acid, carbonic acid or diphenylphosphinic acid. Classical 
way of generating these anhydrides compound involves the use of chloroformate, 1-ethoxycarbonyl-
2-ethoxy-1,2-dihydroquinoline (EEDQ), etc. Generating an activated C-terminal using the anhydride 
method has the advantage of speed and economy. Reagents are usually inexpensive and readily 
available. The anhydride amino acids are generally reasonably stable, hence handling are much easier 
compared with acyl-compounds. Coupling is very clean producing easily separable by-products, the 
procedure is robust and the performance is highly repeatable, hence it is an attractive way of 
activating the C-terminus. However, this technique is not used for fragment condensation due to the 
risk of racemisation.  
There are other different types of activators developed over the past century following the criteria 
mentioned above that can be applicable to both stepwise synthesis and fragment condensation, 
namely the traditional carbodiimide family to the modern advanced phosphonium family and 
uronium family.  
The carbodiimide family, Figure 11 i) – iii), has been the most important coupling reagent for the 
activation of the carboxyl functional group. It can trigger the formation of both amide bonds and ester 
bonds. Although the family had been introduced decades ago it is still the most widely used activator 
[39] and it has been continuously redeveloped to adopt modern day peptide chemistry. From the most 
well known N,N-dicyclohexylcarbodiimide (DCC or DCCI), Figure 11 i), to the more recent N,N-
diisopropylcarbodiimide (DIC), Figure 11 ii), which is safer to use, easier to handle and generates an 
easily separable urea by-product.  
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Figure 11: The carbodiimide family for activating coupling reaction with i) DCC, ii) DIC and iii) EDC. The 
triazole family for suppression of racemisation with iv) HOBt, v) HOAt and vi) HOCt 
Like most modern coupling agents, the carbodiimide family uses the substitution coupling activation 
mechanism, where the carboxylate anions attack the keteneimine centre (-N=C=N-) and generates an 
active O-acylisourea complex, it follows by nucleophilic substitution at the activated carbonyl centre 
by the N-terminus of the peptide building block. Unfortunately there is the potential for side reaction, 
racemisation or the collapse of the active urea complex due to external nucleophilic attack on the 
highly reactive complex. The result is the formation of less reactive N-Acylurea that causes 
separation problems and reduces product yield. A common solution to this problem is to introduce a 
suitable α-nucleophile that will react with the O-acylisourea complex quickly, before any side 
reaction occurs. Different α-nucleophile additives have been developed to prevent side-reactions, and 
the most common one is the 1-hydroxybenzotriazole (HOBt), Figure 11 iv). It competes with the 
racemisation forming new complexes that are more stable during the pre-activation stage, Figure 12, 
it then follows the normal substitution mechanism on the activated carbonyl centre. Recently 
developed competitors such as HOAt [40] and HOCt [41], Figure 11 v) and vi), have showed even 
more superior performance in suppressing racemisation. The major downside of these benzotriazole 
additives is their explosive nature, hence increasing restriction on their purchasing and transportation 
from suppliers. Non-explosive but highly active α-nucleophile additives such as Oxyma [42] have 
recently developed to replacing the traditional HOBt.  
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Figure 12: Activation of the C-terminal of a Fmoc-amino acid and coupling mechanism with carbodiimide family 
using DIC as activator and with HOBt as racemisation suppresser 
The phosphonium and uronium activators (members of the onium family) are a more advanced class 
of activator. These cationic derivatives are highly active toward amide bond formations, 
incorporating an azole component that suppresses racemisation during the coupling reaction. It only 
requires equivalent amounts of activator with respect to protected amino acids in an inert solvent to 
promote the coupling reaction, with a small amount of tertiary base to keep the C-terminal of the 
amino acid in anionic form. These onium reagents give excellent yields, produce easily separable by-
products, and minimise side-reactions. Modern phosphonium reagents, Figure 13 i) and ii), such as 
Benzotriazol-1-yl-oxytripyrrolidino-phosphonium hexafluorophosphate (PyBOP) [43], [44], not only 
have the above advantages, but also give off less toxic by-products in comparison to BOP. The 
activation of phosphonium reagents follow the substitution mechanism with carboxylate anions 
attacking the phosphonium cation centre and releasing an α-nucleophile (in case of PyBOP is HOBt), 
this helps to increase the reaction rate and minimises racemization. The large phosphonium cation 
also produces a steric hindrance effect that further suppresses racemization,Figure 14. Compared to 
the phosphonium family, some researchers believe that the uronium family is a more powerful 
coupling reagent, for the reason that it succeeds in difficult sterically hindered coupling, gives faster 
coupling performance and gives a minimal level of racemisation [45]. Uronium reagents [46] such as 
O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU), Figure 13 iii), 
have a similar a reaction mechanism to the phosphonium reagents, with carboxylate anion attack to 
the keteneimine centre instead of the phosphonium cation centre. Its reactivity is comparable to the 
phosphonium family, but generally gives non-toxic by-products. Due to the similarity of both 
families they can replace each other during the synthesis procedure without causing a major impact 
on the process or final outcome of the peptide product. Other more recent developed onium reagents 
including TBDMS-OBt [47] and COMU [48] which been shown to have superior coupling 
performance in SPPS.  
N
N
N
O
P
N
N
N
F
P
F
FF
FF
N
N
N
O
P
N
N
N
F
P
F
FF
FF
N
N
N
O
C N
N
F
P
F
FF
FF
i) ii) iii)
 
Figure 13: The onium family with i) BOP and ii) PyBOP, and the uranium family with iii) HBTU, both uses for the 
activation of coupling reaction 
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Figure 14: Activation of C-terminus and coupling mechanism with phosphonium family using BOP as activator. 
2.1.3 Racemisation, Impurities and Difficult Sequences 
There are number of challenges when it comes to peptide synthesis, especially with racemisation 
which includes isomerisation and sequencing impurities. As for most complex molecules, a peptide 
contains many stereo-centres that arise from the chiral centre of an amino acid. The isomeric purity 
of the peptide is essential, as for every active pharmaceutical ingredient (API). The racemisations of 
an amino acid in peptide synthesis is often referring to the chiral α-carbon which changes from a 
purely L-form into a mixture of L- and D- forms. The two major causes of enantiomeric racemisation 
during peptide synthesis are “direct enolization” and “oxazolone”. Both are predominately triggered 
under basic conditions.  
Normally, the acidic proton of the free carboxylic acid group is readily deprotonated under basic 
conditions and forms a carboxylate anion, Figure 15 i). Further removal of the α-proton on the chiral 
centre can produce a highly unstable di-anion; in such a case direct enolization is suppressed. 
However, during synthesis with an activated C-terminus the carboxylate anion cannot be formed to 
protect the α-proton from nucleophilic attack; Furthermore activation on the C-terminus usually 
involves attachment of an additional electron-withdrawing group, X, onto or near the carbonyl centre 
to promote strong positive charge at the centre which makes the α-proton even more easily removed. 
Both cases increase the likelihood of direct enolization, Figure 15 ii).  
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Figure 15: Direct enolisation under basic condition, with i) deprotonation of carboxylic acid to form carboxylate 
anion and not carboxylate di-anion; ii) direct enolisation racemisation with activated carboxylic terminal. 
The oxazolone racemisation is a cyclization of an activated C-terminus, which follows the conjugate 
base unimolecular elimination, E1CB mechanism that is triggered under basic conditions, as shown in 
Figure 16. Although the resulting oxazolone species is active towards peptide formation, the α-
proton is readily removed and forms a mixture of L- and D- enantiomers during the process. The rate 
of oxazolone racemisation is often higher than the rate of peptide bond formation, especially when 
the anion is stabilised by the cyclic structure and is in a polar solvent. Nevertheless, for some 
enantiomeric racemisations such as direct enolization and oxazolone, racemisation can be avoided by 
choosing the synthesis strategy correctly, since both racemisations are known to be enhanced by  
synthesizing the peptide from the C-terminus. Therefore, synthesis from the C-terminus is usually 
avoided.  
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Figure 16: Oxazolone racemisation forming a mixture of L- and D- enantiomers 
Aspartimide is a racemisation [49], [50] which can be triggered under basic or acidic conditions. It 
caused by the nitrogen on the amide backbone attacks the protected aspartic acid side chain and 
results in the formation of an imide ring. The imide ring then either breaks down by hydrolysis giving 
a mixture of α- and β-peptide; or by nuceophilic addition of piperidine giving a mixture of α- and β-
peptide-piperidide. In both cases, the purity of the peptide product will reduce and cause potential 
difficulty in final peptide purification. Aspartimide is peptide sequence dependence but generally can 
be minimised by careful selection of protection strategy [34], [51]. Keeping in mind that the physical 
and chemical properties of protection groups affect the separation performance of the membrane, 
careful consideration should be taken to ensure the synthesis conditions and protections are suitable 
for the membrane process.  
Other then enantiomeric racemisation, the two most common impurities in peptide synthesis are 
“deletion sequencing” and “random sequencing”. Deletion sequencing is simply due to incomplete 
attachment of amino acids or incomplete deprotection of the protection groups; this leads to one or 
more amino acids missing from the final peptide sequence. The use of a more powerful coupling 
activator or slightly longer reaction time could reduce this racemisation; however, this isn’t always 
the case, some peptide sequences are more troublesome to synthesize. These peptide sequences are 
generally referred to as “difficult sequences”. When this occurs, a sudden decrease in reaction 
kinetics results in an incomplete coupling reaction and no significant improvement of conversion 
with further repeating coupling reaction or lengthen reaction time. The major contributing factors of a 
difficult sequence are generally accepted to originate from the intrinsic properties of the peptide 
sequence itself, which results in partial or total aggregation of the peptide building block, leading to 
hindrance of the amino termini. In such a case a number of scenarios would arise: 
1. Self-associated aggregation through intra-chain hydrogen bonding or intra-section folding due 
to repeating of hydrophobic amino acids 
2. Formation of a cross-linked matrix through inter-chain interactions that make peptide building 
blocks less mobile or accessible by reagents 
3. Poor solvation of the polymeric resin which in solid phase synthesis causes the collapse of the 
matrix and hinders the accessibility of the reagents 
Due to the popularity of solid phase synthesis, much research has been done to understand the effects 
of difficult sequence in solid phase; whereas for liquid phase synthesis, the effects of difficult 
sequence remain less well-known. A quick summary on the subject and prediction of difficult peptide 
sequences can be found in many publications [52] - [55].  
Random sequencing is caused by post-reaction waste such as un-reacted amino acids or excess 
deprotection reagent remaining in the reaction mixture after the interstep separation, these waste 
products are then carried onto the next coupling step. The major cause of this impurity is insufficient 
separation, hence it is important to minimise the level of impurities after each step of the synthesis. 
Because this impurity arises from an insufficient separation, it will be the major focus for this project.  
A less common impurity that is known to peptide chemists is “transpeptidation”, in which one amino 
acid or a section of the peptide building block is interchanged from one peptide chain to another. 
Although the mechanism of this racemisation is unknown, it usually occurs when peptides are 
synthesized in a confined space, such as in solid phase. Schaefer et al. [56] observed that 
transpeptidation took place most frequently with N-terminal addition of Arg or Lys to a peptide, and 
pointed out that transpeptidation could occur even at low concentrations. It not only affects the final 
purity of the peptide, but also disturbs analysis such as MS or LC-MS. Schaefer et al. urged the need 
for research to elucidate the mechanism of this racemisation. Others such as Dölling et al [57] 
reported piperidine induced racemisation on Asp(OtBu) containing peptides using the Fmoc- strategy, 
and Quibell [58] suggested a strategy to overcome it. There are many types and classes of 
racemisation but most are related to aspect of peptide chemistry that requires chemistry solutions. 
Although the separation process condition depends on the chemistry, this topic will be beyond the 
scope of this project. 
2.2 Peptide Synthesis Processes 
A number of peptide synthesis strategies have been developed over the past century. Synthesis 
methods change as peptide chemistry becomes more advanced with higher requirements. Here, a 
summary of these strategies gives us some understanding of peptide synthesis over the past decades, 
as well as what to expect and what to compare to as a new paradigm for peptide synthesis methods 
are developed.  
Chemical peptide synthesis consists of three distinctive sets of procedures: 
1) Chain assembly by a coupling reaction with a protected amino acid 
2) Functional group regeneration by deprotection of one end of the chain 
3) Inter-step separation of peptide building blocks from post-reaction waste. 
Generally, chains are synthesized from the N-terminal direction i.e. coupling the C-terminus of the 
next amino acid onto the N-terminus of the growing peptide, as this allows minimisation of 
enantiomeric racemisation as mentioned before.  
2.2.1 Solution Phase Peptide Synthesis (SolPS) 
The solution phase peptide synthesis (SolPS), known as the “classical peptide synthesis” was the first 
synthesis strategy developed. The synthesis is performed in a homogenous phase where all reagents 
are fully dissolved in an organic solvent. The peptide is formed from a coupling reaction between an 
N-terminal protected amino acid with a C-terminal protected amino acid or peptide building block, as 
shown in Figure 17. Homogenous reactions are known to have fully utilised the intrinsic rate of the 
reaction, with complete accessibility to the active site. The major set-back with SolPS is the inter-step 
separation of the peptide building block from post-reaction waste. Separation of a single protected 
amino acid from a low generation of protected peptide building block is not easy. Chromatography 
and crystallisation seems to be the only separation method for SolPS. It is both labour and solvent 
intensive, and is undesirable when synthesising a long sequence or for application to large-scale 
peptide production. 
 
Figure 17: Schematic representation of solution phase peptide synthesis 
As mentioned, SolPS process is fairly troublesome in synthesising long peptide sequences, but it is 
still very popular and useful in fragment condensation and chemical ligation reactions such as Native 
Chemical Ligation (NCL). In both synthesis, short sequences of peptide, typically 8 – 10 amino acids 
long are synthesized by other synthesis methods, mainly SPPS (refer to 2.2.2) follow by connecting 
these peptide fragments together to form a larger peptide sequence in solution phase.  
2.2.2 Solid Phase Peptide Synthesis (SPPS) 
Solid phase peptide synthesis (SPPS) was developed by Noble Prize winner Robert Bruce Merrifield 
in 1984 [59], [60]. Peptides were synthesized on an insoluble polymer support which contained 
reactive sites. It avoided problems associated with separation and inter-step losses. The procedure for 
SPPS is similar to SolPS, but with four distinctive steps: 
1) Attachment of protected amino acid 
2) Deprotection of amino acid 
3) Inter-step separation by microfiltration (MF) 
4) Cleavage of peptide from solid support 
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The schematic representation of SPPS is shown in Figure 18. Three of the steps are the same as 
SolPS, in which the target peptide is generated, but with an additional step that removes the peptide 
from its solid resin.  
 
Figure 18: Schematic representation of solid phase peptide synthesis 
The separation procedure for SPPS has been simplified from time consuming 
chromatography/crystallisation to rapid microfiltration washing. Washing in SPPS generates less 
solvent waste and is generally faster with excellent peptide-building block recovery. In recent years, 
the process has also been developed an automated machine-driven process, and has been used in 
many small-scale applications. Careful studies of the SPPS resin showed that the peptide grows 
beyond the surface of the solid polymeric resin but predominately within the polymeric matrix. This 
means that SPPS inherits the common disadvantages of any heterogeneous synthesis system, such as 
steric hindrance, mass transfer limitation for both reagents to diffuse into the solid matrix and by-
products to diffuse out of the matrix, hence slower reaction rate. SPPS also suffers issues with the 
solvation and swelling properties of solid resin. Other drawbacks of this technique are the cost of 
SPPS insoluble polymeric supports, which are often expensive. The type of resin applied is also 
peptide sequence dependent. For instance, most SPPS resin offers either “normal loading” (typically 
0.5 – 1.3 mmol/g resin) or “low loading” (typically 0.2 – 0.5 mmol/g resin). Low loading resin is 
generally recommended when synthesizing difficult sequence peptides, since “low loading” reduces 
aggregation or interaction between two growing peptides.  
A “linker” is often attached onto the solid resin before the first protected amino acid is coupled onto 
it. The linker serves two purposes; 1) it increases the activity of the reactive site, hence promoting the 
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coupling reaction of the first amino acid onto the linker-resin and 2) it eases the final cleavage of the 
peptide from the resin by generating a highly stable ion after cleaving the ester bond that connects the 
peptide to the insoluble support.  
The kinetics of SPPS were investigated by Gut and Rudinger [61], who showed that the reaction rate 
varies with the type of amino acid coupled, since different amino acids do have slight variations in 
reactivity caused by differences in polarity, nucleophilicity or steric effects resulting from the 
different side-chain types. Rate constants based on Pseudo-First-Order reaction are illustrated in 
Table 1, obtained for both initial and subsequent periods for the synthesis of a penta-peptide. 
According to Rudinger, the observed rate constants decrease as the reaction proceeds, which is one of 
the classic properties of heterogeneous reactions. Various sites on the resin were used up during the 
reaction therefore the site concentration decreases and causes site competition. The reduction in 
reaction rate was also affected by the hindrance effect/accessibility of the reactive site. Whilst the 
peptide grew on the resin during the reaction, it reduced the accessibility to the neighbouring site. 
This is another characteristic of heterogeneity. As the peptide chain grows the hindrance effect 
reduces, hence increasing the reaction rate. However, when the peptide chains become too long they 
have the tendency to aggregate, which again increases the hindrance effect and decreases the reaction 
rate. To overcome the problem with chain aggregation during synthesis of long peptide chains, 
chemists fashion to synthesize the peptide in smaller fragments by SPPS and connect them together 
afterward by SolPS, fragment condensation (refer to 2.2.1), which less affected by aggregation of the 
peptide chain.  
Table 1: Reaction rates of pentapeptide synthesis on a resin from Gut and Rudinger work [61] 
Rate constant, k × 104 min-1  
Conversion 
Ala Val Val Val Phe Resin 
0- 25%  - 77 60 42   
25 – 50%  - 71 56 40   
50 – 75%  - 68 49 38   
75 – 90%  5000 - 33 27   
2.2.2.1 Solvent and Swelling Properties of Peptide Synthesis Resin 
Peptides are known to grow on the inside and outside of the SPPS resin. Therefore, the solvation and 
swelling properties of the resin can affect the performance of the SPPS by reducing the accessibility 
of reagents. The use of aprotic solvents such as DMF, NMP, etc. has been proven to be critical to the 
solvation of peptide-resin [62]. It swells the peptide-resin matrix, and in the case of synthesizing 
difficult sequences, the addition of salt may be used to reduce aggregation of the peptide chain in the 
resin.  
The swelling properties of some polystyrene resins have been carefully studied by Sarin et al. [63] to 
answer fundamental questions, such as “how is the swelling of the peptide-resin affected by solvent(s) 
properties?”; “what is the maximum swelling volume for different resins?”; and “how are peptides 
distributed within the resin?”. A uniform distribution of peptide growth was observed throughout the 
resin using autoradiography, it also showed diffusion plays a major role in SPPS with protected 
amino acids because peptides are constantly transferring in and out of the resin. Traditionally, the 
“ultimate swollen volume” of a peptide-resin was assumed to be approximately the same as the 
volume of the fully swollen un-substituted resin in the given solvent. However, Sarin showed that 
while the peptide chain grows, the free volume within the resin also increases. He concluded that the 
swelling properties of the peptide-resin are a function of all components within the system rather than 
just associated with the solvent alone, as the assumption suggested. This means it is more difficult to 
predict the swelling volume than originally expected. A more complicated diffusion model is 
required to describe and predict the swelling effect. Nevertheless, one factor for sure definitely 
affecting the degree of swelling is the effect of cross-linking within the resin. Lower degree of cross-
linking would improve swelling property but would also decrease the stability of the resin.  
Taylor et al. [64] on the other hand compared the coupling reaction performance in N-
methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), dimethylaceamide (DMA) and DMF. They 
concluded that although the resin swelled well in NMP and DMSO, the solvation of peptide-resin is 
more important and the use of DMA and DMF has advantages over NMP and DMSO, such as better 
coupling yield. Taylor also pointed out that the use of different side-chain protecting groups could 
affect the solvation of the resins, hence SPPS’s performance.  
Several reviews on SPPS have been published, for instance Kent [65] and Amblard et al. [66] gave a 
comprehensive review on the application of SPPS, while Chan & White [52] give an introduction to 
the basic principles and general protocols for performing SPPS. 
2.2.3 Liquid Phase Peptide Synthesis (LPPS) 
The major difference between LPPS and SolPS is that LPPS uses a soluble polymer as the C-terminal 
protection and peptides are grown from this soluble polymeric support. As in SPPS, a linker strategy 
again applies to the LPPS. During the reaction, the polymeric support bounded with linker-peptide 
building block is dissolved into the reaction mixture. Upon the completion of the reaction, anti-
solvent is added into the mixture to precipitate out the peptide-building block, while other impurities 
such as un-reacted reactant and by-products remain in the solution phase. The peptide product can 
then be removed from solution either by micro-filtration or centrifugation, as show in Figure 19.  
 
Figure 19: Schematic representation of liquid phase peptide synthesis 
Although the separation procedure of performing LPPS still requires an intensive amount of work, it 
is still an attractive alternative peptide synthesis technique as the solvent and time consumption is 
less than in SolPS. Both LPPS and SolPS share the advantages of homogeneous reactions; including 
having faster reaction rates, being less affected by hindrance and accessibility problems, having no 
mass transfer limitations and having no polymer solvation constraints.  
The kinetics of LPPS was studied by Bayer et al. [67] with both “EDTQ” program and “formal-
integration” methods for the formation of H-Gly-Gly-Gly-O-PEG·HCl from Boc-protected glycine. 
Based on the reaction equation Boc-Gly-OH + H-peptide-PEG  Boc-peptide-PEG + waste, a 
second-order reaction rate constant was estimated for both SolPS and LPPS methods, Equation 3. 
The rate constants, k of t-butyl ester and ethyl ester of glycine synthesized in SolPS was estimated to 
be 0.24 ×10-1 mol-1 sec-1 and 0.12 ×10-1 mol-1 sec-1 respectively. These were used as control 
references to compare the kinetics of SolPS with LPPS. The first observation was these rate constants 
were much lower when compared to the coupling rate constant of n-butylamine. The k value of this 
primary amine was 2.78 mol-1 sec-1; approximately 10 times higher than the k valuve of t-butyl ester. 
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This is believed to be due to the fact that amino acids have lower nucleophilicity than primary amines. 
This provides an alternative method for removing any excess C-terminal species after the coupling 
reaction, by reacting them with a primary amine. Polyethylene glycol (PEG) was used as the soluble 
polymeric support for the kinetic studies on LPPS [67]. The rate constants for LPPS varied with the 
molecular weight of PEG used, as shown in Table 2. The difference in k values between the use of 
PEG smaller than PEG(4,000) and larger than PEG(6,000) was alleged to be due to the use of larger 
PEG resulting in an increase in solution viscosity that hindered the mass transfer within the solution.  
 
Equation 3 
Bayer [67] observed that as residues of Gly increase, so does the rate constants for both LPPS and 
SolPS. A possible explanation for this phenomenon is an increase in solubility and less constraint by 
steric effects as the peptide chain increases. This is a very interesting result indeed, considering that it 
behaves the same as SPPS for the synthesis of a short sequence; and encouraging if it still holds true 
for long sequences which behave in an opposite way to SPPS. Comparing the slowest rate of 0.12 
mol-1 sec-1 reported by Bayer with the fastest rate of 0.5 min-1 (8.3×10-3 sec-1) obtained by Rudinger 
[61] in SPPS, it is approximately 1.5 times faster, demonstrating the advantage of using LPPS in 
terms of reaction rates.  
Table 2: Rate constants for liquid phase Gly coupling on PEG from Bayer et al. work [67] 
Amine Component Rate constant, k (mol
-1
sec
-1
) Conversion (%) 
Gly-O-PEG (2,000) ⋅ HCl 0.16 × 10-1 65 
Gly-O-PEG (4,000) ⋅ HCl 0.17 × 10-1 75 
Gly-O-PEG (6,000) ⋅ HCl 0.13 × 10-1 64 
Gly-O-PEG (10,000) ⋅ HCl 0.12 × 10-1 60 
Gly-O-PEG (20,000) ⋅ HCl 0.12 × 10-1 57 
(Gly)3-O-PEG (20,000) ⋅ HCl 0.32 × 10
-1 86 
It is also worth mentioning that some researchers have tried different approaches to obtain the 
advantages of liquid phase reaction with improved separation procedure. Chiba et al. [69] explored 
the thermodynamic behaviour of two solvents by introducing a biphasic system at low temperature 
and a homogeneous phase at higher temperature. Obviously, a biphasic system is composition as well 
as temperature dependent. Many solvent systems have been investigated, including a DMF/DMA 
system, cyclohexane/nitroalkane system and many more. With the reaction being performed in a 
miscible phase, hindrance effects and solvation problems were avoided and a higher reaction rate was 
achieved as in homogeneous synthesis. Separation was performed via simple phase separation 
followed by draining the phase that contained excess reagent and wastes. This achieved the 
advantages of both SPPS and LPPS, but it requires good control of temperature and upper/lower 
layer ratios. Detailed investigation of partitioning and solubility are also essential as ineffectiveness 
at the miscible temperature was observed in several solvent systems (at certain temperature ranges 
and composition) resulting in product loss and lowering of overall yield. 
2.3 Membrane Processes in Peptide 
Synthesis 
No prior art has been found for the separation of peptides or peptide synthesis which incorporates a 
membrane separation in organic solvents. Most researchers have concentrated on the separation of 
amino acids and peptides in aqueous systems. Their common strategy was to re-concentrate peptide 
products from a biosynthesis broth or to recover un-reacted amino acids [70] - [84]. The major reason 
for no prior art being found is that most available membranes are not resistant to organic solvents 
hence membranes tend to break down before separation can be performed. The focus for applying 
membrane technology to peptide production turned to biosynthesis, where traditional NF membranes 
are well studied and the membranes are widely available.  
A few researchers did attempt to incorporate a membrane filtration system into separating peptide 
building blocks synthesized by LPPS from its post-reaction mixture. In 1972, Bayer and Mutter [85] 
published their work in Nature on separation of peptide building blocks from its reaction mixture 
using diafiltration. Their idea was to grow peptide chains on poly(ethylene) glycol (PEG) to give 
additional physical properties between mono-protected amino acid and the peptide building block 
using the Boc/Z strategy. Reaction was performed in DCM solvent using DCC as a coupling 
activator. It is followed by heterogeneous deprotection with hydrogen gas on Lead/active carbon or 
with strong HCl in acetic acid solution. DCM solvent was evaporated from the peptide mixture 
before being re-dissolved back into water and diafiltration in the aqueous phase. Water was removed 
in a vacuum before the next attachment and these procedures were repeated until the required 
sequence had been reached. The final peptide was cleaved from PEG using sodium hydroxide in 
dioxane/water mixture, and purified by chromatography.  
A similar process was patented by the company F. Hoffmann-La Roche & Co. [86] in 1972. Peptides 
were built on PEG-linker in DCM solvent with DCC and triethylamine for activation of Boc-
protected amino acid. The solvent in the post-reaction mixture was evaporated and treated with HCl 
in dioxane before adjusting pH with triethylamine and re-dissolving into water for ultrafiltration. 
Retentate from the filtration was evaporated and azeotropically distilled twice with a benzene/ethanol 
mixture to ensure trace amounts of water had been removed before the next attachment. The 
procedure was repeated until the target size of peptide was reached. 
A problem with these processes is that the solvent exchange process is complex, making the process 
impractical for industrial application. The application of membrane separation in this case led to 
constraint for the synthesis process. Even if the synthesis was successfully performed in liquid phase 
and achieved the advantages of homogeneous reaction, is the separation method really that much 
better than the traditional chromatography/crystallisation? Is it worth diverting the production method 
from the more advanced SPPS? 
Chapter 3.  
 
The Membrane Enhanced Peptide 
Synthesis (MEPS) Process 
3.2 Introduction 
An ideal peptide synthesis process would give 1) high reaction rate; 2) high product purity; 3) 
minimum reagent requirement; and 4) fast production rate (i.e. fast inter-stage separation) with 5) the 
use of a minimum amount of washing solvent. Even with decades of peptide research and 
applications, not all of these criteria were met in a single peptide synthesis process. The traditional 
SolPS gives much higher reaction rates and requires less reagent consumption compared with SPPS, 
since SolPS is less affected by mass-transfer phenomena and reaction within a confined space, and is 
less restricted by the type of solvent applied to the synthesis. In addition, in terms of scale-up, SolPS 
is much simpler and easier, without the issues relating to swelling effect and channelling within the 
solid resin, while SPPS has the advantages of a faster and easier inter-stage separation. In general, 
homogenous phase peptide synthesis has chemistry advantages whereas heterogenous phase peptide 
synthesis has the engineering/operational advantages. 
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Figure 20: Schematic representation of membrane enhanced peptide synthesis (MEPS). Peptide chain assembly 
was performed following this scheme using the apparatus presented in Figure 23 and Figure 32. 
The overall objective of this chapter was to develop a process that could meet all of the previously 
mentioned criteria. The success of this process would give both production and economical 
advantages in future large-scale peptide production. With the success of the recent applications in 
organic solvent nanofiltration (OSN), here we propose to incorporate OSN into LPPS process. This 
gives Membrane Enhanced Peptide Synthesis (MEPS) process. The demonstration of the MEPS 
process would result in a novel process that achieves the advantages of both LPPS and SPPS 
processes. 
The MEPS process is illustrated in Figure 20. Peptide chain assembly via 4 steps: 1) the coupling of 
amino acid; 2) washing out of post-reaction waste via constant volume diafiltration; 3) deprotection 
of peptide chain; 4) washing out of by-products and excess deprotection reagents. The cycle is 
repeated as many times as necessary, adding a further amino acid at each cycle, until the desire 
peptide sequence is obtained.  
3.2.1 Objective and Strategy 
The objectives of this chapter are: 
1. To understand whether any commercially available membrane is capable of separating the 
peptide building blocks from the post-reaction wastes; 
2. To evaluate whether the MEPS process is feasible: Does it require an un-reasonable amount 
of solvent to washout the post-reaction waste? Does it require a solvent exchange procedure 
as described by Bayer & Mutter [85]? 
3. To evaluate the performance of the MEPS process in terms of the product purity and yield 
and comparing them with the traditional LPPS and SPPS. 
In this chapter, both polymeric and ceramic membrane will be tested to determine the most suitable 
membrane for the MEPS process. To select a workable membrane for the MEPS process, some basic 
criteria have been devised to focus the selection process. These criteria include:  
• Good membrane stability in peptide coupling reaction and deprotection conditions; 
• High retention of peptide building block by the membrane. In order to maximise the 
production yield and minimise inter-step product loses, the rejection of the peptide building 
block has to be > 99%, ideally it has to be 100%;  
• Low retention of post-reaction waste by the membrane. To minimise the washing solvent 
consumption and increases the competitiveness of the MEPS process, the rejection of these 
post-reaction waste should be no more than 50% for the MEPS.  
Even though the selection of a membrane is important, another essential consideration is the 
synthesis strategy. This governs the type of post-reaction waste that needs to be separate, and the 
conditions require for the deprotection. The Fmoc-/Boc- strategy was chosen because it is one of the 
most commonly used strategies in modern peptide chemistry and requires a milder deprotection 
condition when compared to other strategies such as Boc-/Z-. This should give a higher chance for 
the membrane to survive in the reaction mixture during the diafiltration and a better chance for the 
success of the MEPS process.  
Many peptide synthesis procedures have been published in the past (mainly on SPPS process), but 
our attention has been concentrated on the one described by Fischer [87]. The peptide was built on 
medium molecular weight PEG to improve solubility of the peptide building block in the solvent of 
choice. For the MEPS process, this increases the molecular weight of the peptide building block, 
hence increases its rejection by the membrane and improves the selectivity between the building 
block and the post-reaction waste. Fischer [87] chose the DMF/DCM (50/50 v/v) solvent system for 
their coupling reaction. This is because PEG is highly soluble in DCM but Fmoc-amino acid has 
much lower solubility in it. While Fmoc-amino acid is highly soluble in DMF solvent, but PEG is not. 
A mixture of the two solvents would give an excellent solubility for all of the reagents. However, 
deprotection was performed in DMF solvent alone with piperidine hence solvent exchange may be 
required for the MEPS process.  
In terms of soluble polymeric support, PEG was chosen for the MEPS process because of its 
excellent solubility in the synthesis solvent and good availability of all sizes, and more importantly it 
is commonly applied in LPPS which allows an easy comparison between the two processes. More 
specifically MeO-PEG5k with molecular weight of 5,000 g.mol
-1 was chosen because it is the largest 
and most common commercially available PEG that contains a methoxy end group (MeO-). The 
presence of the MeO- group provides an internal reference for NMR analysis, and allows easy 
estimation of the loading of the linker and the first amino acid onto the polymeric support.  
With the synthesis strategy chosen, the membrane selection process is refined and the membrane 
selected must contain a number of specific characteristics. These includes 1) excellent long term 
stability in the reaction solvent – DMF (or mixture of DMF/DCM), the process also involves 
continuous switching of reaction media between the coupling step and the deprotection step and the 
membrane performance should not be affected by these changes; 2) High selectivity between the 
peptide-PEG building block and the reaction by-product and excess reagents such as un-reacted 
amino acids, activator and the deprotection reagent. The retention of the peptide-PEG building block 
is important, and its rejection should be as close to 100% as possible, but removal of the waste is also 
extremely crucial, since residual waste could lead to random sequencing. Thus the rejection of waste 
should be sufficiently low to avoid the need for a large washing volume, which would make the 
MEPS process less economically viable. But what is the wash volume required? Is the total removal 
of waste possible? Can we estimate the wash volume requires and the concentration of waste in the 
retentate at a given time? 
3.2.2 Wash Volume Estimation Model 
It is possible to estimate the washing volume and the concentration of all species in the filtration 
system at a given time, t during the diafiltration. Using a simple material balance (Equation 4) around 
the diafiltration system combines with the definitation of rejection (Equation 3 in section 2.2.3), the 
concentration of species Ci can be simulate. For the simplest model, it was assumed that 
concentration polarization has been suppressed and the MEPS process has a constant performance. 
Based on the 2 molar equivalents of synthesis reagents per 1 molar equivalent of polymeric anchor 
and assuming 100% conversion after each coupling step. Based on the washing volume per starting 
volume ratio, VPerm/PFeed, it yields Equation 5 that describes the performance of the system, Figure 21 
and Figure 22.  
 
Equation 4 
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Figure 21: Percentage of peptide building block losses from the system as a function of the wash solvent volume 
per starting solution volume estimated from material balance using different rejection of peptide building block 
There are two important facts observed from the model. Firstly, with 99% rejection of any valuable 
species, for instance the peptide building block, a 10% loss of material is expected after each 10 
volume diafiltration wash, Figure 21. This loss is too high for the MEPS process to be considers as a 
feasible process, since peptide synthesis is a “sequential synthesis” in which repeating-step of 
reaction are required before obtaining the final peptide product. Hence extremely low yield is 
expected if the rejection of the peptide building block remains at 99% or less throughout the whole 
process. Secondly, the concentration of post-reaction waste decreases quickly at the beginning of the 
wash but their concentration profile flattens and further washes become inefficient, Figure 22. This 
also suggests complete wash out of post-reaction waste will be very difficult, exposing a potential 
limitation of the MEPS process. However, this does not necessarily means that combining peptide 
synthesis with membrane separation is not feasible, since for some reactions there is a certain 
tolerance of the impurities before the reaction performance is affected. The question is whether the 
coupling reaction can tolerate a small amount of post-reaction waste before causing any racemisation? 
And what is the limit of this tolerance? Can we explore it? 
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Figure 22: Impurities remaining in the system as a function of the wash volume per starting solution volume 
estimated from material balance using different rejection of impurities 
3.3 Materials and Analytical Methods 
All Fmoc-protected amino acids, 1-hydroxbenzotriazole (HOBt), 4-hydroxymetylphenoxyacetic acid 
(HMPA), benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluoro-phosphate (PyBOP) and 
O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) activators used for 
the peptide synthesis and membrane characterisation were purchased from Merck Biosciences, 
Novabiochem (Switzerland). p-Toluenesulfonyl chloride, potassium phthalimide, hydrazine hydrate 
and pyridine used for the synthesis of methylated amino PEG and the N,N’-diisopropylcarbodiimide 
(DIC), piperidine, trifluoroacetic acid (TFA) and diisoproyl ethyl amine (DIPEA) required for the 
peptide synthesis were supplied from Sigma-Aldrich (UK). Peptide synthesis grade 
dimethylformamide (DMF) solvent purchased from Rathburn Chemicals Ltd. (UK) was used in both 
peptide synthesis and diafiltration wash. GPR graded dichloromethane (DCM), diethyl ether and 
ethanol used in methylated amino PEG synthesis were supplied from BDH Co. (UK). Acidolysis 
solution used for cleavage from support and global deprotection was made up from 
phenol/water/TFA (0.7/1/10 in w/v/v ratio). 
Ultraviolet (UV) spectrometry. A Shimadzu UV-2101 PC, scans between 200 – 350 nm was used to 
calibrate and measure the concentration of all Fmoc-protected amino acids, HMPA, HOBt, DIC, 
PyBOP and HBTU in the single component rejection experiment. 
Gel Permeation Chromatography (GPC). A Waters GPC system equipped with both Gilson 132 
refractive index (RI) detector and Waters 996 Photodiode Array detector scanning between 250 – 300 
nm, was used to measure the PEG and piperidine single component rejection as well as monitoring 
the peptide-PEG building block losses during the diafiltration. A Waters Styragel HT2 GPC column 
was used with N-methyl pyrrolidone (NMP) as the mobile phase, and operating at a constant flow 
rate of 0.5 ml.min-1 at 100°C. The yield of the MeO-PEG-peptide product was calculated according 
to Equation 6.  
Yield = 100×


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
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Equation 6 
Nuclear Magnetic Resonance (NMR) spectrometry. NMR was used to determine the structure and 
the initial progress of the peptide-PEG building block. Samples of building block such as MeO-PEG-
HMPA and MeO-PEG-HMPA-Tyr(tBu)-Fmoc were prepared in D-chloroform. The two-dimensional 
spectrum was recorded at 400MHz with the Bruker DRX-400 spectrometer and analysed with 
MestRe-C software. The loading of the HMPA linker and the conversion of the attachment of the 
first amino acid were estimated by integrating the aromatic group on the HMPA linker (6.7, d) (6.9, d) 
or the Fmoc-protection group (7.2, t) (7.3, t) (7.5, d) (7.7, d) against the reference MeO-group on 
MeO-PEG (3.4, s).  
High Performance Liquid-Chromatography (HPLC). HPLC was used to measure the final purity of 
the peptide crude product and the level of residual impurities in the post-reaction mixture during 
diafiltration wash, as well as membrane characterisation with the polystyrene oligomer. An Agilent 
HPLC system installed with an ACE C-18 reverse-phase HPLC column (250 mm × 4.6 mm) packed 
with 5 µm diameter silica particles with 300 Å pore size was operated at 25°C. For peptide purity 
analysis, water and acetonitrile (AcCN) with 0.1% trifluoroacetic acid (TFA) was used as the mobile 
phase and at a constant flow of 0.5 ml.min-1. A method with ramp from 0% AcCN to 80% AcCN in 
30 minutes, followed by 5 minutes at 100% AcCN and 5 minutes at 0% AcCN was used. UV 
detection at 210 nm was used to detect the presence of the amide bonds. For membrane 
characterisation, pre-mixed 65% Tetrahydrofuran (THF) and 35% water with 0.1% TFA was used as 
the mobile phase. A method with ramp from 1 ml.min-1 to 0.5 ml.min-1 in 5 minutes, followed by 
ramp back to 1 ml.min-1 in 30 minutes was applied. UV detection at 260 nm was used to detect the 
aromatic ring of the polystyrene oligomer.  
Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) mass spectrometry. 
MALDI-TOF was used to determine the molecular weight of the final peptide product. A Bruker 
Reflex IV MALDI-TOF mass spectrometer using infrared ionisation techniques with ionisation 
power set at 20 kV was used. The α-Cyano-4-hydroxycinnamic acid (CHCA) was used as the carrier 
matrix for the MALDI-TOF samples and was prepared in a mixture of AcCN and ethanol (ratio 1:1) 
with 0.1% TFA.  
3.4 MEPS Process with Polymeric 
Membrane 
Commercially available polymeric membranes for the OSN process includes the StarMem™ series 
from W.R. Grace (USA), SelRO™ series from Koch Membrane System Ltd. (USA) and BV series 
from SolSep (Netherlands). However, due to the un-availability of the BV membrane, no test was 
performed with this membrane. Based on the literature review, the loosest of the StarMem series, 
StarMem 240 has a MWCO of 400 mol.g-1. This would be too tight to allow most of the Fmoc-amino 
acids to pass through the membrane and so would not be able to wash out from the process. Another 
issue with the StarMem series is that these membranes are made from a polyimide that dissolved in 
the DMF solvent, which is the same process solvent used in peptide synthesis. Membrane stability 
testing showed the separation layer of the StarMem membrane dissolved almost instantly in the 
peptide synthesis mixture. Hence, it was concluded that the StarMem series would not be 
appropriate for the MEPS process. The DuraMem™ series by MET (UK) was only at its developing 
stage at the time and was not commercialised until later. 
3.4.1 Experimental Apparatus and Methods 
Experiments with polymeric membranes were preformed in a Sepa ST dead-end filtration cell 
(Osmonics, USA). There are a number of advantages of using a dead-end cell for the filtration 
experiment, such as easier manual operation procedure, but the most important advantage is that it 
has a smaller feed volume and dead volume. A smaller feed volume allows small-scale experiment to 
be performes, which helps to reduce the amount of reagent required during the initial trials. A small 
dead volume would minimise the amount of solution lost at the end of the filtration, thus maximising 
the production yield. A schematic representation of the set-up is presented in Figure 23. 
 
Figure 23: Experimental set-up of the Sepa dead-end filtration cell used for both batch rejection experiments and 
MEPS process experiments.  
The desired membrane was cut into a disc of 49 mm in diameter and fitted into the stainless steel 
filtration cell with the active side of the membrane facing toward the test solution. A stainless steel 
sinter plate was placed behind the membrane to provide mechanical support during the filtration. 
Finally, the filtration cell was closed by clamping the cell base against the body with a set of high 
pressure clamps. The maximum operating pressure of the filtration equipment was 69 bars. Due to 
the aggressiveness of the solvent used in the peptide synthesis, Perlast™ perfluoroelastomers o-rings 
supplied by Precision Polymer Engineering Ltd. (UK) were used to instead of the normal Viton® O-
rings. 
Test solution was added into the filtration cell, and pressure was applied by connecting the system to 
a pressured nitrogen cylinder. It is important for the solution to be well mixed during filtration test to 
ensure concentration polarisation has been minimised [23]. In the batch rejection experiment, 50 ml 
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of the test solution was charged into the cell and 25 ml of permeate was collected for analysis. In the 
MEPS process experiments, 10 ml of the reaction mixture was charged into the filtration cell. 100 ml 
of pure solvent was used per wash and the same volume of permeate was collected for the analysis. 
3.4.2 Koch MP-50 Composite Membrane Characterisation 
The commercial MP-50 is a composite membrane from the MP series manufactured by Koch 
Membrane Systems. It consists of a PDMS dense top-layer and a porous PAN supporting layer [13]. 
The membrane has a MWCO of 700 g.mol-1 defined by the manufacturer. Based on the protocol by 
Fischer [87] which used a mixture of DCM/DMF (1:1 ratio) for the coupling reaction and DMF 
alone for deprotection with piperidine, the MP-50 membrane was characterised by the batch rejection 
experiment with a number of peptide synthesis reagents and in different solvents and their mixture. 
The first and most important observation was that there were no changes to the MP-50 membrane in 
the three solvent systems. It suggests that the MP-50 membrane has good short term stability in these 
solvent systems, but long term stability testing is required. Permeation flux in DCM on average was 
about 130 L.m-2.h-1 and as a mixture was 120 L.m-2.h-1, while in DMF alone was only 20 L.m-2.h-1 at 
20°C and 30 bar. This difference in permeation flux is predominately caused by two reasons, firstly 
DMF (0.92 cP at 20°C) is a more viscous solvent than DCM (0.44 cP at 20°C), which generally 
decreases the diffusion across the membrane hence a lower flux; secondly many polymeric 
membranes and polymeric matrices are known to swell well in DCM [10]. The MP-50 membrane has 
a PDMS top separation layer that has been known to swell exceptionally well in chlorinated solvents. 
Swelling experiment revealed a 5.4% expansion of the MP-50 membrane in DCM, while only 0.9% 
expansion in the DMF. Both contribute greatly to the higher permeation fluxes.  
The rejection of some of the peptide synthesis reagents is illustrated in Table 3. Amino acids 
containing different N-terminal protection group in different solvent systems were examined, and in 
general Fmoc-protected amino acids showed the highest rejection when comparied with other 
protection group. It was followed by Boc-protected amino acids, and Z-protected amino acids were 
the least retained by the membrane in the case of DCM/DMF solvent mixture. While in DCM solvent, 
the Z-protected amino acids was more rejected than the Boc-protected amino acids. This could be 
due to the difference in solvent/solute and/or solvent/membrane interactions or a combination of the 
three. This is an interesting phenomenon, as the protecting group shows predominating effect on the 
properties of the amino acid. It seems the interaction between the protecting group and solvent has 
plays a major role in the transport mechanism of the molecule across the membrane.  
Table 3: The characterisation of Koch MP-50 polymeric membrane using PEGs, protected amino acids and 
reagents commonly used in peptide synthesis tested in DCM, DMF and 50%DCM/50%DMF solvent mixture at 30 
bar and 20°C 
Entry Compound MW [gmol-1] MPF-50 Membrane Rejection [%] / Error [%] 
Solvent 
DCM DMF 
DCM/DMF 
(1/1) 
1 Fmoc-Ala 311   73 / 3 
2 Fmoc-Trp 427 68 / 21 73 / 16 74 / 32 
3 Fmoc-Tyr 403 64 / 19  76 / 17 
4 Fmoc-Trp(Boc) 527   72 / 13 
5 Fmoc-Tyr(tBu) 460   73 / 8 
6 Z-Trp 338 59 / -  26 / - 
7 Z-Tyr 315 40 / -  57 / - 
8 Boc-Trp 304 20 / -  66 / - 
9 Boc-Tyr 281 35 / -  60 / - 
10 DIC 126   24 / 9 
11 HOBt 135   42 / 2 
12 HBTU 379   91 / 8 
13 PyBOP 520   98 / 10 
14 HMPA 182   65 / 27 
15 Piperidine 85  9 / 25  
16 PEG-Dendrimer 2000   98 / 3 
17 PEG 3000 97 / 10 96 / 8 92 / 5 
18 MeO-PEG 5000   99 / 13 
Results also showed the rejection of amino acid in pure DCM solvent was lower than in DMF or in 
their mixture. This can be explained by the higher degree of swelling in DCM and lower viscosity 
when compared to the DMF, which gives faster diffusion of the solute. Similar rejections were 
observed with the acidic Fmoc-Tyr and the basic Fmoc-Trp (both unprotected) (Table 3, entry 3 and 
4 respectively) and with the smaller hydrophobic Fmoc-Ala (Table 3, entry 1) in DCM/DMF (1:1) 
solvent mixtures. This again suggests that the nature of the N-terminal protecting group dominates 
the physical properties of the amino acid and governs its rejection. This is quite different from the 
results reported in an aqueous systems, where the rejection of the amino acid strongly depends on the 
nature of the amino acid, such as its acidity, basicity and hydrophobicity, as well as the filtration 
conditions i.e. the operating pH and ionic strength [70], [90]. This domination can be rationalised by 
attaching a large hydrophobic group onto a small ion. The effect of the molecular charge is 
suppressed by probable shielding and group contribution of the larger Fmoc-protecting group, 
especially the effect of deprotonation in organic solvent is not the same as in polar protic solvents 
such as in water. The steric effect of the Fmoc-group becomes more important in this case and the 
relationship between solute structure and its permeability through the membrane has been studied by 
many researchers [71], [91] - [95] . Nevertheless, the rejection of the Fmoc-protected amino acids 
were very high and referring back to the wash-out curve in Figure 24, it suggests even 10 volume 
washes will only reduce the level of Fmoc-amino acid to < 10% of the initial concentration, which is 
likely to be too high for the MEPS process. 
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Figure 24: The wash-out profile of peptide-building block and impurities from the post-reaction mixture based on 
rejection data from characterisation of MP-50 membrane 
The rejection of the traditional DIC coupling reagent (Table 3, entry 10) and HOBt, racemisation 
suppressor (Table 3, entry 11) were measured in DCM/DMF solvent mixture. Results shows both 
have low rejection by the MP-50 membrane. This was expected since both molecules are much 
smaller and less hindered in structure when compared to the Fmoc-amino acid. The rejection of the 
Fmoc-deprotection reagent, piperidine (Table 3, entry 15) was measured in DMF and the results 
shows almost no retention of this molecule. Furthermore, the MP-50 membrane shows some 
resistance to the piperidine in DMF solvent, although long term stability remains a question, the MP-
50 membrane demonstrated its stability in the presence of a strong organic base in organic solvent. 
Sadly, the rejection of coupling reagent, HBTU and PyBOP were both extremely high, suggesting 
these coupling reagents will not be ideal for the MEPS process using MP-50 membrane as the 
separation membrane. Their high rejection is presumably due to the fact that these activators are very 
bulky salts hence both steric hindrance and Donnan’s effects contribute greatly to their retention. 
Rejection of the HMPA linker was also measured to determine the possibility of starting the MEPS 
process from synthesis step 1 – the attachment of the linker onto the soluble PEG support. Result 
from Table 3 showed 65% rejection of HMPA, and it is possible to incorporate step 1 into the MEPS 
process. The rejection of the soluble support, MeO-PEG5k only reached 99% (Table 3, entry 18) but 
with the attachment of HMPA the rejection of the MeO-PEG-HMPA is likely to increases to 100%.  
Three different polymeric supports were tested (Table 3, entry 16 – 18) and none of them gave 100% 
rejection, even their molecular weight were much bigger than the MWCO of 700 g.mol-1 quated by 
its manufacturer. Linear PEG may not be the best soluble support for the MEPS process, since its 
shape might allow it to “worm through” the membrane. While the lower molecular weight, globular 
shaped PEG-Dendrimer showed compatible rejection with the MeO-PEG5k, which demonstrates the 
dominating effect of steric hindrance over molecular weight.  
In conclusion, the MP-50 membrane provided some insight on how peptide synthesis reagents likely 
to behave with polymeric membrane. It demonstrated that 1) the N-terminal protection group plays a 
dominant role in the rejection of the amino acid by the membrane; 2) the uronium and phosphonium 
coupling reagents will be a challenge for the MEPS process, and can be uses as the “marker” for 
quick screening test to identify a feasible membrane for the MEPS process; 3) Large and bulky 
supports such as dendrimers will be better rejected by the membrane than linear supports; and finally 
4) due to the high rejection of Fmoc-amino acids it is concluded that the MP-50 membrane is not 
suitable for the MEPS process. This meant no commercial organic membrane was available for the 
MEPS process and the search continue for a feasible membrane for the process. 
3.4.3 Cross-Linked Polyimide Membrane Characterisation 
A newly cross-linked asymmetric polyimide membrane was developed from our research group at 
the time [97], here coded as PI001YST. The stability of this membrane was tested in pure DMF 
solvent and in DCM/DMF (1:1) solvent mixture. The PI001YST membrane showed resistance in 
both solvent systems, which was encouraging for the MEPS process. For characterisation of the 
membrane, after learnt from the MP-50 membrane experiment, the strategic approach was refined for 
a faster membrane characterisation process, using mainly the larger Fmoc-Tyr(tBu), PyBOP activator 
and MeO-PEG5k as the “marker” for the membrane selection. This does not complete the membrane 
characterisation but will provide information regarding the feasibility of applying this membrane for 
the MEPS process. For the feasible membrane, a complete characterisation can be easily performs 
after proving the principle of the MEPS process.  
Table 4: The chatacterisation of the PI001YST cross-linked polyimide membrane using for PEGs, protected amino 
acids and reagents commonly used in peptide synthesis tested in DMF and 50%DCM/50%DMF solvent mixture at 
30 bar and 20°C 
Entry Compound 
MW 
[gmol-1] 
PI001YST Membrane Rejection [%] / Error [%] 
Solvent DMF DCM/DMF 1/1 
1 Fmoc-Tyr(tBu) 403  5 / 7 
2 DIC 126  21 / 13 
3 HOBt 135  30 / 1 
4 PyBOP 520  55 / 2 
5 HMPA 182  20 / 3 
6 Piperidine 85 7 / 35  
7 PEG-Dendrimer 2000  97 / 7 
8 MeO-PEG5k 5000  100 / 6 
The rejection of Fmoc-Tyr(tBu) and MeO-PEG5k (Table 4, entry 1 and entry 8 respectively) were 
measured. The low rejection of Fmoc-Tyr(tBu) and 100% rejection of MeO-PEG5k suggested that the 
PI001YST membrane was a promising membrane for the MEPS process. The rejections of DIC and 
HOBt were determined (Table 4, entry 2 and entry 3 respectively), and these rejections were higher 
than Fmoc-Tyr(tBu), which was different when compared to the MP-50 membrane. Nevertheless, 
these rejections were low and were encouraging to start the MEPS process. The rejection of PyBOP 
was also measured (Table 4, entry 4) and although it was slightly higher than the criteria of 50%, 
however based on the wash-out profile in Figure 25, it shows that it could still be wash out efficiently 
by the MEPS process. In addition, the PI001YST membrane showed some stability in the 
piperidine/DMF system. This allows the rejection of piperidine to be measured (Table 4, entry 6) and 
the result suggested that the membrane almost has negligible rejection for the piperidine in DMF.  
However, the rejection of PEG-Dendrimer showed the opposite effect to the MP-50 membrane and 
has a lower rejection than the linear MeO-PEG5k. The difference may be caused by the additional 
functional on the PEG-Dendrimer surface (approximately 22 hydroxyl group) when compared with 
the MeO-PEG (exactly one hydroxyl group), which changes the physical properties as well as the 
membrane/solute interaction and gives different rejection profit and membrane performance.  
In conclusion, the cross-linked polyimide membrane, PI001YST, demonstrated stability in peptide 
synthesis solution and showed to have an excellent selectivity between the post-reaction waste and 
the soluble support that will be used for the peptide synthesis. With these great encouragement MEPS 
process was performed with the PI001YST membrane. 
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Figure 25: Wash out profile of peptide-building block and impurities from post-reaction mixture based on 
rejection data from characterisation of PI001YST membrane  
3.4.4 MEPS Process with Cross-Linked Polyimide Membrane 
A simple penta-peptide with repeating units, H-Tyr-Ala-Tyr-Ala-Tyr-OH, was used as a model 
peptide and synthesized to prove the concept of the MEPS process. This sequence was chosen in 
order to include one of the largest protected acidic amino acids, Fmoc-Tyr(tBu) and one of the 
smallest protected hydrophobic amino acids, Fmoc-Ala. For the first attempt, it was hoped to obtain 
information on the performance of the MEPS process with respect to different molecular sizes and 
properties of amino acids.  
Both PyBOP and DIC were used in the MEPS process. PyBOP was chosen as the main coupling 
reagent for amide bond formation. Since it is among the most effective commonly used activator and 
is the largest of the commercially available activators, it represents a challenge for the MEPS process. 
DIC was used to attach the first amino acid onto the solution support, MeO-PEG-[linker] via 
esterification. This gave insight into how both activators behave during the diafiltration, where their 
post-reaction forms could perform differently to the original compounds. It also sought to answer the 
question about the membrane stability at high concentration of organic base (piperidine) during the 
deprotection step and the potential of membrane fouling during the process operation that may result 
from the membrane-peptide or membrane-reaction mixture interactions.  
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Figure 26: MeO- PEG-NH2 synthesis proposed by Pillai et al. [101] 
The hydroxyl functional group (HO-) on the MeO-PEG has limited reactivity hence was likely to 
restrict the conversion of attaching the HMPA linker directly onto the MeO-PEG. Therefore the HO- 
group on the MeO-PEG was transformed into amine group (H2N-) before attaching the HMPA linker. 
A common transformation route proposed by Pillai et al [101] is illustrated in Figure 26. The HO- 
group was first substituted via tosylation, Figure 26 (1), followed by a second substitution into 
phthalimide, Figure 26 (2), and finally into MeO-PEG-NH2 Figure 26 (3) by ring opening of the 
phthalimide. For detailed procedures refers to section 8.5. Although Fischer [87] reported 80% 
conversion of HO- group to H2N- group, repeating this synthesis route showed a large variation in 
conversion from 80% to 0%. This difference in the conversion was likely caused by its complex 3-
steps transformation procedure, especially the moisture sensitive first step to generate the MeO-PEG-
tosy, Figure 26 (1). This explained the lower conversion of step 1 in Table 5.  
A control sample of the H-Tyr-Ala-Tyr-Ala-Tyr-OH was synthesized by LPPS for the comparison of 
the process performance with the MEPS process. The yield of the LPPS was monitored based on 
mass recovered after each step while the MEPS were monitored through GPC analysis of permeate. 
Rejection of the peptide-building block can also re-estimated by analysing the concentration of 
peptide building block in the permeate. Although the result from Table 4, suggest that the rejection of 
MeO-PEG was 100%, during the MEPS process the rejection of MeO-PEG-HMPA (Table 5, step 1) 
and MeO-PEG-HMPA-Tyr(Bu) (Table 5, step 2) were only 98.6% and 97.1 % respectively. These 
lower rejections were suspected to be caused by changes in the hydrophobicity of the building block, 
hence its interaction with the cross-linked membrane. Polymeric OSN membranes are generally 
considered to be hydrophobic, unless post treatment modifies their properties. Thus usually allows a 
more hydrophobic molecule to pass through the membrane by absorption effect, when comparied to a 
hydrophilic molecule with the similar size and structure. MeO-PEG is a fairly hydrophilic polymer, 
but as components such as the HMPA linker or the protected amino acids are attached onto it, its 
physical properties changes. For instance MeO-PEG has solubility of < 150 g.L-1 in DMF at 25°C but 
once converted into MeO-PEG-HMPA it solubility increases to ≈ 300 g.L-1 at 25°C. Similar 
behaviour was observed between step 5 to step 8. The rejection of the peptide building block 
increased as more amino acids were attached onto it hence the rejection of the building blocks at step 
6 and step 8 were 100%, and so were its recovery which gave the same amount of yield for these 
steps. However, the deprotected building block showed lower rejection hence lower yield. Results 
from Table 3 suggested that the size of the protection group affects the rejection of the amino acid 
and it seems that the size and bulkiness of the Fmoc- group has again plays an important role in the 
retention of building block.. 
The yield from the LPPS continuously decreased over the synthesis. The main causes for the 
reduction came from material loses during precipitation and solid handling. An important observation 
was that the uses of DCM helps in dissolving the MeO-PEG5k support and its derivatives. However 
when precipitating out the peptide-building blocks during the inter-step separation, DCM kept the 
building block in solution and even when an excess amount of ether was used at low temperature 
some loses were still observed.  
The permeation flux during the MEPS process was approximately 90 (±10) L.m-2.h-1 for all steps up 
to step 8. A much higher flux was observed (140 L.m-2.h-1) during the diafiltration of step 9 and a 
sudden increase in concentration of the peptide building block in permeate, suggests that the 
PI001YST was degraded during the separation. The peptide building block was recovered by 
reconcentration of the synthesis solution using the MP-50 membrane followed by precipitation. It 
was decided to complete the remaining peptide sequence by the LPPS method and analyse the purity 
and sequence of the final product. This would give information regarding the progression of the first 
4 amino acids attached (up to step 8) using the MEPS process.  
 
Table 5: The performances of the MEPS process with PI001YST membrane and thetraditional LPPS. 
Theconversion estimated by 
1
H-NMR analysis and product yield approximated by mass-balances after each 
synthetic step. Notation of (L) representing attachment of HMPA Linker; (Co) representing coupling of Fmoc-
amino acid; (D) representing deprotection of the Fmoc- group and (Cv) representing cleavage of peptide from 
soluble anchor 
Separation Method MEPS LPPS 
Synthetic step Yield* 
[%] 
Conversion 
[%] 
Solvent 
used** 
[L.g-1] 
Yield* 
[%] 
Conversion 
[%] 
Solvent 
used** 
[L.g-1] 
Step 1 (L) 86 50 0.74 82 50 0.72 
Step 2 (Co) 61 100 0.95 77 100 0.69 
Step 3 (D) 58 100 1.04 66 100 0.75 
Step 4 (Co) 54  1.07 55  0.75 
Step 5 (D) 47  1.26 51  0.95 
Step 6 (Co) 47  1.26 42  0.82 
Step 7 (D) 41  1.24 41  1.05 
Step 8 (Co) 41  1.24 37  1.20 
Step 9 (D) -   20  2.18 
Step 10 (Co) -   18  2.34 
Step 11 (D) -   16  2.46 
Step 12 (Cv) -   13   
*The yield is calculated as a percentage from the starting material in step 1 
**The amount of solvent is calculated per g of the dry product obtained at each step 
The purity of the final product was analyzed by HPLC and is illustrated in Figure 27. The purity of 
the H-Tyr-Ala-Tyr-Ala-Tyr-OH product synthesized by the MEPS process was estimated to be 
80.5%, excluding the peaks that came after 20 minutes (peaks 4 and 5) which were identified as the 
PEG polymeric support. Peak at 8 minutes was identified as the phenol scavenger. Peptide products 
were separated by preparative HPLC and each fraction was analysed by MALDI-TOF to identify 
their molecular weights. The MALDI-TOF analysis, Figure 28 suggested that the major peak was the 
target product H-Tyr-Ala-Tyr-Ala-Tyr-OH (peak 3) (MH+ = 650 g.mol-1, MNa+ = 672 g.mol-1 and 
MK+ = 688 g.mol-1) and the minor peak as the single deletion of Ala (peak 2) (MH+ = 579 g.mol-1, 
MNa+ = 601 g.mol-1 and MK+ = 617 g.mol-1). Even though the peptide purity was not 100%, the 
result was encouraging as it showed no sign of “random sequencing”. The “deletion sequencing” 
impurity was likely due to inexperience with the peptide synthesis procedure. The results also 
signified that diafiltration with 10 wash volumes/starting volume for each coupling step and 12 wash 
volumes/starting volume for each deprotection step is sufficient to eliminate traces of post-reaction 
waste and piperidine from the system and prevent undesirable coupling to occur. The cause of the 
unidentified mass at 440 and 442 was unknown, but it appeared in all MALDI-TOF samples 
including with the solvent blank.  
 
Figure 27: HPLC analysis of peptide crude peptide product from MEPS and LPPS processes. Peak 1 was 
identified as phenol residue used as scavenger during the cleavage step; Peaks 2 and 3 were identified as peptide 
product and peaks 4 and 5 were PEGylated impurities.  
 
Figure 28: MALDI-Tof mass spectrometry analysis of peptide crude product, with a) sample equivalent to peak 2 
from Figure 27; and b) sample equivalent to peak 3 from Figure 27 
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Many attempts were made to reproduce the original PI001YST membrane, which had been fabricated 
using the 16% weight P84 PI, 2% PVP additive with 1:3 DMF to 1,4-dioxane solvent ratio membrane 
formulation. Unfortunately, the development of the cross-linked PI membrane was still at an early 
stage and so it was not possible to reproduce this membrane within the research group. This was a 
set-back and alternative membranes were investigated. Although the original PI001YST membrane 
could not be reproduced, a similar cross-linked polyimide membrane (code 22WP84PP10J001) was 
made and was used for long-term stability testing. The set-up of the soaking stability experiment is 
illustrated in Figure 29. The experiment was performed for over 30 days at 30°C. Strips of the 
membrane samples were taken from the deprotection mixture and from the control (DMF solvent) for 
FTIR-ATR analysis in every 2-3 days. Sample strips were cleaned by gentle pressed with a smooth 
paper towel followed by rinsing and soaking in methanol for 5 minutes. The cleaning procedure was 
repeated 3 times to remove traces of DMF solvent and piperidine in the membrane, before it was 
drying in a fume cupboard and analysed.  
 
Figure 29: Stability experiment of the cross-linked poly(imide) membrane. Strips of PI membrane were cut out 
from a single sheet of cross-linked PI membrane and soaked in 20% piperidine/DMF deprotection mixture and 
pure DMF control solutions at 30°C for 30 days 
The FTIR-ATR Spectrum of the 22WP84PP10J001 membrane is presented in Figure 30. The two 
key wave numbers here are 1,643 cm-1 and 1,538 cm-1, which corresponds to C=O and C-N bonds in 
the amide system [97]. Both signals seem to remain in the FTIR spectrum over the experimental 
period, suggesting the presence of an amide bond. No appearance of 1,718 cm-1 and 1,780 cm-1 for 
the C=O bond and 1,351 cm-1 for the C-N bond in the imide ring indicate the cross-linking of PI was 
not reversed. No changes were observed in the FTIR spectrum of the cross-linked PI membrane after 
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48 hours, suggesting no degradation occurs with the cross-linked PI membrane. This was supported 
by the constant performance at the beginning of the MEPS process. However, after 264 hours the 
transmission signal at 1,614 cm-1, 1,442 cm-1, 1,276 cm-1, 1,124 cm-1 and 1,091 cm-1 began to 
decrease. The decreasing signal at 1,614 cm-1 corresponded to an increasing concentration of free H-
N groups, while the other decreasing transmission wave number at 1,442 cm-1, 1,276 cm-1, 1,124 cm-1 
and 1,091 cm-1 corresponds to piperidine [98].  
 
Wave Number (cm
-1
)
10001200140016001800
10001200140016001800
T
ra
n
s
m
is
s
io
n
 (
%
)
DMF Control
48 hours
120 hours
264 hours 
360 hours
480 hours
600 hours 
768 hours
 
Figure 30: Stability test of the cross-linked polyimide membrane, 22WP84PP10J001 using FTIR-ATR analysis.  
Based on the FTIR-ATR analysis here, two hypotheses were proposed. Membrane degradation was 
caused by either 1) simple absorption of piperidine which is physically bonded onto the cross-linked 
polymer structure by weak interaction and it modified the physical properties of the membrane 
without breaking the cross-linking bond; or 2) nucleophilic substitution occurs with piperidine acting 
as a nucleophile and attacking the amide bond that interconnects the polyimide chains. This 
disconnected cross-linking network in the polyimide and the polymer redissolves back into the DMF. 
The proposed degradation mechanism for the cross-linked PI membrane under high concentration of 
piperidine in DMF is illustrated in Figure 31. 
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Figure 31: Proposed degradation mechanism of cross-linked PI membrane by piperidine 
Both hypotheses would lead to an increase in the concentration of free H-N bond and the presence of 
piperidine signals within the membrane. However, the first hypothesis is less likely since methanol is 
known to be able to swell the membrane and allow good diffusion of solute into or out-of the 
membrane and with multiple washing procedures I am confident that trace amount of piperidine 
should be removed. Furthermore, pitting was observed on the surface of the membrane when the 
cross-linked membrane was soaked for > 1 month. The best evidence for the second hypothesis is to 
locate the FTIR transmission signals of the benzoylpiperidine substituent generated from the 
substitution reaction. However, due to the similarity in structure, the wave number corresponding to 
the benzoylpiperidine [99] (1,630 cm-1, 1,575 cm-1, 1,440 cm-1  and 1,275 cm-1) are located at similar 
wave numbers as for both amide bond from the cross-linking and piperidine itself. Therefore, there is 
no strong evidence to support the second hypothesis over the first. 
3.5 MEPS Process with Ceramic 
Membrane 
Commercially available ceramic membranes for OSN purposes include the ZrO2/TiO2 ceramic 
membrane from Sterlitech Crop. (USA), the TiO2 ceramic membrane from TAMI industries (France) 
and the Inopor series from Inopor GmH (Germany). The MWCO of the ZrO2/TiO2 ceramic 
membrane from Sterlitech is claims to be 1,000 g.mol-1 with a mean pore size of 1.4 µm. However, 
characterisation of this membrane using PEG in DMF showed the rejections of PEG with molecular 
weight of 3,000 g.mol-1 and 8,000 g.mol-1 were only 62% and 85% respectively. Therefore, it was 
concluded that the ZrO2/TiO2 membrane from Sterlitech was not applicable to the MEPS process due 
to low retention of the polymeric support.  
The TiO2 membrane from TAMI, [100] has a very similar specification to the ZrO2/TiO2 membrane 
from Sterlitech. The MWCO of the TiO2 membrane given by TAMI was also 1,000 g.mol
-1. Due to 
the similarity between the two membranes, it was assumed that the TAMI membrane would give 
similar performance to the Sterlitech membrane. Meanwhile, a ceramic OSN membrane that met the 
process requirements mentioned in section 3.2.1 was identified. This membrane is the Inopor 
zirconium oxide (ZrO2) coated membrane using alumina (Al2O3) supporting layer with a mean pore 
size of 3 nm and hydrophobic surface modification from Inopor GmH.  
3.5.1 Experimental Apparatus and Methods 
The Inopor ZrO2/Al2O3 membrane came with its unique housing and a cross-flow filtration rig was 
constructed to adapt this housing system. The schematic representation of the filtration rig is 
illustrated in Figure 32. The Inopor cross-flow system was pressure-up in the same manner as the 
Sepa dead-end filtration system, by feeding pressured nitrogen gas into the “Reaction Vessel” where 
test solution was fed. A gear pump was used to circulate test solution between the “Reaction Vessel” 
and the “Membrane Housing”. Due to the aggressiveness of the peptide synthesis condition, Perlast® 
perfluoroelastomers o-ring were used for the sealing of the membrane.  
 
Figure 32: Experimental set-up of the Inopor cross-flow filtration rig that used for both batch rejection 
experiment and MEPS process experiment. 
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Batch rejection experiments were performed for the characterisation of the Inopor ZrO2/Al2O3 
membrane using peptide synthesis reagents. The experimental setup is represented by the solid lines 
in Figure 32. 200 ml of test solution was charged into the “Reaction Vessel” and 100 ml of permeate 
was collected for analysis. Unlike the previous MEPS example with the polymeric membrane, MEPS 
process with the Inopor ZrO2/Al2O3 membrane was performed with constant volume diafiltration 
(CVDF). The dashed line in Figure 32 represents the additional units requires to feeds in fresh 
solvent for the CVDF. Operates with CVDF theoretically has the advantages of less manual operation 
(moving toward an automated system); steadier filtration performance in terms of permeation flux 
and rejection; and minimising fouling/concentration polarisation. Both coupling and deprotection 
reactions were performed in the “Reaction Vessel” and continuous circulation provides the mixing 
require for these reactions. The system was pressurised to 7 bar (max. pressure 15 bar) when the 
reaction was completed. Fresh DMF was pumped into the system to replace the permeation and 
maintaining a constant liquid volume within the “Reaction Vessel”.  
 
 
3.5.2 Inopor ZrO2/Al2O3 Membrane Characterisation 
The MWCO of the ZrO2/Al2O3 membrane provided by the manufacturer was useful, but as shown 
previously membrane performance is not always in agreement with the MWCO when applied to a 
real chemical process. Therefore, it was essential to characterise the membrane following the process 
specification. A number of techniques were employed to characterise this ceramic membrane, 
investigating both membrane structure and performance. This provided a better understanding of this 
membrane and its separation performance. 
3.5.2.1 Scanning Electron Microscope (SEM) 
SEM analysis was performed on the cross-section of the Inopor ZrO2/Al2O3 membrane. As shown in 
Figure 33, the ceramic membrane itself comprises a multilayer structure. Although the actual 
composition is unknown, literature reviews have identifies similar structure to Figure 33 often 
produces from multi-step sintering method. Sections (f), (d) and (c) are most likely Al2O3 supporting 
layers, which was sintered first with various sizes of particles. The much denser layer shown in 
section (b) is expects to be the ZrO2 separation layer and the ultra-thin top layer shown in section (a) 
is the hydrophobic polymer layer that grafted on by post-treatment of the membrane. 
 
Figure 33: SEM image of Inopor ZrO2/Al2O3 ceramic membrane. The actual composition of the Inopor 
ZrO2/Al2O3 membrane was unknown but the image reveals the membrane consists of a multilayer structure. 
3.5.2.2 Rejection Curve Characterisation 
Besides developing new cross-linked membranes, our research group had also been investigating 
ways of characterising the performance of membrane. There are many different ways has been 
reported for membrane characterisation, from using ionic dyes to protein or sugar. Each has its own 
advantages and disadvantages. A detailed summary can be found in different reviews [90], but 
recently See-Toh [21] has described a more efficient way for characterising polymeric membranes 
using polystyrene (PS) oligomer to generate a characterisation curve rather than a single rejection 
point. It was decided to apply the same characterisation method for the Inopor ZrO2/Al2O3 membrane. 
Even though the rejection curve does not always necessarily reflect the solute’s rejection, it would 
give some idea of the membrane performance and speeds-up the membrane selection process. The PS 
characterisation technique described covering the molecular range between 200 g.mol-1 to 1,200 
(a) (b) (c) (d) (f) 
g.mol-1. For characterisation beyond this molecular weight we had used polyethylene glycol (PEG) 
with various molecular weights.  
As expected the Inopor ZrO2/Al2O3 demonstrated excellent stability in DMF solvent. The MWCO of 
the Inopor ZrO2/Al2O3 membrane in DMF was estimated to be 2,000 g.mol
-1 (Figure 34), which was 
in agreement with the MWCO provided by its manufacturer which characterised in water. It 
suggested that the MWCO was not affected by the use of different solvents. This is different when 
compared to polymeric membranes and it is because ceramic membrane does not swell in organic 
solvents, hence the structure remains independent of the solvent, and the molecular transport 
mechanism is not affected. The end point of the PS curve met nicely with the starting point of the 
PEG curve, which was least expected. PEG is often appeared to be less rejected than PS when the 
same characterisation method was employed with a polymeric membrane. This was believed to be 
due to the steric effect of the aromatic group on the PS helps the retention of the oligomer by the 
polymeric membrane. However, that was not the case in Figure 34, which suggests that there could 
be other factors causing the higher rejection of PS compared with PEG. For instance, the physical 
properties of the aromatic group will affects the interaction between solute and membrane, or any 
effects of the group on the aggregation of the oligomer; etc. This brings the actual molecular 
transport mechanism of polymeric and ceramic membranes into questioning.  
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Figure 34: Characterisation of Inopor hydrophobic ZrO2/Al2O3 ceramic membrane in DMF using polystyrene 
oligomers mixture (PS) and different molecular weight of poly(ethylene glycol) (PEG).  
3.5.2.3 Batch Rejection Experiment 
As mentioned in the previous section, there are a number of factors that affect the rejection of a 
molecule by the membrane. This includes the molecular size (usually referred to as its molecular 
weight), the molecular shape/steric affects, charges on the molecules and on the membrane’s surface, 
hydrophobicity, etc. Characterisation with PS and PEG would only give an estimation of how the 
membrane behaves with respect to molecular size. It is important to investigate the rejection with the 
target molecule(s) in order to have a clearer understanding on the behaviour of the membrane, before 
deciding whether a particular membrane is feasible for the MEPS process. Batch rejection 
experiments were preformed in DMF solvent with a number of Fmoc-protected amino acids, PEGs 
and reagents commonly used in peptide synthesis, and the results are illustrated in Table 6.  
The Inopor ZrO2/Al2O3 membrane exhibited 99% rejection for both MeO-PEG5k and MeO-PEG5k-
[HMPA]. As alluded to previously, even a rejection of 99% would still result in approximately 10% 
losses of peptide building block per inter-step wash, based on the 10 wash volumes per reaction 
volume assumption. However, the rejection of the building block was expected to increase to ≈100% 
as the sequential synthesis progresses due to the molecular size of peptide building block increases 
and the structure of becomes more steric hindered.  
The choice of Fmoc-amino acids used for the characterisation covers a wide range of properties, 
including one of the lowest MW amino acids and the highest MW amino acid, acidic, basic and 
hydrophobic amino acids and some of the most frequently occurring amino acids in protein. The 
rejections of the Fmoc-protected amino acids (Table 6, entry 1 – 9) by the Inopor ZrO2/Al2O3 
membrane appear to be dependent on the character of the side-chain protection group. For the Fmoc-
protected amino acids that do not contains any Boc-side chain protection the rejections are between 
40 – 50%. While Fmoc-amino acid with Boc-side chain protection exhibits rejection within the range 
of 60 – 70%. In general, the rejection increases by 10% per Boc-group regardless of the nature of the 
amino acids. This behaviour is similar to that observed with the polymeric membranes. The possible 
explanation is that these protecting groups are bulky and hydrophobic and governs the transport 
mechanism through the membrane, as mentioned in section 3.4.2.  
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The rejection of the coupling and deprotection reagents was also investigated (Table 6 entry 10 – 16). 
Results showed PyBOP and HBTU both exhibit relatively high rejection by the membrane, mostly 
due to the fact that they are bulky salts so both steric hindrance and Donnan effects would contribute 
to their retention by the membrane. Fortunately, during the coupling reaction these reagents will 
break down into smaller molecules hence their post-reaction rejection is expected to be lower. The 
traditional DIC coupling reagent showed very low rejection of 13%. Similarly with piperidine, the 
deprotection reagent for the Fmoc-protection group was rejected only 5%. This is expected since both 
molecules are small and non-branched, and should permeate easily through the membrane, which 
allows fast removal from the system and reduces of the solvent wash require.  
There are two types of HOBt racemisation suppressor available on the market, one is crystalline flake 
HOBt (Table 6, entry 11), the other is a wet powder HOBt·H2O (Table 6, entry 12). Both behave 
similarly during the coupling reaction, but the moisture content seems to affect the rejection of the 
HOBt by the membrane. The Inopor ZrO2/Al2O3 membrane used here had been surface modified to 
be hydrophobic. From experience the presence of water tends to affect the performance of this 
membrane. Hence the most probable causes of the difference in rejection between the HOBt comes 
from the interaction between the water and the membrane. The use of PyBOP or HBUT does not 
require addition of HOBt [102]. The rejection of HOBt that breaks off from these coupling reagents 
during the coupling reaction is expected to be low, since it is free of moisture. The rejection of 
HMPA linker was also investigated (Table 6, entry 15) to evaluate the possibility of incorporating 
step 1 – the attachment of linker onto the MeO-PEG, into the MEPS process. Its rejection by the 
membrane was relatively low at 39% but because the rejection of MeO-PEG5k-[HMPA] was only 
99%, therefore it was concluded that it is not feasible to incorporate Step 1 into the MEPS process.  
The estimating wash-out curve of the Inopor ZrO2/Al2O3 during the MEPS process is illustrated in 
Figure 35. The two reagents that exhibit the highest rejections are the largest activator, PyBOP and 
the largest protected Fmoc-amino acid, Fmoc-Arg(Boc)2. The wash-out curve suggests the 
concentration of most reagents remaining in the system after 10 solvent wash volumes were 
negligible, while the concentration of these largest reagents falls below 3% of the starting 
concentration. For PyBOP, traces amount of reagents remaining within the system are not likely to 
cause too much concern, but with Fmoc-Arg(Boc)2, extra precautions should be taken into account to 
avoiding racemisation caused by insufficient washing. Despite the high excess of piperidine used in 
the deprotection step (∼40 equivalents) due to its low rejection of ∼5% it is relatively easy to wash it 
out and 10 – 12 wash volumes was sufficient to completely remove it from the system.  
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Figure 35: The wash-out profile of peptide-building block and impurities in the retentate using Inopor ZrO2/Al2O3 
ceramic membrane 
3.5.2.4 MEPS Process with Inopor ZrO2/Al2O3 Membrane 
Two penta-peptide sequences were synthesized as the examples for the MEPS process. To prove the 
concept we started with the simpler H-Tyr-Ala-Tyr-Ala-Tyr-OH model peptide. It provided 
information regarding the membrane’s long-term stability in the reaction mixture, including 
concentrated piperidine solution, which is believed to have caused the cross-linked polyimide 
membranes to degrade; also the potential of membrane fouling or dramatic changes in rejection due 
to membrane-peptide or membrane-post-reaction mixture interaction. PyBOP was again chosen as 
the coupling reagent for the amide bond formation in the MEPS process and DIC was used for the 
esterification that links the first Fmoc-amino acid onto the MeO-PEG-[HMPA]. The wash volumes 
were set at 10 wash volumes per starting volume for each coupling reaction and 12 wash volumes per 
starting volume for each deprotection reaction. The bigger wash volume after the deprotection step 
would ensure complete elimination of piperidine from the system and prevent undesirable reactions 
from occurring.  
Gel permeation chromatography (GPC) results showed the rejection of the MeO-PEG-peptide to be 
>99.7% after the first and the second amino acid attachment, and 100% for the later attachments. 
This was expected since the sequential synthesis progresses the peptide building block grows larger 
and the membrane separation method becomes more favourable. The permeation flux of 27 – 30 Lm-
2L-1 at 7 bar operating pressure was achieved, it is comparable with fluxes obtained during the 
rejection of individual compound experiment. This suggests no membrane fouling or significant 
concentration polarization [23] had occured. A higher permeation flux is achievable simply by 
increasing the operating pressure and/or using a multi-channels membrane module to increase the 
membrane area, making the washing step even more time efficient. The purity of the final H-Tyr-
Ala-Tyr-Ala-Tyr-OH peptide produced by the MEPS process was excellent, with the purity of 100% 
achieved. This was confirmed by both HPLC and MALDI-TOF analysis shown in Figure 36 and 
Figure 37 respectively. The lack of any detectable “random sequence” in the final product proves that 
the membrane inter-step purification was efficient during the whole process and demonstrates 
excellent membrane performance and lifetime. Our wash-out model suggested traces of impurities 
would still remains in the system after each inter-step separation, but the level of these residuals did 
not seem to affect the final peptide product purity. Apparently the level of impurities that can be 
tolerated in the system without provoking side reactions is higher than anticipated and less volumes 
of washing solvent may be used.  
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Figure 36: HPLC chromatography of Tyr-Ala-Tyr-Ala-Tyr produced from the MEPS process and Tyr-Ala-Tyr-
Ala-Tyr standard produced from the SPPS process. Results showed target peptide produced from MEPS eluted 
12.5 minutes was ~100% pure. The large peaks eluted between 19 - 21 minutes were PEGylated wastes such as 
MeO-PEG-HMPA. 
 Figure 37: MALDI-TOF mass spectrum of final model peptide Tyr-Ala-Tyr-Ala-Tyr after preparative HPLC 
purification. Molecular weight 650, 672 and 688 correspond to the target peptide mass, 649 Da, in the ionic form of 
MH+, MNa+ and MK+, while peaks at 440 and 442 corresponding to the matrix itself. 
Encouraged by the success of the previous H-Tyr-Ala-Tyr-Ala-Tyr-OH pentapeptide example, a 
second pentapeptide, Thymopentin (H-Arg-Lys-Asp-Val-Tyr-OH) was synthesized as a second 
demonstration of the MEPS process. Thymopentin (TP-5) is a derivative of the naturally occurring 
hormone Thymopoietin, which differentiates and matures T cells in the human immune system [103]. 
Recent studies have shown that this immunomodulator has great potential to treat rheumatoid arthritis, 
AIDS and other primary immunodeficiencies. Besides being a potential active pharmaceutical 
ingredient (API), this sequence covers a variety of amino acids from acidic (Tyr and Asp) and basic 
(Lys and Arg) amino acids to a hydrophobic amino acid (Val). It also contains the largest Fmoc/Boc 
protected amino acid (Fmoc-Arg(Boc)2, M.W. 597 g.mol
-1), and so this synthesis represented a 
significant challenge for the MEPS process. HPLC analyses of the TP-5 product synthesized from 
MEPS and SPPS are illustrated in Figure 38. The purity of the MEPS product was estimated as ∼94%. 
The MALDI-TOF analysis, shown in Figure 39 confirmed the target product’s molecular weight of 
MH+ 650 and the two impurities to be the deletion of Asp, MH+ 564 and Lys, MH+ 550. The TP-5 
produced by SPPS under the same conditions was only 77% pure and the main impurity was 
identified as the deletion of Arg. MH+ 524. This result demonstrates the advantage of homogenous 
reaction, in terms of a lower excess of reagents required (typically larger equivalents reagents are 
needed for SPPS [66], while also obtaining higher purity).  
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Figure 38: HPLC chromatograms of peptide TP-5 produced by MEPS and SPPS processes, and a standard 
purchased from Sigma-Aldrich (UK). The target TP-5 peptide was eluted at 10.3 minutes. Both syntheses (MEPS 
and SPPS) were performed under the same reaction conditions of 2 equivalents of reagents per 1 equivalent 
peptide and single reaction cycles. Peptide purity was determined as a ratio between the target peptide TP5 peak 
area and the total area of the peaks corresponding to peptide sequences in the solution. The purity of TP-5 
produced by MEPS was determined as ~94% (two impurities eluted at 10.0 minutes and 10.4 minutes) while TP-5 
produced by SPPS was ~77% pure (one impurity eluted at 10.5 minutes). 
The overall yield of the H-Tyr-Ala-Tyr-Ala-Tyr-OH penta-peptide was only 48%. There are 2 main 
causes for this low yield. Firstly, the methoxyl-amino-PEG used in the MEPS process was 
synthesized by the method described by Pillai [101] and the conversion was only 55% which 
dramatically lowered the loading of peptide onto the support. Although these non-converted MeO-
PEG was eventually depleted from the system due to <100% rejection, but the presence of non-
productive material increases the solution viscosity and reduces the filtration efficiency, therefore it 
should be minimised if possible. Secondly, due to the viscosity of the product solution it tends to 
cling onto the pipes walls. The protocol for emptying the filtration system was not well established at 
the time, and the combined effect was the product material was trapped within the filtration system 
thus lowering the product yield.  
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Figure 39: MALDI-TOF mass spectrum of the different peptides produced by MEPS and SPPS TP5 synthesis and 
isolated using preparative HPLC. Spectrum B) – from the MEPS process and D) – from the SPPS process 
correspond to the peak eluted at 10.3 minutes. It was identified as TP5 and showed the target molecular mass, 
MH+ of 680 Da. Spectrum A) and C) – from the MEPS process correspond to the two impurities eluted at 10.0 and 
10.4 minutes respectively and were identified as deletion of Asp, MH+ 564 Da and Lys, MH+ 550 Da. Spectrum C) 
from the SPPS process corresponds to the impurity eluted at 10.5 minutes and was identified as deletion of Arg, 
MH+ 524 Da. 
To minimise losses and improve the yield, a better draining protocol was devised and a new synthesis 
route to make the MeO-PEG-NH2 support was investigated. An inexpensive Fmoc-amino acid such 
as Fmoc-Ala or Fmoc-Gly was directly attached onto the MeO-PEG by esterification using DIC, 
Figure 40. The main advantages of this method are that it has a very simple procedure (refer to 
section 8.6) and the conversion of the attachment can be very easily tracked by NMR analysis. In the 
case of unsatisfied conversion from the reaction, re-coupling of the Fmoc-amino acid is a viable 
option. With these protocols in place, the yield of TP-5 synthesized by the MEPS process was 
dramatically improved and was estimated to be 94% with respect to the starting MeO-PEG-NH2 
material.  
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Figure 40: MeO-PEG-NH2 synthesis by direct coupling method 
Beside product purity and yield, another key attraction of the MEPS process is the production scale 
and scale-up ability. For this investigation a 2 mmol batch of peptide, H-Tyr-Ala-Tyr-Ala-Tyr-OH 
and a 1.2 mmol batch of TP-5 were produced which yielded approximately 1 g and 0.8 g of product, 
respectively. With the current laboratory set-up it can easily synthesizing 20 mmol batches of peptide 
by simply increasing the feed volume and using identical operating conditions. Further scale-up to 
kilogram and even ton scale should be possible by simply increasing the size of the equipment.  
It demonstrated the principle of our MEPS process and synthesized two penta-peptides as examples. 
The Inopor ZrO2/Al2O3 membrane had been shown to be ideal for the MEPS process, but it has other 
technical issues that require further attention. Sealing was one of the major challenges for both 
membrane installation and process maintenance. During installation, the membrane can be easily 
cracked if the o-ring was over tightened. However if the seal was not tighten enough the membrane 
will started to leaks. The type of o-ring used for sealing was also very important. Beside issues with 
chemical stability, the degree of swelling of the O-ring during the synthesis conditions must be taking 
into consideration. Even with the use of perfluoroelastomers O-ring which shown excellent chemical 
stability, when contacted with solvent for a long period of time, i.e. 3 months with DMF solvent, the 
o-ring showed some degree of swelling, which could loosen the contact between membrane and o-
ring results to leakage.  
The membrane housing adopted the “fringe” design using nuts and bolts to keep the end piece in 
place, and from experience vibration caused by the circulation pump during operation led to the nuts 
and bolts to become untied and increase the potential for leakage through the o-ring.  
The supply of the Inopor ZrO2/Al2O3 membrane was also a great concern. Although this membrane is 
a commercially available, experience showed not all membranes delivered had the same performance. 
This was likely due to the top hydrophobic layer occasionally not coated evenly or less stable than 
anticipated. This makes the membrane supplies to the MEPS process unreliable.  
Another down-side of the MEPS process is that the crude product generated containes a large mass 
fraction of PEGylated waste such as MeO-PEG-[linker]. Both peptide product and PEGylated waste 
were precipitated together by ether, and the only viable way of separating the two was by 
chromatography. This is inefficient since a majority of the mass sent to chromatography belongs to 
the PEGylated waste and therefore the amount of peptide purified per batch was lower than 
anticipated. 
3.6 Conclusion 
A number of ceramic and polymeric membranes have been investigated for their feasibility to be 
applies to the MEPS process. There are no commercially available polymeric membranes that are 
suitable for the MEPS process. However, a cross-linked polyimide membrane developed within our 
research group showed great potential for this application, but further investigation and membrane 
development is required. A single commercially available ceramic membrane was identified to be 
applicable to the MEPS process. It is the Inopor hydrophobic ZrO2/Al2O3 ceramic membrane. This 
membrane demonstrates excellent stability in the DMF coupling mixture and in 20% piperidine in 
DMF deprotection solution. This allows simple diafiltration washing to be performed immediately 
after each peptide synthesis step, and no solvent exchange is necessary. It also exhibits good rejection 
of peptide building block at the beginning of the process, and as the synthesis progresses the rejection 
of the building block reached 100%. Although the rejection of some reagents was not as ideal as we 
expected, nevertheless the majority of the waste were washed out after 10 wash volumes per starting 
volume. Trace amounts of impurities remaining within the system does not seems to cause major 
problem to the MEPS process. Two penta-peptides were synthesized with the MEPS process. The 
purity of the model peptide H-Tyr-Ala-Tyr-Ala-Tyr-OH was excellent with purity of 100%. The 
yield of this first attempt was lower than expected and estimated to be 48%. This is due to problems 
with the synthesis of MeO-PEG-NH2 and issue with the dead-volume. The purity of the second 
peptide TP-5 was again excellent at 94%, which was higher than one synthesized from SPPS which 
had a purity of 77%. The yield of this second example had improved to 94%. This improvement 
came from the exploration of a new synthesis route for the MeO-PEG-NH2, and the advancement of 
the MEPS operating and recovery procedures.  
In general, the MPES process proposed in this work integrates the simplicity of performing peptide 
synthesis in solution with an efficient and simple membrane purification procedure of the post-
reaction mixture. We demonstrated the principle of our MEPS process and achieved a simpler 
process than Bayer & Mutter [85] reported. The purity of the peptide product from the MEPS was 
excellent but the true potential of the MEPS process may not yet been fully explored. Further 
optimisation of the separation step and wash solvent volume will led to solvent savings and improved 
the process economics. Thus, as can be concluded from this work, the MEPS process offers an 
important alternative route for peptide and PEGylated peptide production at industrial scale. 
Chapter 4.  
 
Controlling the Selectivity of Cross-
Linked Polyimide Membrane 
4.1 Introduction 
Chapter 3 demonstrated the feasibility of combining membrane separation with peptide synthesis – 
the MEPS process. Good membrane stability and selectivity between peptide building blocks and 
post-reaction waste are essential for the MEPS process. But for the MEPS process to be 
commercially interesting, the membrane must be reproducible. The current Inopor hydrophobic 
ZrO2/Al2O3 membrane had showed excellent stability in peptide synthesis conditions. However, the 
rejections of some of the Fmoc-amino acids were considerably high, which risks insufficient washing 
performance. The sealing of this tubular membrane was difficult. The performance of the 
commercially available Inopor hydrophobic ZrO2/Al2O3 membrane also varied between batches, 
affecting the separation behaviour. Ideally, synthesizing membrane within our research group would 
give this research project more flexibility, a chance to improve the selectivity of the membrane and 
provide a better supply of reproducible membrane. The performance of the PI001YST membrane 
was encouraging and it showed the possibility of using a cross-linked PI membrane for the MEPS 
process. The challenges with the cross-linked PI membrane are stability, selectivity and 
reproducibility. This chapter will be concentrating on the selectivity and attempt at reproducing the 
PI001YST cross-linked PI membrane.  
4.1.1 Objective and Strategy 
The aim of this chapter was to improve the MEPS process through the “better membrane” strategy. 
Some of the fundamental parameters for membrane fabrication were selected and investigated. The 
overall objective of this chapter included two tasks:  
• To synthesize a more open membrane with a sharp MWCO curve which would improve 
selectivity between the growing peptide and post-reaction wastes hence reducing solvent 
requirement  
• To have a membrane fabrication method that generates a reproducible membrane for the 
MEPS process. Ideally, the method should be simple and up-scalable 
The strategy adopted was to identify and understand the most influential parameters in membrane 
fabrication, and attempt to manipulate and control these parameters to generate our desired 
membrane. 
4.1.2 Phase Inversion of Polymeric Membranes 
The ultimate goal of membrane fabrication is the ability to control the membrane properties as we 
wish to meet the membrane application requirement. Here, manipulation of the MWCO curve to gain 
better selectivity between growing peptide and post-reaction impurities is the ultimate goal. An 
appropriate model that describes the phase inversion process would give engineers a better 
understanding of membrane formation and be a valuable tool for manipulating the membrane. To 
keep the description of the membrane fabrication simple, researchers divided the process into 2 parts 
dry phase inversion and wet phase inversion. The description for dry phase inversion generally 
applies to the fabrication of gas separation membranes, which are generally considered as dense 
membrane. Meanwhile the wet phase inversion generally describes the formation of symmetric and 
asymmetric porous membranes, covering molecular weight range for MF to NF. To be able to 
manipulate the membrane performance it is sensible firstly to understand how both phase inversion 
processes work. When a membrane is formed by wet-phase inversion it generally goes through three 
different stages: 
1) Composition changes in the polymer solution by evaporation, before immersion into the 
coagulation bath; 
2) Composition changes in the polymer solution after immersion into a coagulation bath prior to 
possible demixing processes; 
3) Demixing processes taking place when the composition of the polymer solution becomes 
metastable and/or unstable. 
The asymmetric structure of the integrally skinned OSN membranes can be formed by either 1) the 
use of volatile solvents in a polymer casting solution. In this case the duration of the evaporation step 
strongly influences the membrane structure and the asymmetric structure is created by evaporation of 
the volatile solvent which leads to an increase of polymer concentration in the top layer of the cast 
film; or 2) the use of a non-volatile solvent in the polymer casting solution. In this case the polymer 
composition changes by the ternary diffusion process during the submerging of cast polymer film in a 
non-solvent bath and it is strongly influenced by the solvent to non-solvent interaction.  
Summarising from the works published by many researchers [104] - [141], the morphology and 
performance of a membrane is influenced by a number of parameters during casting. These include:  
 The type of polymer used 
 The type of solvent used 
 The polymer and solvent composition in the polymer solution [104] 
 Additives in the polymer solution [107], [108] 
 Addition of a non-solvent or co-solvent in the polymer solution 
 Supporting material during casting 
 The casting thickness 
 Evaporation time [109] 
 Temperature of the polymer solution, coagulation bath and environment [107] 
 Moisture content in the atmosphere 
 Viscosity of the polymer solution [104] 
 Post treatment of the membrane [110] 
4.1.2.1 Dry-Phase Inversion 
As mentioned, the dry phase inversion generally generates dense membranes for gas separation. 
However, it still plays an important role in the first few seconds of pre-submerging the cast polymer 
film into the coagulation bath for the wet phase inversion. There are many publications [119] - [124] 
regarding dry phase inversion but the majority of these systems depend on the use of a volatile 
solvent such as acetone. Many parameters affecting the evaporation of the solvent such as vapour 
pressure of the solvent, concentration of the polymer in solution, temperature, etc. will contribute 
mostly in the dry phase inversion. There are other important parameters including moisture content in 
the air and aerodynamic parameters such as convection or force evaporation, which will also change 
the behaviour of the inversion.  
The composition of the polymer in the cast film generally increases as more solvent evaporates, and 
it will transform directly into solidification of the membrane film. This composition changing process 
is strongly influenced by the interaction between the polymer/non-solvent and solvent/non-solvent. 
For a strong interacting system such as using acetone as solvent, it attracts moisture from air which 
alters the composition pathway and has to refer back to the ternary phase diagram to follow the 
changes. In some extreme cases where vapour pressure of the solvent is low but the solvent used is 
hydrophilic such as NMP or DMF, it is possible to decrease the concentration of the polymer. It is 
not common for a membrane fabricated by dry phase inversion to have macrovoids, but it has been 
reported before [120], [121]. A number of hypotheses have been drawn to explain the formation of 
macrovoids in dry phase inversion. Most hypothesize the intrusion of non-solvent (moisture from air) 
and the initiation of nucleation of the polymer-lean phase followed by liquid-liquid demixing. Finally, 
the growth of macrovoids penetrates to the bulk polymer solution as more non-solvent diffuses into 
the cast film and promotes continuation of liquid-liquid demixing.  
4.1.2.2 Wet-Phase Inversion 
The general guideline accepted by most researchers is that conditions which favour faster demixing 
(or solidification) of the membrane result in a more open membrane with a sponge-like bottom 
structure; while slower demixing promotes tighter membranes with macrovoids structure. The reason 
for this belief comes from how the composition changes during the phase inversion and correlates 
back to what has been observed in the membrane structure through techniques such as SEM. The 
detailed description of the phase inversion will be the key and a good starting point for this chapter. 
 
Figure 41: Ternary phase diagram of the polymer/solvent/non-solvent system with composition pathway during 
phase inversion  
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 Figure 42: The general structure that forms from the 4 type of composition pathway on the ternary phase diagram 
Wet phase inversion is best described by the ternary-phase diagram of the polymer system, Figure 41. 
The diagram is separated into 3 regions: I) homogeneous region, II) 2-phase liquid region and III) 
solidified region. The boundary separating these regions plays an important role in phase inversion as 
it determines when the phase inversion occurs, while the composition pathway decides how the phase 
inversion occurs and is controlled by the ratio of the solvent exchange, ker, Equation 7. Where solventn  
and 
solventnonn −  are the diffusion flux of the solvent and non-solvent, respectively. The diffusion flux of 
i,  can be calculated by Equation 8, where Dij is the diffusivity of i in j and l is the thickness of the 
boundary layer. ∆C is the concentration driving force across the boundary layer. There are different 
ways to estimate the diffusivity, Dij and the most commonly used correlations include the Stokes-
Einstein equation and the Wilke-Chang correlation. For simplicity, the Stokes-Einstein equation, 
Equation 9 was used to estimate the diffusivity of the solvent i in polymer solution j. The 
hydrodynamic radius, RA of solute A is assumed to be a hard spherical particle diffusing through 
solvent B. The diffusion of A is directly proportional to the temperature, T (in K), and inversely 
proportional to the dynamic viscosity of the solvent B, µB. Where kB is the Boltzmann constant. 
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The liquid-liquid critical point is where a homogenous liquid phase exists and beyond this point 
biphasic liquid phases will be formed due to thermodynamic instability. The composition of each 
liquid phase is governed by the tie-line across the 2-phase region.  
During the phase inversion process, the composition of the polymer solution changes following 
different composition pathways [115], [125], [126]. The composition pathway P1 occurs when the 
diffusion of the solvent out of the cast polymer solution is much faster than the non-solvent diffusing 
in, giving ker >> 1. In such cases the polymer concentration increases as the solvent depletes and 
overall cast volume decreases, the cast solution directly solidifies by gelation and/or crystallisation 
leaving a dense and compact structure, Figure 42 a). All k values from lower layers (middle layer and 
bottom layer) depends on the top skin layer, since the top dense layer acts as a barrier for the 
diffusion of the solvent from and non-solvent into the lower layers. This unifies the middle layer and 
the bottom layer into a single sub-layer and introduces 2 scenarios: 1) where the top layer is limiting 
the diffusion of the solvent from the sub-layer (ker of sub-layer < 1), the composition pathway of the 
sub-layer will cross the binodal boundary and cause liquid-liquid phase separation. This results in a 
porous sub-layer structure and gives an asymmetric membrane with a thin dense top separating layer 
followed by a thick porous supporting sub-layer; 2) when the top layer limits the diffusion of the non-
solvent (ker of sub-layer >1), the composition pathway of the sub-layer enters directly into region III, 
same as the top layer giving an overall homogenous dense membrane structure. 
When there is a certain level of diffusion of the non-solvent into the cast solution it introduces 
thermodynamic instability into the system causing liquid-liquid phase separation: pathways P2 to P4. 
The composition pathway P2 occurs when ker  > 1. The diffusion of the solvent is only moderately 
higher than the diffusion of the non-solvent, the composition pathway entering the polymer-rich side 
of the metastable area (region between binodal and spinodal boundaries) in the 2-phase liquid region. 
This leads to the composition of the polymer solution splitting into two following the tie-line, with 
the bulk concentration base on the polymer-rich phase and nucleation of polymer-lean phase, Figure 
42 b). The nuclei of the polymer-lean phase will continue to grow until the surrounding polymer-rich 
phase completely solidifies, giving a semi-dense structure with a predominantly solid open 
framework construction and globular voids. As a consequence the lower layer follows similar 
scenarios as in pathway P1.  
The composition pathway P3 occurs when ker ≈ 1, the diffusion of the solvent and non-solvent are 
similar. The pathway quickly enters the 2-phase liquid region through the thinnest part of the 
metastable area and the spinodal boundary into the unstable area. Immediate phase inversion occurs, 
spinodal demixing leading to growth of both polymer-rich and polymer-lean phases that solidify into 
an interconnecting 3-D network, Figure 42 c). The massive connection of the polymer-lean phase 
which then leaches out during the phase inversion means it gives a very porous structure and thus 
generally giving an open membrane with high permeation fluxes. When the top layer is highly porous 
it posts negligible mass transfer resistance to lower layers, meaning ker values of lower layers are 
similar to the ker values of the top layer, resulting in the homogenous porous membrane structure.  
The composition pathway P4 occurs when ker < 1, the diffusion of the non-solvent into the cast 
polymer solution is higher than the solvent diffusing out. The concentration of polymer decreases as 
a result from non-solvent rushing into the structure and the overall volume increases. The pathway 
entering the polymer-lean side of the metastable area in the 2-phase liquid region, consequently the 
composition separates following the tie-line, with the bulk concentration based on the polymer-lean 
phase and nucleation of the polymer-rich phase, Figure 42 d). As the concentration of the polymer-
rich nuclei increases and its growth rate reaches a certain level, these growing droplets of polymer-
rich phase will come into contact, compact and stick together forming a semi-dense structure with a 
predominating solid balls (or nodules) interconnected structure and channelling voids. The mass 
transfer to the lower layer will depend on the density of the nodules and the size of the channels, but 
the ker value of the lower layers cannot be < 1 as this indicates continuous expansion of the cast 
polymer until dissolution.  
Macrovoids, which are also known as finger-pores and sponge-like structures are the two common 
terms uses in membrane science. They are important because they strongly influence the mechanical 
strength of the membrane and hence constrain the maximum operating pressure. When there is a high 
driving force between the solvent and non-solvent (i.e. high affinity force between the two), even a 
small amounts of the non-solvent diffusing into the system will induce large amounts of solvent to 
deplete from the surrounding of the contacted area. The equivalent representation on the ternary 
phase diagram will be the moving speed of the composition pathway. This results in fast 
solidification of the top layer and reduces the mass transfer in or out of the lower layer. This slows 
the solidification of the lower layer and allows more time for the polymer-lean phase to grow. As the 
nuclei of polymer-lean phase grow into a large droplet in a confined space they merge together. 
When a certain amount of these coalescences of the polymer-lean phase are formed before the wall 
solidifies they will further combine into voids. This will continue to amplify the size of the voids into 
macrovoids as long as sufficient driving force is provided by the decrease of free energy of mixing 
between the solvent and non-solvent. Adversely, the shortest distance and least resistant way for the 
non-solvent to diffuse into the lower layer is perpendicular to the top layer and hence the macrovoids 
continue to grow and extend into the cast film forming a finger-like structure that is perpendicular to 
the top layer. 
In contrast, systems with a low driving force (i.e. low affinity force between the solvent and the non-
solvent) means a delay in the composition pathway to cross the binodal boundary and more non-
solvent can diffuse into the system. This slower diffusion process results to increase in nucleation but 
decrease in the growth of the polymer-lean phase, therefore the droplet size is comparatively smaller. 
Furthermore, due to mass nucleation in a confined environment, each nucleus competes with others 
for solvent and non-solvent, which limits the growth of each nucleus. Due to the higher level of non-
solvent in the overall system (especially to the lower layers) it still favours demixing and when the 
droplet reaches a certain size and composition, it solidifies the wall and constrains further growth. 
The combined effect is that the growth of macrovoids or large voids becomes difficult and only small 
and partially connected spherical pores are formed, giving a sponge-like structure.  
4.1.2.3 Rheology 
In the recent years, an increasing number of publications had been published on the effects of 
rheology has on the membrane morphology and performances [104], [111] - [113]. In general, an 
increase in polymer concentration increases the solution viscosity. The resulting membranes are 
usually thicker and in some cases it affects the membrane performance, such as permeation flux and 
rejection [104]. The shear rate, Sr, given by Equation 10 describes the force experienced by the 
polymer solution during casting and it also contributes to the outcome of the membrane. For instance, 
Ismail [104] showed with higher shear rate it gives a small increase in water permeation with their 
polysulfone membrane. While Ren [113] reported with the same adjustment of parameter, it 
decreases the permeation flux of their polyimide co-polymer membrane and forming a lower MWCO 
membrane. Besides performance, the morphology also changes with the shear rate. For example, 
macrovoids in some cases were suppressed when the casting thickness was reduced.  
 
Equation 10 
4.1.2.4 Phase Inversion Models 
So far, all of the above reviews are based on the experimental results that collected by numerous of 
researchers. There is also many reports on the modelling of phase inversion using thermodynamic 
models [114] - [118]. However, only a few of these models included any kinetic or dynamic 
component [114] in them. A number of recent publications [104] suggested the kinetic of the 
polymer solution such as viscosity, shear rate and even the hydrodynamics of the casting knife plays 
an important role in the formation and overall morphology of the membrane. Therefore, these 
thermodynamic models were never able to gives a complete description of the membrane formation 
and the prediction of membrane performance.  
Nearly all of the models developed are based on the assumption of a moving boundary, this account 
for the changing thickness of the phase inversing membrane during solvent exchange. The solvent 
and non-solvent diffusion process is generally described by Fick’s law, and the binodal boundary is 
estimated based on Flory-Huggins theory. These models only attempt to explain the formation of 
membrane morphology not performance. Although the two are related however with the current 
understanding of phase inversion it is not yet predictive. Furthermore, when applying these models to 
describe the membrane formation, generally researchers have to go back to empirical formulation. 
Since some of the parameters require in the model are difficult to be measure, such as some of the 
solvent/polymer/non-solvent interaction parameters. As the membrane technology advances, more 
components such as additives in the polymer solution or additives in the coagulation bath are used 
during the membrane casting and the interaction of all these components has to be included into the 
model. A more comprehensive model is required to describe the phase inversion process, this include 
up-grading of the Flory-Huggins theory into a multicomponent system, determining the kinetic and 
thermodynamic effects of the additives during the phase inversion and many more. Post-treatment 
such as thermal annealing, acid/base treatment, etc. has also been proven will affects the membrane 
performance, but no solid mathematical model has been reported to predict the outcome of the 
treatment.  
In conclusion, the current thermodynamic models give a brief explanation to the membrane 
morphology for the simplest membrane system. But they are generally not complete enough to 
predict the membrane morphology and the performance of any more advance membrane system.  
4.2 Material and Analytical Methods 
All the polymeric PI membranes were fabricated using Lenzing P84 polyimide that supplied from HP 
polymer GmbH (Germany). It was used without any pre-treatment or purification. Hexane-diamine 
(HDA) cross-linker and 1,4-dioxane co-solvent were purchased from Sigma-Aldrich (UK). DMF was 
purchased from Rathburn chemical Ltd. (UK). Methanol used as coagulation medium and toluene 
used in membrane characterisation were supplied from VWR (UK). Polystyrene (PS) oligomer used 
for membrane characterisation was purchased from Polymer Laboratory (UK), with mean molecular 
weight of 575 g.mol-1 and 780 g.mol-1, and polydispersity of 1.10 for both polystyrene standards.  
High Performance Liquid-Chromatography (HPLC) was used to measure the rejection of the 
polystyrene oligomer. Agilent HPLC system installed with the ACE C-18 reverse-phase HPLC 
column (250 mm × 4.6 mm) packed with 5 µm diameter silica particles and 300 Å pore size was 
operated at 30°C. Pre-mixed 65% tetrahydrofuran (THF) and 35% water with 0.1% TFA was used as 
the mobile phase. A method with ramp from 1 ml.min-1 to 0.5 ml.min-1 in 5 minutes, followed by 
ramping back to 1 ml.min-1 in 30 minutes was applied. UV detection at 260 nm was used to detect the 
aromatic component of the polystyrene oligomer.  
4.3 Results and Discussion 
During the dry-wet phase inversion, the polymer film first experiences open atmosphere where 
solvent evaporation takes place, it is then places into a coagulation bath where solvent exchange and 
phase inversion occurs. Therefore this investigation proceeds with the examination of the dry phase 
inversion followed by the wet phase inversion. 
4.3.1 Dry Phase Inversion Investigation 
For the dry phase inversion, the most significant parameter is the evaporation rate of solvent. Other 
parameters such as moisture content in air, temperature, atmospheric pressure, etc. are also important. 
This section concentrated on the effect of evaporation by natural convection, which experience 
during normal laboratory bench casting conditions.  
4.3.1.1 Evaporation Investigation 
Evaporation of solvent from the cast polymeric films is known to be vital in membrane fabrication. 
This is generally referred to as the “evaporation time” in flat sheet casting and “air-gap” in hollow 
fibre making. A number of researchers have reported the effect of evaporation time on the structural 
and performance changes of their membrane [128] - [131]. The general observation is that an 
increase in evaporation time will result in a thicker top separation layer, hence lower permeation flux. 
Meanwhile it suppresses the formation of macrovoids [105], [133]. The effect of evaporation time is 
strongly influenced by the concentration of the polymer solution, and the solvent to co-solvent ratio 
when co-solvent is used. Therefore it was decided to study the rate of evaporation from the cast 
polymer film for different ratio of solvent to co-solvent.  
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Figure 43: Evaporation rate measurement of PI film made from different DMF: Dioxane ratio cast at 20°C, 1mm 
thickness  
A small film of polymer with the casting height of 300µm was cast on a high accuracy electronic 
balance, which had been enclosed in a controlled environment. The solvent was allowed to evaporate 
freely from the polymer film into the surrounding at 18°C and atmospheric pressure. The weight 
change of the cast film due to evaporation was measured with a 22% weight P84 PI polymer solution 
made with 1:3 (code 22WP84-13), 1:1 (code 22WP84-11) and 3:1 (code 22WP84-31) ratio of DMF 
to 1,4-dioxane. Each composition was repeated 3 times and the averaged results are illustrated in 
Figure 43. There are two major observations from this experiment. Firstly, polymer film with higher 
content of DMF showed less weight lost due to evaporation. This can be easily explained base on the 
vapour pressures of DMF solvent and 1,4-dioxane co-solvent. The vapour pressure of DMF is 2.7 
mmHg at 20°C, 1 atm pressure, while 1,4-dioxane is 27 mmHg at 20°C, 1 atm pressure. This shows 
DMF is not a volatile solvent and therefore the evaporation rate is expects to be lower when more 
DMF is involves. Secondly, when solidification or gelation occurs at the surface of the polymer film 
the evaporation rate is expects to change results in obvious changes in the gradient of the evaporation 
curve. However, even under careful examination of the evaporation curve it was difficult to conclude 
where and when exactly the gradient of the evaporation curve changes. The best estimation of the 
gradient changes for the evaporation curve was around 350 – 400 seconds for the 22WP84-31 film, 
200 – 250 seconds for the 22WP84-11 film and 150 – 200 seconds for the 22WP84-13 film. The 
exact location was very difficult to pinpoint, since the gradient changes were so small and the 
estimated location of the changes occured vary slightly over the 3 repeated experiments, probably 
due to difference in film mass, film area/volume, solvent vapour in the atmosphere, etc. By physical 
observation, the transparent polymer film began to turn cloudy at approximately 500 seconds for 
22WP84-31 film, 400 seconds for 22WP84-11 film and 300 seconds for 22WP84-13 film. 
Comparing these numbers and results from Figure 43 to the typical evaporation time of 10 seconds 
from the normal bench casting of membrane (8 seconds for casting and 2 – 3 seconds for taking the 
membrane and submerging it into the coagulation bath), it suggests that the weight loss during the 
casting is < 1% of the total weight. It is within the experimental error and is far away from the 
gelation or the solidification of the top skin layer. So is evaporation important during membrane 
casting? The evaporation rate, UE and solvent mass transfer coefficient, kc was determined, Table 7. 
The evaporation rate estimated was very small, however, when compared to the mass transfer 
coefficient of the solvent in the film, the UE were 10
2 – 103 times faster than kc. This suggests the 
diffusion of the solvent is not fast enough to diffuse from the bulk to replace any solvent evaporated 
at the surface. Therefore, the polymer concentration increases at the surface and introducing a 
concentration gradient within the cast film. Even though gelation has not yet occurred but it will 
affects the starting polymer concentration at the surface of the film when the wet-phase inversion 
takes place.  
 
Table 7: The molar volume of the 3 compositions of PI polymer solution and estimation of their evaporation rate, 
mass transfer coefficient and their ratio 
Composition 
Molar volume 
(g.ml-1) 
Evaporation rate, 
UE (m.s
-1) 
Mass transfer 
coefficient, kc (m.s
-1)* 
UE/kc 
22WP84-13 0.228 3.133 × 10-7 2.998 × 10-10 1045 
22WP84-11 0.236 2.270 × 10-7 2.618 × 10-10 867 
22WP84-31 0.227 7.745 × 10-8 2.712 × 10-10 285 
Estimated based on diffusivity calculated from Equation 9 
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Figure 44: The cross-section SEM picture of the 22WP84-11 membranes with 8 seconds and 38 seconds 
evaporation time 
SEM pictures of the 22WP84-11 membranes with 8-seconds and 38-seconds evaporation time are 
shown in Figure 44. The overall structure were similar between the membrane cast with 8-seconds 
and 38-seconds evaporation time, however it is clear that the top layer is thicker for the membrane 
cast with 38 seconds evaporation time. The middle layer and the bottom layer of both membranes 
seem to be porous. The 8-seconds evaporation time membrane seems to have a more compact 
nodular structure in the middle layer and a thicker framework with a less porous bottom structure 
when compared to the 38-seconds evaporation time membrane. The solvent exchange ratio, ker, was 
estimated to be < 1, meaning the composition pathway is going downward. Assuming the thickness 
of the interface which the solvent and non-solvent diffuse through is the same, i.e. lsolvent = lnon-solvent. 
When evaporation occurs at the surface of the film it reduces the concentration of the solvent at the 
top, leading to a decrease in concentration driving force, Csol giving ker
38 seconds < ker
8 seconds. The 
gradient of the composition path reduces further, Figure 45.  
As the thickness of the top layer increases due to evaporation, the mass transfer of the solvent and the 
non-solvent into the bottom layers will be constrained. The question is does this limits more to the 
solvent or non-solvent? Based on the explanation in 4.1.2.2, it would suggest the 8-seconds 
evaporation time membrane solidifies faster than the 38-seconds evaporation time membrane. To 
obtain a larger nodules and more open frameworks as showed in the 38-seconds evaporation time 
membrane, a longer residence time is require for the composition pathway to be in the binodal region. 
This will gives sufficient time for the nucleation of the polymer-rich phase and polymer-lean phase to 
occur in the middle layer and bottom layer, respectively. The two possible causes for the longer 
residence time are 1) the thickness of the top layer is thicker in the 38 seconds evaporation time 
membrane i.e. l38 seconds > l8 seconds, therefore , the speed of the composition 
pathway travelling in the 38 seconds evaporation time membrane is general slower; and 2) because of 
ker
38 seconds < ker
8 seconds the angle of the pathway entering the binodal region will be steeper meaning it 
will take longer for the pathway to entre the 2-phase region, see Figure 45. As the phase inversion 
progresses, the  will decreases as l increases, the concentration driving force of the non-
solvent in the lower layer will reduces and the composition pathway eventually bends up as ker > 1.  
 Figure 45: Ternary phase diagram with theoretical composition pathway during casting with 1) short evaporation 
time, P<eva and 2) longer evaporation time, P>eva   
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Figure 46: PS characterisation of 22% weight P84 PI membrane made with 1:1 DMF to 1,4-dioxane solvent, 
operated at 15 bar and 30°C 
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The performance of the cross-linked PI membranes was characterised using PS oligomer. As shown 
in Figure 46, the rejection performance was similar between the two membranes fabricated with 
different evaporation time. This suggested evaporation in this case has a negligible effect on the 
rejection of the membrane. Theoretically, the performance of the membrane depends on the structure 
and the formation of the top layer, which is affected by a number of parameters such as the location 
where the composition pathway enters the binodal boundary. If both composition pathways happen to 
be enter at a similar location the resulting membrane could have similar performances. Furthermore, 
the evaporation time between the two membranes was only 30 seconds hence the difference of the 
starting composition and the top layer concentration is expects to be small. But it is enough to 
provide an evaporation time window of 0 - 38 seconds, and the membrane fabricated within this 
window are likely to have a reproducible membrane preformance. It also suggests that it is difficult to 
shift the MWCO of the PI membrane to higher molecular weight by the evaporation method. The true 
effect of evaporation can still be debatable since the evaporation time in this experiment wasn’t long 
and the method of evaporation was by natural convection evaporation. Any weight lost or 
concentration variation due to evaporation was too small to be measure accurately. For further 
investigation on the true effect of evaporation, it will be ideal to examine other fundamental 
parameters such as temperature, moisture content in air, forced convection evaporation, etc. or some 
experimental effect such as solvent or co-solvent content in air, introduction of solvent/co-
solvent/non-solvent vapour gradient, pressure etc. Nevertheless, these are beyond the scopes of this 
chapter’s objective and this research project. 
4.3.2 Wet Phase Inversion Investigation 
As with the dry phase inversion there are many parameters affecting the outcome of the membrane 
fabricated from wet phase inversion. These include changes of the coagulation bath, polymer solution, 
or post-treatment. Control over the solvent to non-solvent exchange rate, ker might allow 
manipulation of the phase inversion mechanism, hence the membrane morphology and performance. 
This section mainly focuses on applying this concept. 
4.3.2.1 Temperature during Phase Inversion 
Phase inversion at higher temperature should allow faster solvent exchange rates and possibly the ker, 
therefore changes the characteristic of the final membrane.. Results from Chaturvedi et al. [108] 
showed higher water permeability was achieved by phase inversing their polyethersulfone (PES) 
membrane in a coagulation bath at above ambient temperature. Their explanation was performing 
phase inversion at higher temperature introduces faster diffusion of the non-solvent into the cast film, 
hence a more open porous channels. Furthermore, Nora’aini [134] reported their PES membrane that 
had been phase inversed at a higher temperature gave lower rejection of NaCl salt in water. They also 
observed an optimum permeation flux when phase inversion took place at 28°C, and claiming phase 
inversion at a higher temperature would give lower permeation flux. Li [107] also reported the effect 
of the coagulation temperature has on the membrane fabrication and pointed out that phase inversion 
at a higher temperature changes the solvent to non-solvent exchange rate and increases the rate of 
membrane precipitation. The resulting membrane contains larger pores with higher porosity and 
generally gives higher flux, forming a MF membrane. Meanwhile, phase inversion at low 
temperature suppresses formation of large pore giving an UF membrane.  
The formulation of 22% weight PI polymer with 1:3 DMF to 1,4-dioxane solvent ratio was chosen 
for this investigation. Membranes were cast at 2°C, 20°C, 40°C and 60°C using water as the 
coagulation medium and 300 µm as the casting height. SEM pictures of the cross-section of the 4 
membranes are illustrated in Figure 47. The overview of the membrane structure shows that the 
membrane cast at 2°C has a complete sponge-like structure with signs of a more dense top layer; the 
membrane cast at 20°C and 40°C both shows small amount of macrovoids, but the lower layer of the 
20°C cast membrane shows a more compacted and finer structure than one cast at 40°C; while the 
60°C cast membrane shows organised macrovoids across the whole membrane. The top layer of the 
40°C and 60°C cast membrane can be easily identifies since there is a distinctive difference between 
the top layer and the lower layer. The thickness of the top layer for both membranes were estimated 
to be 2.5 – 3 µm. Membranes cast at 2°C and 20°C were more difficult to identify exactly where the 
top layer is locate, a rough estimation of the top layer’s thickness would be 1 – 2 µm. The structure 
below the top layer was also very fine and compact. It was difficult to see whether it has a nodular 
structure or interconnecting 3-D structure that caused by spinodal demixing. Higher resolution SEM 
would be useful here to identify the boundary that separates the top layer and the lower layer. It also 
can be uses to estimating the size of the nodule at the top layer.  
Before examining the rejection data that shows in Figure 48, it is important to clarify one very 
important assumption: is the mass transfer (MT) faster than the heat transfer (HT)? Or are they 
similar? No one has mentioned this assumption within their publications [133] - [134], and adversely 
the HT in this case is as essential as the MT and is dependent on the composition, the type of polymer 
and solvent used, the temperature difference, etc. The important point here is if the HT << MT then 
the temperature of the contacting cast film can be assume to have no temperature rise; but if HT ≈ 
MT then it is important to takes into account the temperature changes of the film and its 
consequences. An energy balance was performed on the top layer of the PI membrane, taking the 
average top-layer thickness to be 2 µm from Figure 47. The maximum time required to raise the 
temperature of the top layer from 20°C to 40°C would only require < 0.5 second. Majority of the heat 
energy during HT will go into raising the temperature of the solvent, which is the largest mass 
component in the polymer solution. Meanwhile, as phase inversion occurs, the hot coagulation 
medium will diffuse into the membrane and the solvent will diffuse out of the cast film, the real time 
require to raise the temperature from 20°C to 40°C is expected to be even shorter. For MT, as 
reported by other researchers [135] and our later result in Figure 55, the solidification of the PI 
membrane at 20°C takes a similar amount time. Therefore, it is assumed that the HT is as fast as the 
MT. 
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Figure 47: The cross-section SEM picture of PI membrane made from 22% weight PI with 1:3 DMF to 1,4-
dioxane solvent ratio phase inversed at 2°C, 20°C, 40°C and 60°C 
40°C 
60°C 
Figure 47: The cross-section SEM picture of PI membrane made from 22% weight PI with 1:3 DMF to 1,4-
dioxane solvent ratio phase inversed at 2°C, 20°C, 40°C and 60°C 
The performance of the 4 membranes, cast at 2°C, 20°C, 40°C and 60°C were characterised using the 
PS technique in toluene. Results are illustrated in Figure 48, membranes cast at 2°C, 20°C and 40°C 
had showed very similar rejection curve. The rejection curve from the membrane cast at 60°C was 
flattening at 80%, an indication of leakage with this membrane. The permeation flux were similar 
between the 20°C and 40°C cast membranes, while the permeation flux for the 2°C and 60°C cast 
membrane were higher than the other. The diffusivity of the solvent and non-solvent at 2°C, 20°C, 
40°C and 60°C were estimated based on Equation 9. The ker values of the 4 systems were very 
similar giving 0.664 (±0.0004). This suggests the composition pathways are the same but with a 
faster solidification rate (the speed in which the pathway moves) at a higher temperature. Since the 
pathway entering the binodal boundary at a similar place, the formation of the top layer is expects to 
be the same hence they gives similar rejection. As the temperature changes so do the position of the 
spinodal boundary, see Figure 49. When temperature increases, the binodal boundary will move 
toward the non-solvent axis and the gelation boundary will shift upward and the overall 2-phase 
region reduces. Let takes the membrane cast at 20°C as the reference point for comparison with the 
other membrane cast at different temperature. At lower casting temperature, the direction of the 
composition pathway and binodal boundary movement goes in opposite directions. The pathway still 
enters the binodal boundary at a similar composition and position forming a comparable top layer, 
but as the phase inversion progress the lower layers enter the spinodal boundary earlier at lower 
temperature than at 20°C. This forces the lower layer to have spinodal demixing that generates a 
more irregular porous structure with a lower mass transfer resistance. This would explain the similar 
rejection but a higher permeation flux for the 2°C cast membrane when compared to the 20°C cast 
membrane. At the mid-range temperature (40°C) the direction of the composition pathway and the 
binodal boundary movement were the same, and the pathway was only slightly faster than the 
boundary movement. The effect was minimised, slightly looser lower layer structure was observed 
that could caused by shorter residence time in the binodal region and more spinodal demixing at the 
bottom layer. With the similar entry point for the composition pathway and residence time in the 
binodal region between the 20°C and the 40°C cast membranes, a comparable performance would be 
expected. 
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Figure 48: PS characterisation in toluene of non-cross linked PI membrane phase inverted at different 
temperature. Characterisation was performed at 10 bar and 20°C  
For the phase inversion at a higher temperature such as 60°C there were thermodynamical and 
technical issues. At high temperature, the composition pathway moved faster than the binodal 
boundary movement. It reached the spinodal region before complete nucleation and packing of the 
polymer-rich nodule at the top layer, therefore frequently resulting in defects at the top layer and 
lower mechanical strength, as reported by other researcher [107], [135]. Also when phase inversing 
the membrane at a higher temperature it generates wavy and whirl patterns on its surface. These 
patterns were generally observed when non-uniform phase inversion occurs. At high temperature, 
very fast solvent exchange rates resulted in instantaneous solidification of the membrane and since 
uniform contact of the cast film with the coagulation medium is very difficult to achieve, partially 
solidification would introduce stress on the membrane surface and creating defective membrane.  
 
Figure 49: Theoretical changes of the ternary phase diagram with respect to temperature variation 
4.3.2.2 Coagulation Medium for Phase Inversion 
Water is the most commonly used coagulation medium for wet phase inversion. However, 
theoretically any medium in which the polymer is insoluble in but is miscible with the solvent and 
allows solvent exchange to takes place can be use as the coagulation medium. Taking this 
fundamental idea, a few researchers [135], [136] have examined the effects of changing the 
coagulation medium. Fan [135] investigated the separation performance and morphology of their 
polyamide (PA) membrane cast in water and in different alcohols for pervaporation separation of 
ethanol from water. According to Fan, their PA membrane showed improved selectivity of ethanol 
from water and suppressed macrovoids formation when phase inversion took place in alcohol. This 
was believed to be caused by differences in affinity force and the solubility parameter between PA-
to-coagulation medium and solvent-to-coagulation medium. With the PA membrane phase inversed 
in alcohol the binodal boundary lay further away from the starting composition and with a slower 
solidification rate. This results in delaying the demixing time therefore giving a spongy structure. 
However, no detail explanation was given for the changes in selectivity of ethanol from water. Fan 
III 
II I 
Polymer 
Solvent Non-Solvent 
↑ T 
↓ T 
↓ T 
↑ T 
[135] also pointed out the use of a larger alcohol (> ethanol) as the coagulation medium could result 
to too fast alcohol diffusion flux into the cast film which potentially damaging the top layer.  
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Figure 50: Rejection characterisation curve for cross-linked PI membrane phase inversed in water, 50% methanol 
in water and in methanol operated at 30°C and 30 bar after 69 hours compaction  
The PI membrane formula of 18% weight P84 made with 1:3 DMF to 1,4-dioxane solvent ratio (code 
18WP84PE13) was chosen for this investigation. This formulation is known to gives a NF membrane 
[137] and therefore any changes, for instance shifting of the MWCO to higher molecular weight 
should be observable. The membrane performance of 18WP84PE13 cast in water, 50% methanol in 
water and in methanol is shown in Figure 50. The rejection of molecular weight below 1,000 g.mol-1 
was determined using PS characterisation method, while molecular weight above 1,000 g.mol-1 was 
characterised by PEG. As expected the “normal” water cast membrane showed the tightest cut-off 
curve and has a MWCO of around 200 g.mol-1, as reported by See-Toh [137]. Membranes cast in 
50% methanol in water and in methanol showed much looser cut-off curves in comparison with the 
water cast membrane. This is in agreement with Fan’s [135] observation, casting in alcohol gives a 
more open membrane. The MWCO of the 50% methanol in water cast membrane was 3,000 g.mol-1, 
whereas one cast in methanol has a cut-off of 5,000 g.mol-1. The permeation flux of the three 
membrane is illustrated in Figure 51, the methanol cast membrane gave the highest flux at 300 L.m-
2.h-1 at 30°C, 30 bar, it is follows by the 50% methanol in waste cast membrane, at 250 L.m-2h-1 and 
the water cast membrane was the slowest at 20 L.m-2.h.-1 
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Figure 51: Toluene permeation for cross-linked PI membrane phase inversed in water, 50% methanol in water 
and in methanol operated at 30°C and 30 bar over 69 hours  
The morphology of the three membranes was examined using the SEM technique and is illustrated in 
Figure 52. For the overview of the membrane structure, membranes cast from 50% methanol in water 
and in methanol both give more and much bigger macrovoids than one cast in water. Referring back 
to Figure 51 the water cast membrane almost showed insignificant compaction in comparison with 
the 50% methanol in water and methanol cast membranes. This can be explained by the size and the 
amount of macrovoids observed within the membrane structure, the more macrovoids in the 
membrane generally means it takes longer for the membrane to compact and more flux reduction. 
Besides macrovoids, the membranes cast from methanol showed almost no sign of a top-skin layer, 
only magnified on the top layer it showed the top layer was very thin. The close approximation of 
this top layer was < 1µm, while both water cast and 50% methanol cast membranes were about 2 µm, 
which are much thicker than on the methanol cast membrane.  
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Figure 52: The cross-section SEM picture of the 18WP84-13 PI membrane phase inversed in a) water, b) 50% 
methanol in water and c) in methanol 
Having investigated the performance and the morphology of the water cast and methanol cast 
membranes, the next logical step was to examine the ternary-phase diagram to determine the impact 
of using methanol as coagulation medium. As shown in Figure 53, the spinodal line of the methanol 
cast lie to the left of the spinodal line of the water cast that is further away from the starting 
composition. This is in agreement with the result reported by Fan et al. [135] with their PA 
membrane.  
However, the general guideline that most researchers believe is “faster phase inversion gives a more 
open membranes; slower phase inversion gives a tighter membrane”. The closer the binodal 
boundary is to the starting composition normally gives a faster phase inversion, but this isn’t the case 
for the methanol cast membrane. The next logical step was to investigate the speed of the 
composition pathway, i.e. the solidification rate.  
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Figure 53: The ternary-phase diagram of P84 PI polymer, 1:3 DMF/1,4-dioxane solvent mixture and non-solvent 
measured at 25°C 
 
Figure 54: Experimental set-up for monitory of phase inversion of 18WP84-13 PI polymer solution 
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A simple and increasingly popular technique for monitoring phase inversion has emerged [135], 
[141], where sample of the polymer solution is places between two microscope slides and a powerful 
microscope is places on top of the sample which connected to a computer. This allows continuous 
monitoring of the progression of the phase inversion when non-solvent is added between the slides, 
Figure 54. The advantage of this technique over the traditional “light transmission” technique is it 
allows researchers to see what is happening during the phase inversion in cross-section, for instance 
the formation of macrovoids. Although current microscopic technology only permits the monitoring 
of microstructure during the phase inversion rather than nano-structure such as the top separation 
layer of the membrane, nevertheless, this gives a new prospective on how the membrane structure 
was formed during the phase inversion.  
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Figure 55: Photos of the progress of phase inversion with 18WP84-13 PI polymer solution in water and methanol 
initially at time zero and at ½ second. The scale bar of each photo representing 500 µm 
The monitoring of phase inversion is illustrated in Figure 55 to Figure 61. At time zero, when the 
non-solvent came into contacts with the polymer solution, a clear smooth fine interface was observed 
under the microscope. At ½ a second, the interface begins to thicken as phase inversion occurs. 
However, this transition phase was not completely solidified, since solid polymer is non-transparent 
under the microscope and the image showed the colour of the interface begins to darken but still 
highly transparent. The speed of the phase transformation can be measure base on the scale at the 
corner of the image and the time inwhich the photo was taken. In the case of water an average rate of 
150 µm.s-1 was estimated but in the case of methanol a much higher rate of 250 µm.s-1 was obtained, 
it is1.7 times higher than in the case of water.  
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Figure 56: Photos of the progress of phase inversion with 18WP84-13 PI polymer solution in water and methanol 
at 1 second. The scale bar of each photo representing 500 µm 
At 1 second, Figure 56, the darker phase transition region continues thickening as the solidification 
progresses, the average growing speed in the water case was 150 µm.s-1 and in the methanol case it 
was 250 µm.s-1; same as before. Interestingly, in both cases some “bubbles” were observed at the 
interface between the phase inverting region and the liquid polymer solution.  
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Figure 57: Photos of the progress of phase inversion with 18WP84-13 PI polymer solution in water and methanol 2 
seconds. The scale bar of each photo representing 500 µm 
At 2 seconds, Figure 57, solidification continues to occur in both cases. The average growing speed 
of the interface for water was 25 µm.s-1 while for methanol it was 75 µm.s-1. The phase inversion is 3 
times higher in methanol than in water and when compared to “at 1 second” the rate of phase 
inversion in both cases has decreases with more significant reduction in the water case. The slower 
phase inversion rate could be indication of increase in mass transfer resistant across the interface. 
However, the transparency of the interface suggests the solidification was not completed. The 
“bubbles” observed previously in the case for water has grow along the phase transition region and 
turn into the shape of a “capsule”. While in methanol case, no changes to “bubbles” at the interface 
of the homogenous phase transition region.  
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Figure 58: Photos of the progress of phase inversion with 18WP84-13 PI polymer solution in water and methanol 5 
seconds. The scale bar of each photo representing 500 µm 
This become interesting at 5 seconds, the “capsules” in the case of water had grew into a long, 
narrow “cylindrical” shape, similar to the “macro-voids” that observed during SEM analysis. The 
diameters of these “cylinders” are approximately 25 µm, about 6 times larger than the normal 
“macro-voids” observed in SEM, but the dimensions are consistent for all of the “cylinders” in the 
image. The transition phase continues to grow but at a slower rate of 17 µm.s-1 and the decreases in 
transparency indicating the region is solidifying. Meanwhile no structural changes were seen in the 
methanol case. A homogeneous region was observed with “bubbles” at the interface as before, but 
the phase inversion rate was only 42 µm.s-1, which is almost half of the rate estimated at “2 seconds” 
and only 2 times higher when compared with the water case.  
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Figure 59: Photos of the progress of phase inversion with 18WP84-13 PI polymer solution in water and methanol 
15 seconds. The scale bar of each photo representing 500 µm 
At 15 seconds, Figure 59, the end of some “cylinders” blasted open and bigger “voids” were 
generated. This suppresses the growth of the neighbouring “cylinders” led to preservation of their 
structure and suggests local completion of solvent and non-solvent. Based on the colour of the 
interface, it suggests the interior structure of the “cylinders” has been solidified, but the interface of 
the “voids” are only semi-solidified. A homogenous phase transition region was observed in the 
methanol case but the “bubbles” has disappeared. The solidification rate for water was 27 µm.s-1 and 
methanol was 17 µm.s-1, the continuation of reducing solidification rate in methanol case was 
expected, but the reason for an increasing solidification rate in the water case was not clear.  
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Figure 60: Photos of the progress of phase inversion with 18WP84-13 PI polymer solution in water and methanol 
30 seconds. The scale bar of each photo representing 500 µm 
At 30 seconds, Figure 60, the “voids” in the water case  collapsed inward and it surrounding rushes 
toward the centre. This lead to a flat progressing interface towards the polymer solution, similar to 
that observed in the methanol case at 15 seconds, but showing a clearer interior structure. No 
structural change was observed with the methanol case, a thick dense homogenous structure was 
observed as before. The solidification rate of water was just over 3 µm.s-1 and the methanol was 
about 25 µm.s-1. An increase in the solidification rate could be indication of changes in solvent 
exchange ratio, ker or phase inversion mechanism. Comparing difference in transparency and colour 
of the phase transition region at “30 seconds” to “2 seconds”, it confirms the transition region at 30 
seconds was close to complete solidification. 
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Figure 61: Photos of the progress of phase inversion with 18WP84-13 PI polymer solution in water and methanol 
60 seconds. The scale bar of each photo representing 500 µm 
Water Cast Methanol Cast 
Figure 62: The overview of polymer solution phase inversion in water and methanol after 5 minutes 
At 60 seconds, Figure 61, the “erupted voids” in the water case continued to expend and formed a 
“fan” shape. Some “shade particles” was observed diffuses into the voids, which could be the solvent 
(due to difference reflectivity of the solvent to non-solvent which gives it darker colour) or lower 
molecular weight PI from the polymer-lean phase. These particles use the un-erupted “cylinders” and 
“voids” as channels and escapes from the phase inversing polymer solution to the non-solvent. The 
front-line of phase transition region on the polymer side was smooth and flat just like in the methanol 
case. There were no physical structural changes in the methanol case besides thickening of the phase 
transition layer but its thickness was almost the same as observed at 30 seconds. The solidification 
rate for water was 10 µm.s-1 and for methanol was only 2.5 µm.s-1, which is now a quarter of the rate 
compared to the case with water. Figure 62 showed the overview of the polymer sample after 5 
minutes and in the water case solidification continued until the whole polymer sample was 
completely solidified with a clear “snow-flake shape” internal structure connecting the centre of the 
sample to the outer surface. Meanwhile in the methanol case, a dense solid layer was formed around 
the polymer sample. It acts as a barrier and leaving the centre of the polymer sample remaines as 
liquid. This illustrates the importance of “macrovoids” in phase inversion, and its role during the 
solvent and non-solvent exchange.  
This study concentrated on the formation of the microstructure during the phase inversion. There are 
many similarities between what this experiment has shown and the nanostructure of the common 
membrane that observed by SEM analysis. For instance, the “cylinders” compared to the “macro-
voids” in the membrane, the dense interface on the non-solvent side to the dense skin top-layer of the 
membrane, the position where the solvent exclused from the sample during the phase inversion to the 
whirl of the solvent observed coming out of the membrane surface during phase inversion. Thus 
gives some insight into the formation of the microstructure during phase inversion and lead to a 
number of hypotheses: 
1) The formation of “voids and channels” came before the solidification of top layer and is likely 
due to the flows of the non-solvent into the polymer film during phase inversion. If that is true, 
then could it also be the intrusion of the non-solvent into the polymer film during phase 
inversion that generates the nano-pores in the membrane; 
2) The formation of macro-voids channelling the solvent to escape from the phase inversing 
polymer. This is important since this will change the “observed” solvent to non-solvent 
exchange rate and the mechanism is no longer limited by the simple diffusion mechanism as 
most models assumed. For instance, no voids or channels were observed in the methanol case, 
the solidification rate continuously decreases to almost zero, which is a classic situation for 
diffusion mechanism. In the water case, the solidification rate decreases until the eruption of a 
void which connects the inner polymer solution to the outer section, resulting to an increase in 
the solidification rate again and allowed total solidification of the polymer sample. Another 
interesting observation is the occurrence of “shade particles”, if they are really a 
representation of the solvent coming out that would mean phase inversion occurs first with 
intrusion of the non-solvent into the polymer solution, followed by extrusion of the solvent 
back into the bath – the phase inversion mechanism of the P84 polymeric membrane! This 
brings to the next argument that the membrane actually swells first during phase inversion. 
The ker at 20°C was estimated to be 0.664 that is < 1 which supports the above comment; 
3) What determines the initiation and location of the formation of the “bubbles” or “cylinders”, 
hence “macro-voids” in the membrane? Is it a thermodynamic issue similar to crystallisation? 
Or a rheology problem? Can we predict them? 
4) Finally, what causes the eruption of voids? There must be an optimum composition or a 
maximum stress level that the voids can hold. Can we estimate them? 
Referring back to the performance of the methanol cast membrane, based on the results from Figure 
55 and Figure 62 it was concluded that the phase inversion was very fast with the methanol cast 
membrane (2.5 – 5 times faster than water) meaning it reached the binodal and spinodal boundary 
much faster than in the case of water, even through the binodal boundary is further away in 
comparison to water, see Figure 53. Moreover, the ker was estimated to be 0.794 for the methanol and 
0.664 for water, the composition pathway was more directly toward the binodal boundary than water 
meaning 1) it is a shorter distance that again suggests faster phase inversion; and 2) it passes through 
the binodal region much faster resulting in less time for nucleation and higher potential for spinodal 
demixing on the top layer, giving a more open separation layer hence a looser membrane with higher 
MWCO.  
In summary, phase inversion of PI membrane in different coagulation media was examined and 
showed it can manipulate the phase inversion mechanism and hence the performance of the 
membrane. Results showed that phase inversion in methanol generates a more open PI membrane 
with MWCO curve closer to a region ideal for the MEPS process. Some detailed investigations were 
performed to find the causes of this shift. Results was in agreement with the general acceptance that 
“faster demixing generates a more open membrane”, however this doesn’t necessary mean “a binodal 
boundary closer to the solvent axis would give faster demixing” as showed in the ternary phase 
diagram. In addition, we may have discovered some insights into the phase inversion mechanism of 
the P84 PI membrane which would be a great starting point for constructing a phase inversion model 
for the P84 PI membrane.  
4.3.2.3 Solvent to Co-Solvent Ratio in Cast Solution 
Another viable method for tailoring a membrane to meet the MEPS process specification is by 
varying the solvent to co-solvent ratio in the polymer dope solution.  
The basic principle behind the use of a solvent mixture is to taking the advantage of the co-solvent 
having a lower affinity with water (the coagulation medium) and hence manipulating the solvent to 
non-solvent exchange ratio, ker value. This technique has been reported by a number of researchers 
before [137] - [140] and has been proven to be a reliable technique for altering the MWCO of the 
polymeric membrane.  
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Figure 63: Rejection profile characterised using PS in toluene for the 24% weight P84 PI membranes with 
different DMF to 1,4-dioxane composition and the reference 18% weight PI P84 membrane taken after 48 hours 
operation time and operated at a) 5 bar; b) 10 bar; c) 20 bar and d) 30 bar 
The 24% weight P84 PI formulation with 300µm casting height and 20°C water coagulation bath was 
chosen for this investigation. The use of this higher polymer content often gives a more reliable 
performance and more importantly in this project it should provides a longer lasting membrane for 
the MEPS process than the previous PI001YST membrane that used 16% weight P84 PI formulation. 
Three solvent compositions were investigated and these were DMF to 1,4-dioxane ratio 1:1 (code 
24WP84PP11), 2:1 (code 24WP84PP21) and 3:1 (code 24WP84PP31), together with the reference 
18% weight 1:3 DMF to 1,4-dioxane ratio membrane (code 18WP84PP13) for comparison. The 
rejection profiles of these membranes are illustrated in Figure 63 and it is clear that using a higher 
ratio of DMF solvent to 1,4-dioxane co-solvent indeed gives a more open membranes. However, the 
sharpness of the MWCO curve reduced when more DMF solvent was used, and therefore some 
rejection of impurities such as PyBOP and certain larger Fmoc-Amino acid is expected but it is still a 
feasible option to fabricate membranes for the MEPS process. As mentioned earlier, the manipulation 
of solvent to co-solvent ratio has been studied before by See-Toh et al [137] and the general 
conclusion was the binodal boundary for the higher DMF content PI solution lay closer to the starting 
composition and resulting to faster phase inversion rate and a more open membrane.  
Further to See-Toh’s [137] explanation, here I attempt to explain the formation of the nodule 
observed on the membrane top layer by the ker value. The ker of the 3 membranes was estimated using 
Equation 9 and a trend was observed with ker(1:1) = 0.621, ker(1:2) = 0.592 and ker(3:1) = 0.577. This 
suggested as the ratio of DMF solvent increases the ker value decreases, meaning more DMF content 
in the polymer solution would results to a higher intrusion rate of the non-solvent into the cast film 
when compared to the extrusion rate of the solvent and thus givs a more swelled and opened structure 
in the solidifying membrane. Also, a smaller ker value means the composition pathway entering the 
lower part of the binodal boundary that has the larger separation between the binodal and the 
spinodal boundaries. This gives a longer residence time for the composition pathway in the region to 
nucleate and grow the polymer-rich phase. When the polymer-rich phases solidify it turn into nodules 
with a larger diameter which should provides a less packed matrix with more free interstitial volume 
in between and hence a more open membrane.  
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Figure 64: Toluene permeation flux at different operating pressures after 48 hours operating time 
Another important observation is that the operating pressure affects the MWCO curve. When 
applying a higher operating pressure, it is likely to compact more on the membrane, hence tightening 
the polymer matrix and increasing the rejection of the solute. This phenomenon has been reported by 
other researchers [10], [137] and is more common to the open polymeric membranes.  
Unsurprisingly, the permeation flux increases wit the operating pressure. After all both OSN and NF 
are pressure driven processes, with a higher operating pressure means more driving force is applies to 
the process. The more open 3:1 DMF to 1,4-dioxane ratio membrane has the highest permeation flux 
followed by the 2:1 and 1:1 membranes, the standard 1:3 membrane gave the lowest permeation flux, 
Figure 64. Compaction is expected with these more open membranes especially operating at a higher 
pressure however the permeation fluxes were fairly constant throughout the experiment. This is most 
likely because a continuous gradient experiment mode was used in which membranes were 
pressurised to 5 bar and operated for 48 hours before ramped up to 10 bar, 20 bar and 30 bar, all 
operated for 48 hours. 
In summary, the manipulation of “solvent to co-solvent ratio” is a viable and reliable strategy for 
tailoring the MWCO of the cross-linked polymeric PI membrane, it gives engineer the ability to 
control the membrane performance and fabricate membrane that will meet the MEPS process 
requirement. Results suggest the use of higher DMF to 1,4-dioxane ratio will generate a more open 
membrane which would be ideal for the MEPS process. However, it is advice to keep the operating 
pressure below 10 bar to avoid collapses of the membrane structure which leads to an increase in 
rejection of all species and decrease in permeation flux.  
4.4 Conclusion 
The objective of this chapter was to investigate way to manipulating the MWCO of the cross-linked 
PI membrane and set to reproduce a membrane that behave similar to the PI001YST cross linked PI 
membrane used in chapter 3.4.4. Which has an good retention of the PEG5k support but low retention 
on the post reaction waste such as Fmoc-Tyr(tBu)-OH. 
The performance of a membrane hypothetically depends on its fabricating parameter, and in this 
chapter a number of parameters that are known to affects the phase inversion mechanism had been 
investigated. These parameters included variable before and during the wet phase inversion, which 
used to fabricate the PI membrane. Out of all the parameter investigated the “coagulation medium for 
phase inversion” and the “solvent to co-solvent ratio in cast solution” have showed the most 
promising ability to shift the MWCO to a higher molecular weight of up-to and above 1,000 g.mol-1. 
Both fabrication methods had shows to be able to change the phase inversion mechanism, hence 
manipulated the characteristic of the cross-linked P84 PI membrane. Membranes generated from 
these methods are likely to allow post-reaction waste such as Fmoc-amino acid and coupling reagent 
to pass through freely and this demonstrated great potential for application to MEPS process.  
Other parameters such as “coagulation bath temperature” and “evaporation rate” were also 
investigated. Phase inversion at of P84 PI membrane 20°C – 40°C showed similar membrane 
performance, while phase inversion at 2°C showed higher permeation rate but similar MWCO as the 
other membrane fabricated. Phase inversion at >60°C would result to too fast solvent exchange rate 
and potentially damaging the top separation layer. Increases in evaporation time prior to the wet 
phase phase inversion results to a thicker top separation layer hence increase in mass transfer 
resistance and decrease permeation flux. The MWCO of the membrane was not affected by the 
longer evaporation time.  
During the investigation I had examined the phase inversion of the P84 PI membrane and have made 
a number of hypotheses for the phase inversion mechanism that theoretically governing the 
performance of the membrane fabricated. These includes the phase inversion of P84 PI membrane 
was initiated with the intrusion of the non-solvent; and the formation of macrovoids within the 
nanostructure promotes phase inversion to the membrane sub-layer by channelling the solvent to 
escape and the non-solvent to intrude. This demonstrated the importance of solvent exchange during 
phase inversion and understanding the diffusion process is the key to manipulating the phase 
inversion of the membrane hence its performance. However, results suggest beside simple binary 
diffusion process it also involves more complex mass transport mechanism such as mass transfer 
with in the macrovoids.  
Chapter 5.   
 
MEPS Process with Degradable 
Polymeric Support 
5.1 Introduction 
The success of the MEPS process showed it is a viable alternative method to current peptide 
production, having the reaction advantages of the liquid phase synthesis and separation advantages of 
the solid phase synthesis. However, the MEPS process is still at its early stage of development, and 
there are several areas where it might be improved. 
The major disadvantage of the current MEPS process is the use of PEG as the soluble support, since 
PEG and the final peptide product both precipitate by ether after the cleavage step. The purification 
of the crude product can only be achieved by chromatography. Besides inheriting the common 
disadvantages of chromatography, such as operation in batch mode, large solvent consumption and 
large waste generation, etc., the majority of the mass fraction of the crude product sent to 
chromatography belongs to PEG support. This makes chromatography inefficient, since each 
chromatography column havs a loading limit and less peptide product will be purified per batch of 
chromatography.  
 
Figure 65: Schematic plan of the final part of MEPS process with a) using PEG as polymeric support and b) using 
degradable polymeric support with complete disassemble of the support during cleavage step. 
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Here, I propose to synthesize peptide on a degradable polymeric support using MEPS process, 
followed by complete degradation of the support once the required peptide sequence has been 
achieved. The schematic plan of the last step of the current MEPS process, and my proposed 
technique and how it integrates into the current MEPS process were shown in Figure 65a) and b), 
respectively. A purer peptide crude product should be produces via route b) in Figure 65, and without 
contamination by PEG support. Ideally, this alternative synthesis will make the use of 
chromatography optional or even make chromatography unnecessary. In reality, depending on the 
efficiency and progression of the coupling and deprotection reactions, chromatography may still be 
require but it will strongly improves the efficiency of the chromatography by increasing the mole of 
peptide purified per batch of chromatography. 
5.1.1 Objective and Strategy 
The objective of this work was to investigate the feasibility of replacing PEG with a degradable 
polymeric support, and incorporating this into the MEPS process. This concept raises several issues 
for investigation, these include: 
1. The stability of the degradable support under peptide synthesis conditions. Which includes the 
stability of the support during the deprotection using 20% (v/v) piperidine in DMF; and 
during the coupling reaction that involves a number of activators. 
2. Can the polymeric support degrade under simple conditions? Ideally, it should degrade / 
hydrolyse during the peptide cleavage step and avoiding any additional procedures. 
3. Will the segment of the degraded polymeric support precipitates with the peptide product? 
Any product contamination by these segments should be minimises. 
4. What are the segments generated from degrading the polymeric support? Are they compatible 
with the peptide product? Are they non-toxic and acceptable by the food and drug 
administration (FDA)?  
5. What is the efficiency of attaching Fmoc-amino acid or peptide onto the degradable anchor?  
The idea for this investigation originated from the ester bond (-CO2C-) that connects the growing 
peptide to the soluble support. During the entire peptide synthesis this bond is stable until the 
cleavage step when hydrolysis reaction takes place. Hence, if the PEG support that containing ether 
bond (-COC-) is replaces with a poly(ester), the latter should degrade under the cleavage conditions. 
The key for controlling the hydrolysis and the success of this concept of MEPS process is the 
stability of the hydrolysed fragment. Applying a suitable linker between the peptide building block 
and the polymeric support allows stabilisation of the cationic leaving group after cleavage, Figure 66 
a). The cationic centre is stabilised by the delocalisation of electrons from the benzene ring adjacent 
to the positive charge. Without the linker, the cationic leaving group is not stabilised, and the 
cleavage of the peptide building block is restricted, Figure 66 b). The stability of the ionic charge 
generally follows the primary ion (1°) as least stable, then secondary (2°) and finally the tertiary (3°) 
ion is the most stable. Other factors including the induction effect and resonance structures would 
also improve the stability of the cation, hence produce better leaving group.  
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Figure 66: Hydrolysis reaction using concentrated acid during cleavage of ester linkage with a) a suitable linker 
used to stabilise the cationic by-product; and b) no linker applied to stabilise the cationic by-product 
Beside poly(ester) there are other types of degradable polymer that other researchers have 
investigated for different purposes. The demand for biopolymers and degradable polymers has been 
expanding for the past decades, as the public’s environmental awareness has been improved, the 
supplies of raw materials (crude oil) for synthetic polymer are depleting, and the development and 
application of biomaterial science is advancing [142] - [144]. Few of these biopolymers were 
explored as potential candidates for the degradable polymeric support for the MEPS process. A short 
introduction of these polymers and their advantages and disadvantages are summarised in the 
followed section. 
5.1.2 Classes of Degradable Polymer 
5.1.2.1 Poly(acetal) 
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*
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Figure 67: General chemical structure of poly(acetal) 
Poly(acetal), Figure 67, is also known as poly(oxymethylene) (POM), acetal resin, 
poly(formaldehyde) and paraformaldehyde. It has been sold under the trade names of Delrin in it 
pure form and Kepital, Celson, Hostaform, Lupital and Ultraform as a co-polymer. POM had been 
proven to be a tough polymer. Depending on the molecular weight of the polymer, it can make into a 
light, smooth, wear resistant thermoplastic or use as a metal substitute. There are many different 
ways in synthesizing POM had been reported over the past decades [147] - [148], but in general the 
synthesis is via anionic catalysis polymerisation of anhydrous formaldehyde.  
POM however is sensitive to acid hydrolysis and oxidation. Under acidic condition it will degrades 
back into corresponding di-alcohol. The kinetics of this degradation had been studied over the past 
decades, for example, Ivanova et al. [150] studied the rate of poly(acetal) oligomer degradation in 
H2SO4 (aq), and concluded the degradation follows the A-1 reaction mechanism with rate constant 
presented in Table 8.  
Table 8: The effective rate constant of poly(acetal) degradation in H2SO4 (aq) presented by Ivanova et al. [150] with 
n representing the generation of poly(acetal) 
H2SO4 
(%) 
Temp 
(°C) 
Keff 
(102 
min-1) 
H2SO4 
(%) 
Temp 
(°C) 
Keff 
(102 
min-1) 
H2SO4 
(%) 
Temp 
(°C) 
Keff 
(102 
min-1) 
n = 2 n = 3 n = 4 
5.04 25 0.6 5.04 25 0.5 5.04 25 0.3 
 30 1.3 - 30 0.8 - 30 - 
 40 3.8 - 40 2.9 - 40 - 
10.1 25 1.8 10.1 25 13 10.1 25 0.8 
 30 3.2 - 30 - - 30 - 
 40 10.6 - 40 - - 40 5.7 
The degradation initiates from the terminal of the POM, it progress through the chain and dissecting 
the polymer from the carbon of the –O–CH2–O– group. The rate of degradation strongly depends on 
the concentration of acid, temperature, molecular weight of POM and the number of terminal.  
5.1.2.2 Poly(carbonate) 
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Figure 68: General chemical structure of poly(carbonate) 
Poly(carbonate) (PC), Figure 68 is a raising class of degradable polymers and has becoming more 
commonly used in houseware, laboratories and in industry where high impact and temperature 
resistance are require. It has been on the market under different trade names, including Calibre, 
Lupilon, Lexan, etc. The synthesis of the PC typically involves reaction of a di-alcohol with a 
phosgene in alkaline conditions, and hence it is expected to be stable under the 20% piperidine 
deprotection condition. Other protocols had also been introduced to synthesize PC [151] - [155].  
Under acidic conditions the carbonate bond will decompose into the corresponding alcohol R-OH 
and carbon dioxide gas. With the release of carbon dioxide gas as the driving force, the rate of PC 
decomposition is expects to be fast. The decomposition is known to be clean and the by-product 
should not affect the peptide product. In comparison with hydrolysis of PE, it is easier to hydrolyse 
PC than PE [159], [160] and this would be an advantage for this project. However, the stability of PC 
could be an issue, since in general PC is incompatible with a number of chemicals including DMF 
[166]. Application of PC as the polymeric support for the MEPS process would require improvement 
of its stability, which can be achieves by changing the R-group on the PC backbone.  
5.1.2.3 Poly(ester) 
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Figure 69: General chemical structure of poly(ester) 
Poly(ester) (PE) is one of the most well known and versatile polymers in the world, it can be divide 
into natural and synthetic polymer. The natural PE generally comes from plant such as cutin, while 
the traditional synthetic PE is produces by condensation reaction between a di-carboxylic acid with a 
di-alcohol or with an α-hydroxy acid such as lactic acid and glycolic acid. The water generates from 
the reaction is continuously removed to shift the equilibrium to favouring polymeric product and to 
drives the reaction to completion. As the demand for PE increases its chemistry becomes more and 
more advance, a common synthesis route for PE nowadays is by ring-opening polymerisation (ROP) 
of lactone, which is a cyclic ester that can be found naturally in plants such as oak.  
Currently, there is a huge market for PE product, covering from textile industry to food and 
packaging industry, such as biodegradable plastic bags and cutlery. Our interests for PE in this 
project is because of its well documented background, such as synthesis protocol, hydrolysis kinetic 
data in both acidic and basic conditions, mechanical properties, etc. [156] - [161]. The massive 
amount of information available in the literature will gives this project a better chance to successfully 
applies PE as the soluble support for the MEPS process.  
5.1.2.4 Poly(urethane) 
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Figure 70: General chemical structure of poly(urethane) 
Poly(urethane) (PUR), Figure 70, is another popular degradable polymer. PUR has been known to 
have high tensile strength, lubricity, etc., but its good abrasion resistance, easy handling and 
biodegradability are the main properties making it attractive for this project. It was introduced to 
medical and bio-application in the 60’s. The PUR is traditionally synthesized by reacting monomer 
containing di-isocyanate (-N=C=O) group with a monomer containing multiple hydroxyl (-OH) 
group, such as low molecular weight PEG. The rate of polymerisation can be increases by addition of 
catalyst and/or performing the reaction at a higher temperature. The oligomer synthesized from the 
reaction between –N=C=O group and –OH group is known as “prepolymer” and the properties of 
this prepolymer can be modifies by varying the ratio between –N=C=O functional group and –OH 
functional group. Molecular weight of the prepolymer is normally increased further by introducing a 
“chain extender”. The chain extenders are often di-amine, which gives the final PUR polymer a 
mixture of urea and urethane linkage. 
The type of isocyanate chosen for the polymerisation depends on the application of the PUR. For 
instance, the use of aromatic isocyanate would improves the stability of PUR when comparied to 
aliphatic isocyanate. This is due to resonance stabilisation effect and therefore may causes difficulty 
in hydrolysis of PUR during the cleavage step, but would improve the stability of the PUR for the 
duration of the MEPS process, especially during the deprotection step. This allows adjustment of 
PUR’s stability according to this project requirement.  
Degradation of PUR in acid generates a di-amine and a di-alcohol by-product and giving off carbon 
dioxide gas as the driving force [162], [163]. The down side of applying PUR is the di-amine by-
product generated after hydrolysis may result to acid-base reaction and salt formation that make 
separation of peptide product difficult. 
A number of articles have reviewed the current application and synthesis of PUR, these include 
Pinchuk’s [164] and Guelcher’s [165] reviews on its synthesis and usage in biomedical sector. 
5.2 Material and Analytical Methods 
All Fmoc-protected amino acids, 1-hydroxbenzotriazole (HOBt), 4-hydroxymetylphenoxyacetic acid 
(HMPA) linker and benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluoro-phosphate 
(PyBOP) activator were purchased from Merck Biosciences, Novabiochem (Switzerland). 
Poly(caprolactone)-diol, Tin (II) 2-ethylhexaneoate and 3,6-dimethyl-1,4-dioxane-2,5-dione (lactide) 
used for poly(lactide) (PLA) synthesis and N,N’-diisopropylcarbodiimide (DIC), piperidine, 
trifluoroacetic acid (TFA) and diisoproyl ethyl amine (DIPEA) required for peptide synthesis were 
purchased from Sigma-Aldrich (UK). Peptide synthesis grade dimethylformamide (DMF) solvent 
purchased from Rathburn Chemical Ltd. (UK) was used in both peptide synthesis and diafiltration 
wash. GPR grade toluene, methanol and chloroform used in PLA synthesis were supplied from BDH 
(UK). Acidolysis solution used for deprotection was made-up from phenol/water/TFA (0.7/1/10 in 
w/v/v ratio) 
Ultraviolet (UV) spectrometry. A Shimadzu UV-2101 PC, scans between 200 – 350 nm was used to 
calibrate and measure the concentration of all Fmoc-protected amino acids, HMPA, HOBt, DIC and 
PyBOP in the single component rejection experiments. 
Gel Permeation Chromatography (GPC). Waters GPC system equipped with both Gilson 132 
refractive index (RI) detector and Waters 996 Photodiode Array detector scans between 250 – 300 
nm, was used to characterising the PLA oligomer, measuring the PLA rejection as well as monitoring 
the PLA-peptide building block loses between each washing step. Waters Styragel HT2 GPC column 
was used with N-methyl pyrrolidone (NMP) solvent as mobile phase and operating at constant flow 
rate of 0.5 ml.min-1 at 100°C. 
Nuclear Magnetic Resonance (NMR) spectrometry. NMR was used to determine the structure and 
the initial progress of the peptide building block as well as characterisation of the PLA synthesized. 
Samples of PLA building block such as PLA-(HMPA)2 and PLA-(HMPA-Tyr(
tBu)-Fmoc)2 were 
prepared in D-chloroform. The two-dimensional spectrum was recorded at 400MHz with Bruker 
DRX-400 spectrometer and analysed with MestRe-C software. The mean molecular weight and the 
structure of the PLA synthesized were estimated by integrating the H-proton on the lactide unit 
located on α-carbon (5.1, q) against the reference -CH2- group on the PEG200 that next to the ester 
bond (3.6, t). The loading of the HMPA linker and the conversion of the attachment of the first amino 
acid were estimated by integrating the aromatic group on the HMPA linker (6.7, d) (6.9, d) or the 
Fmoc-protection group (7.2, t) (7.3, t) (7.5, d) (7.7, d) against the reference -CH2- group on the 
PEG200 that next to the ester bond (3.6, t). 
High Performance Liquid-Chromatography (HPLC). HPLC was used to measure the final purity of 
the peptide crude product and the level of residual impurities in the post-reaction mixture during the 
diafiltration washes, as well as the membrane characterisation with peptide synthesis reagents and 
polystyrene oligomer. Agilent HPLC system installed with ACE C-18 reverse-phase HPLC column 
(250 mm × 4.6 mm) packed with 5 µm diameter silica particle and 300 Å pore size was operated at 
25°C. For peptide purity analysis, water and acetonitrile (AcCN) with 0.1% TFA was used as mobile 
phase, at 0.5 ml.min-1 flow rate. A method with ramp from 0% AcCN to 80% AcCN in 30 minutes, 
follow by 5 minutes at 100% AcCN and 5 minutes at 0% AcCN was used. UV detection at 210 nm 
was used to determine the presence of amide bond. For membrane characterisation, with PS method 
pre-mixed 65% tetrahydrofuran (THF) and 35% water with 0.1% TFA was used as mobile phase. A 
method with ramp from 1 ml.min-1 to 0.5 ml.min-1 in 5 minutes, follow by ramp back to 1 ml.min-1 in 
30 minutes was applied. UV detection at 260 nm was used to detect the aromatic ring of polystyrene 
oligomer.  
Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF). MALDI-TOF mass 
spectrometry was used to determine the molecular weight of the PLA product and the final peptide 
product. Bruker Reflex IV MALDI-TOF mass spectrometer using infrared ionisation techniques with 
ionisation power set at 20 kV was used. α-Cyano-4-hydroxycinnamic acid (CHCA) was used as the 
carrier matrix in a mixture of AcCN and ethanol (ratio 1:1) with 0.1% TFA for the MALDI-TOF 
samples. 
5.3 MEPS Process with Degradable 
Polymeric Support 
The first degradable polymeric support investigated was polyester. PE has been known to have good 
chemical and mechanical stability, it is highly commercially available and is one of the most well 
studied polymers.  
There are many type of commercially available PE, these includes the synthetic PE such as 
poly(ethylene terephthalate) (PET), Figure 71 a) and poly(caprolactone) (PCL), Figure 71 b), as well 
as the natural biodegradable PE, for instance poly(glycolide) (PGA), Figure 71 c), poly(lactide) (PLA) 
Figure 71 d) and poly(hydroxybutyrate) (PHD), Figure 71 d). The use of natural biodegradable 
polymer should have the advantage of more acceptable by the FDA and the public. It also provides 
an alternative degradation method such as enzymatic or catalytic degradation if necessary.  
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Figure 71: Example of polyester family, a) poly(ethylene terephthalate) (PET), b) poly(caprolactone) (PCL), c) 
poly(glycolide) (PGA), d) poly(lactide) (PLA) and e) poly(hydroxybutyrate) (PHB) 
Common laboratory condition for peptide cleavage uses 95% TFA with the addition of water and 
scavengers, which depends on the type of side-protection. Upon completion of the cleavage step, 
ether is often added to precipitate the peptide product. Once the peptide cleaved from the polymeric 
support and fully deprotected, its solubility in water generally improve. Hence, water content in the 
cleavage solution may affect the recovery of final peptide product. The polymeric support chosen for 
this chapter should be able to hydrolyse under the same condition as the cleavage step to avoid extra 
processing step or addition of chemicals. The by-product generated from hydrolysis should be 1) 
easily separable from the peptide product; 2) inert during the hydrolysis and the recovery; and 3) not 
affecting the recovery of peptide product by precipitation. It was expected the application of PE (with 
a common product of carboxylic acid from hydrolysis) will fulfil most of the above requirements.   
5.3.1 Experimental Apparatus and Methods 
The hydrolysis study of degradable polymeric support was performed in glass test tubes. A known 
weight of polymer sample was placed in the test tube followed by addition of the acidic solution to 
simulate the cleavage conditions. Diethyl ether was added to precipitate out the polymer at a given 
time. The precipitate was recovered by centrifugation followed by drying in vacuum. The mass of the 
polymer before and after hydrolysis was recorded. The hydrolysed by-product should be removed by 
dissolution in ether or released as a waste gas. The recovered solid remains were taken as equivalent 
to the un-hydrolysed polymeric support during the cleavage step. Samples of any solid remains was 
be further analysed by GPC and MALDI-TOF for determination of the molecular weight.  
Membrane performance characterisation was performed in the Sepa ST dead-end filtration cell, as 
described previously in Figure 23. The dead-end system was modified with the addition of a fresh 
solvent feeding unit, Figure 72. This modification will allow continues volume diafiltration (CVDF) 
to be performed in the dead-end filtration system during the MEPS process.  
 Figure 72: Modified Sepa dead-end filtration system equipped with continuous diafiltration unit 
5.3.2 Poly(caprolactone) Characterisation 
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Figure 73: Chemical structure of PCD2k investigated for degradable polymeric anchor 
The first poly(ester) investigated was the commercially available poly(caprolactone)-diol (PCD2k). It 
is a waxy solid with a low melting point of 36°C – 48°C. The mean molecular weight of the PCD2k 
provided by its supplier is 2,000 g.mol-1. The PCD was re-characterised using GPC and MALDI-TOF 
mass spectrometry.  
Based on GPC analysis the mean molecular weight of PCD2k was estimated to be 2,980 g.mol
-1 using 
PEG standard for calibration. This is reasonably close to the molecular weight its supplier claimed 
for any non-standard polymeric product. The polydispersity (PDI) of the PCD2k product was 
estimated to be 1.34 and approximating the PCD2k having the lowest molecular weight of 640 g.mol
-1. 
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Figure 74: Characterisation of PCD2k using GPC analysis, the mean molecular weight was estimated to be 2,980 
g.mol
-1
 with PDI of 1.34. 
Characterisation with MALDI-TOF, Figure 75 reveals the spread of molecular weight was very 
broad. It covering molecular weight as low as 400 g.mol-1 and as large as 4,000 g.mol-1, with 
majority of polymer having molecular weight at the lower end. Building peptide onto the PCD2k will 
not provide sufficient difference in molecular weight to the building block and separates it from the 
post-reaction waste. Hence, the recovery of peptide-building block by the membrane after each step 
was not expected to be high enough for the MEPS process to be feasible. Comparing the result from 
GPC with MALDI-TOF, the mean molecular weight from GPC was 2,980 g.mol-1 while MALDI-
TOF was 1,200 g.mol-1. In terms of determination of molecular weight for polymer there are always 
some issues with accuracy. Our GPC equipment was calibrated using standard that is not the same as 
the target polymer, therefore slight variation is possible and according to some manufacturers such as 
American Polymer Standard Corporation the error of using GPC for analysing molecular weight of 
polymer is generally within ± 3% to 10%. Although MALDI-TOF seem to be the better option for 
determining the molecular weight of the polymer, the target polymer will have to be charged through 
protonation by the matrix before it can be analysis by MALDI-TOF and the protonation sometime is 
not straightforward depending on the type of polymer. Given the simplicity and the well documented 
examples of using GPC to characterise polymer product, it was decided to use it as the main method 
for characterising the polymeric support for this chapter. 
 Figure 75: Characterisation of PCD2k with MALDI-TOF analysis 
5.3.2.1 Hydrolysis of Poly(caprolactone)-diol in Cleavage Condition 
Hydrolysis experiment was preformed with PCD2k in 95% TFA acidic solution for 3 hours as used 
previously in the MEPS and the LPPS processes (refer tochapter 3.5.2.4). However, the result from 
this initial test was not satisfactory with >85% of PCD2k remains un-hydrolysed and precipitated out 
by diethyl ether. Different concentration of TFA acidic solution was also tested in an attempt to 
improve the hydrolysis of the PCD2k polymer. The degree of hydrolysis as a function of water 
content is shown in Figure 76. The hydrolysis of PCD2k was improved with increases water content. 
It is possible that the mechanism of the hydrolysis reaction was shifted from A1 mechanism to A2 
mechanism, Figure 77. The A2 mechanism avoided the formation of cation therefore the hydrolysis 
becomes less affected by the stability of the cationic by-product and improves the degree of 
hydrolysis. However, there are concerns on uses of PCD2k as degradable polymeric support for the 
MEPS process. Firstly, PCD2k is insoluble in 100% water and has limited solubility in acidic solution 
with >80% water content. The hydrolysis rate in a heterogeneous system is not expected to be 
improving further when higher water content was used. Secondly, peptide products are often highly 
soluble in water and higher water content would affect solubility of peptide product in the acidic 
cleavage solution and may results to difficult precipitation of peptide product hence lower yield.  
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Figure 76: Weight of PCD2k solid recovered from different ratio of TFA to water of hydrolysis solution 
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Figure 77: Hydrolysis decomposition of ester bond via a) A1 mechanism and b) A2 mechanism 
5.3.2.2 Attachment of Fmoc-Protected Amino Acid onto PCD2k 
One essential question is whether the hydroxyl group on the PCD is active enough to perform peptide 
synthesis on it. The reactivity of a functional group is often affected by its neighbouring groups. The 
difference in activity between primary amine and amino group on amino acid is a classic example in 
this case.  
Insoluble 
region 
Fmoc-Tyr(tBu)-OH was chosen to directly couple onto the PCD2k. The aromatic system on the Fmoc-
protection group and Tyrosine would provide easy monitoring of reaction progress using UV 
detection. Attaching tyrosine onto PCD also allows examination of the attachment after deprotection 
with piperidine. The [Fmoc-Tyr(tBu)]2-PCD product was purified by repeat re-crystallisation method 
to remove any traces of starting reagent and by-products before analysis. 
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Figure 78: Ultraviolet spectrum of starting material PCD2k and Fmoc-Tyr(
t
Bu)-OH and product [Fmoc-
Tyr(
t
Bu)]2-PCD, scanned between 200 nm to 350 nm. The appearance of absorption at 300 nm, 288 nm and 265 
nm indicating attachment of Fmoc-Tyr(
t
Bu)-OH onto PCD2k 
As shown in Figure 78, the attachment of Fmoc-Tyr(tBu)-OH onto PCD2k was successful. Solid 
product recovered after attachment shows UV absorption at 265 cm-1, 288 cm-1 and 300 cm-1, these 
absorption wavelengths are distinctive characteristic of Fmoc-amino acids. However, the conversion 
of the coupling reaction was very low, only 5% of attachment achieved. This could be a result from 
lower activity of hydroxyl functional group on the PCD2k, but also could be due to other effects such 
as inter- or intra- aggregation. Nevertheless, the result suggests PCD is not an ideal polymeric 
support for the MEPS or LPPS processes. 
227 nm 
228 nm 
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288 nm 300 nm 
In summary, it has demonstrated the hydroxyl functional group on the PCD2k is active enough for the 
coupling reaction, and is possible to grow peptide on it. However, due to its highly dispersed 
molecular weight and difficulty in hydrolysis in acidic condition, it was concluded that this 
commercially available PCD2k was not suitable as the degradable polymeric support for the MEPS 
process and further investigation with PCD2k were abandoned. 
5.3.3 Poly(lactide) Characterisation 
Gaining experience from the PCD2k, we investigated another polyester – poly(lactide), PLA. Beside 
the fact that PLA is a natural polyester, under acidic hydrolysis PLA should generate a more stable 
secondary cation hence ease the hydrolysis reaction at high acid, low water content condition. Other 
advantage of using PLA over PCD2k is the solubility of PLA seems to be higher than PCD2k, for 
instance the solubility of PLA with molecular weight of 9,000 g.mol-1 in DMF is >740 g.L-1 at 20°C, 
while the PCD2k has a limited solubility of <5 g.L
-1 under the same conditions. Besides soluble in 
DMF, the PLA is also soluble in many organic solvent such as AcCN, Toluene, NMP, DCM and 
Chloroform. The by-product generated from the hydrolysis of PLA is the natural compound Lactic 
acid. It is also known as milk acid and produced naturally within our body during normal metabolism 
and exercise, and is naturally metabolised on a daily basis. Lactic acid itself also highly miscible with 
diethyl ether, meaning it will remains in the ether while the peptide product will precipitate out. 
PLA is commercially available however these commercially available products are often high 
molecular weight polymer rather than oligomer that the MEPS process requires. The use of high 
molecular weight polymer as soluble support will have the disadvantage of lowering the rate of 
coupling reaction and hydrolysis. The solubility of high molecular weight polymers is generally 
lower in organic solvents, hence limiting the yield per reaction volume. Therefore, PLA oligomers 
used in this investigation was synthesized in our laboratory in order to meet our application 
requirements. There are number of protocols [168] - [170] reported for the synthesis of PLA 
oligomer, mainly using the traditional metallic catalyst combined with an initiator containing 
hydroxyl functional group to trigger the ring-opening polymerisation (ROP) of lactide. Detail of the 
synthesis protocol of PLA for this chapter can be found in section 8.7.  
The characterisation of poly(lactide) generally involves FTIR-ATR, MALDI-TOF, GPC and NMR 
analysis. The FTIR-ATR analysis targets the presence of the ester bond and hydroxyl functional 
group, which has a transmission IR signal at 1750 cm-1 and 3500 cm-1 respectively. MALDI-TOF is 
use to confirm the molecular weight of the PLA product, and identifies the mean molecular weight of 
the PLA product. It also provides information on the minimum molecular weight of the PLA product 
that would be very useful for this project when comparied to the MWCO of the membrane. 
Meanwhile, GPC analysis would provide both the mean molecular weight and the polydispersity 
(PDI) of the PLA product. It is also possible to estimate the conversion of the PLA product base on 
monitoring the unreacted lactide remain in the crude PLA product. NMR would identify the structure 
of the oligomer product and confirms the success of PLA synthesis as well as providing alternative 
way of estimating the mean molecular weight of the PLA product.  
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Figure 79: Poly(lactide) synthesis with tin (II) ethylhexanoate (Sn(Oct)2) as catalysis, PEG200 as initiator and 
lactide as monomer. Polymerisation was carried out at 140°C under continuous stirring and argon inert 
atmosphere 
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The mean molecular weight, mean
PLAM  of the final PLA product can be predicts by Equation 11. [Lact]0 
is the mole or concentration of initial lactide input and [OH] is the mole or concentration of the 
initiating functional group, HO- group in this case. MLact is the molecular weight of lactide and PLAx  
is the fractional conversion of the polymerisation. Several batches of PLA were synthesized based on 
the protocol described in section 8.7. A key issue for the synthesis of PLA is the moisture content 
during the polymerisation. The ROP of PLA was initiated by the hydroxyl functional on the initiator, 
as shown in Figure 79. The molecular weight of the PLA product depended strongly on the ratio 
between the hydroxyl functional group and the lactide reagent. Therefore, moisture could compete 
with the initiator during the PLA synthesis and affects the molecular weight of the PLA product. 
Thus result to a variation to the molecular weight of the PLA product synthesized between different 
batches, and deviation from the expecting mean molecular weight.  
FTIR-ATR analysis of purified PLA product is shown in Figure 80, this was compared with FTIR 
spectrum reported by other researchers [171] - [173]. The strong transmission signal at 1,746 cm-1 
corresponds to C=O stretching in the ester (-O-CO-) group. While signals at 1,182 cm-1, 1,126 cm-1 
and 1,079 cm-1 corresponds to C-O stretching in the ester (-O-CO -) group. The bending of C=O 
gives transmission signal at 1,265 cm-1. For the rest of lactide backbone, the transmission signal at 
1,450 cm-1 corresponds to the bending of -CH3 group, and signals at 1,379 cm
-1 and 1,360 cm-1 
corresponds to the vibration of C-H of -CH3 group. The stretching of C-C bond gives signal at 863 
cm-1. Finally, the bending of –OH group has signal at 1,045 cm-1.  
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Figure 80: FTIR-ATR analysis of purified PLA product scanned between 2000 cm
-1
 to 700 cm
-1
 
1H-NMR analysis of the purified PLA product in D-chloroform is shown in Figure 81. Large signal 
of 1.5 ppm (3H, d) corresponds to –CH3 group of the lactide and 5.2 ppm (1H, q) corresponds to –H 
of the lactide. Signal at 3.7 (2H, t) corresponds to -CH2- group of the PEG next to ester bond, while 
signal at 4.3 (12H, t) corresponds to the -CH2- group on the rest of the PEG initiator [174]. Results 
from NMR analysis together with FTIR-ATR spectrometry provided strong evidence suggesting 
product synthesized from the ROP reaction was indeed PLA. 
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 Figure 81: NMR spectrum of purified PLA product 
A GPC chromatography is illustrated in Figure 82. Negative refractivity was observed for both PLA 
and lactide when NMP was used as the mobile phase. As reported by other researchers, the mean 
molecular weight of the PLA product strongly depends on the molar ratio between lactide input and 
the amount of hydroxyl functional group present. We indeed observed the mean molecular weight of 
PLA product was doubled when the amount of lactide used for synthesis was increased by two-folds.  
The conversion of the PLA synthesis was not easily determined since PLA is not a standard polymer 
uses for the calibration of GPC. Therefore, GPC was calibrated using PEG for both molecular weight 
and concentration. However, the refraction of the PLA and PEG is not the same hence only rough 
estimation can be achieve. Common procedure for synthesizing PLA recommends 48 hours of 
reaction time, but in our current set-up only 45% conversion to PLA product was reached with this 
reaction time. The conversion to PLA was improved by increasing the reaction time from 48 hours to 
72 hours, which gave apprioxmately 70 - 80% conversion. The PDI of the PLA products were 
estimated to be 1.103 (±0.01). Ideally, the polydispersity should be equal to 1, this would give a 
define molecular weight of PLA product and allow more accurate calculation of the reagent required 
for the peptide synthesis as well as more predictable reaction rate and performance. In reality this is 
generally very difficult to achieve since ROP is a free-radical polymerisation therefore the 
Lactide H 
Lactide CH3 
PEG  
-CH2- 
PEG  
-CH2- 
progression of the polymerisation commonly is difficult to control. Nevertheless, as long as the 
selected membrane is able to reject the smallest PLA product, it is sufficient to demonstrate the 
principle of the MEPS process with PLA as the degradable support. 
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Figure 82: GPC analysis of PLA crude product synthesized from ROP of lactide using refractive index detector. 
Negative peak with retention time at 10.9 minutes corresponds to PLA product with mean molecular weight of 
12,500 g.mol
-1
 and PDI of 1.103. A conversion of 45% was estimated. The negative peak with retention time at 19.0 
minutes corresponds to unreacted lactide, while negative peak with retention time at 20.9 minutes correspond to 
DMF solvent.  
5.3.3.1 Hydrolysis of Poly(lactide) under Cleavage Conditions 
The hydrolysis of PLA with mean molecular weight of 12,000 g.mol-1 (PLA12k) was studied in 95% 
TFA and in 70% TFA acidic solutions. Samples of PLA12k were dried in vacuum before being 
subjected to the hydrolysis experiment. A sample of 0.2 g of PLA12k was dissolved in 1 ml of acidic 
solution. Diethyl ether was added into the hydrolysed sample at a given time to precipitate out the 
PLA12k, followed by centrifugation to separate the solid residue from the supernatant. Lactic acid is 
completely miscible with TFA and diethyl ether therefore it should not precipitate out with the 
peptide product in contrast with MeO-PEG thus improves the crude product purity.  
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Figure 83: Purpose hydrolysis mechanism of PLA in acidic condition following a) A1 reaction mechanism and b) 
A2 reaction mechanism 
The rate of hydrolysis of PLA12k can be described by Equation 12. A “zero order” kinetic was 
observed with the 95% TFA:5% water hydrolysis system. This suggests the rate of hydrolysis is 
independent to the concentration of PLA12k. The rate was estimated to be -0.0022 g.L
-1.s-1 at 20°C, 
Figure 84 a). Meanwhile, a “first order” kinetic was observed with the 70% TFA:30% water 
hydrolysis system, which suggests the rate of hydrolysis now depends on the concentration of PLA12k. 
The rate was estimated to be -5x10-5 s-1 at 20°C, Figure 84 b), or initial rate of -0.01 g.L-1.s-1, which 
is five times higher than with the 95% TFA system. Two hypotheses were drawn based on these 
results, 1) “change of reaction order means change of hydrolysis mechanism”. With higher content of 
water, the hydrolysis changed from A1 to A2 mechanism, Figure 83, hence it depends on the 
concentration of PLA; and 2) hydrolysis of PLA’s backbone. The rate constants, kH of both 
hydrolysis experiments were calculated. The kH for 95% TFA system was -1.516×10
-9 g2.L-2.s-1, 
while for 70% TFA was -1.559×10-9 g2.L-2.s-1. The similarity of these constants disproves the first 
hypothesis, since change of hydrolysis mechanism would changes the kH in the process. 
GPC analysis of the hydrolysed PLA12k residue recovered from the degradation experiment showed 
extensive broadening of the PLA peak, Figure 85. The PDI of PLA product before hydrolysis was 
estimated to be 1.103, while the PDI of the hydrolysed PLA12k in 95% and 70% were 1.154 and 
1.268 respectively after 3 hours. If the hydrolysis occurs only at the PLA’s terminal group then 
shifting of chromatography peak toward longer retention time which representing smaller molecular 
weight species, without peak broadening is expected. Since each PLA oligomer is hydrolysed at the 
same rate therefore the molecular weight decrease should be also the same and thus the PDI is 
expected to remain the same. However, peak broadening suggests the generation of smaller PLA 
a) 
b) 
fragments which supports the second hypothesis. The accepted mechanism for hydrolysis of PLA or 
polyester is that it occurs at the terminal of the polymer [159]. However, as the water content 
increased it may be possible that additional chain breakage occurs at the PLA backbone thus the 
molecular weight of polymer decreasing faster. 
a) 95% TFA : 5% water b) 70% TFA : 30% water 
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Figure 84: Kinetic study of hydrolysis PLA12k with molecular weight of 12,000 g.mol
-1
 in a) 95% TFA : 5% water; 
and b) 70% TFA : 30% water 
 
Figure 85: GPC analysis of PLA12k starting material with hydrolysed PLA12k in 95% and 70% TFA 
5.3.3.2 Attachment of Fmoc-Protected Amino Acid onto PLA 
To investigate the reactivity of the hydroxyl group on the PLA9k, Fmoc-amino acid was again 
attached onto PLA9k. Both Fmoc-Ala and Fmoc-Tyr(
tBu) was chosen for this investigation, following 
the amino-group modification procedure mentioned earlier in section 3.5.2.4 and section 8.6. 
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Figure 86: Ultraviolet spectrum of starting material PL8, Fmoc-Ala and products [Fmoc-Ala]2-PLA9k
1
 and [Fmoc-
Ala]2-PLA9k
2
 in DCM solvent, scanned between 350 nm to 200 nm. The appearance of absorption at 300 nm, 288 
nm and 265 nm, and increase absorption at 230 nm confirms the attachment of Fmoc-Ala onto PLA 
Ultraviolet spectrometry was used to determine the appearance of UV signal on the final [Fmoc-
Ala]2-PLA9k product. As shown in Figure 86, the starting PLA9k material has no UV absorption at 
300 cm-1, 288 cm-1 and 265 cm-1. The appearance of UV signals at these wavelengths indicated 
attachment of Fmoc-Ala onto PLA9k and suggested the hydroxyl group on the PLA9k is active enough 
for the coupling reaction and can be serve as a support for growing peptide chain. Taking the 
advantage of the distinctive 1H NMR signal of -CH2- on the PEG that located next to -O(CO)- and 
uses it as a reference signal, the loading of Fmoc-Ala onto PLA9k was determined. NMR analysis 
estimated 100% attachment of Fmoc-Ala onto the PLA, Figure 87. Comparing this with the loading 
onto the PCD2k, it seems the hydroxyl group on the PLA9k was far more reactive than on the PCD2k. 
This could due to a number of reasons, for instance induction effects or solvation phenomena. 
Induction effect is stronger for –CH3 substituent compare with –H substituent therefore improves the 
nucleophilicity of the hydroxyl group. However, –CH3 also gives more steric hindrance than –H thus 
lowering the reaction rate, and in general the steric hindrance has stronger overall effect than the 
induction, hence PCD2k was expected to give higher loading of Fmoc-amino acid than the PLA9k. 
Further investigation is required to determine the causes of different reactivity between PCD2k and 
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265 cm-1 
228 cm-1 
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230 cm-1 
PLA9K, however the much higher conversion makes the PLA a good candidate as the degradable 
polymeric support for the MEPS process.  
 
Figure 87: NMR result of [Fmoc-Ala]2-PLA after second reaction cycle. Integration between H
1
 on PEG at 3.6 
ppm with respect to H
1
 on Fmoc-protection group at 7.4 ppm suggested conversion of attachment to be 100%. 
5.3.3.3 Stability of poly(lactide) in Deprotection Conditions 
The stability of PLA9k in 20% piperidine in DMF deprotection solution was investigated. A number 
of techniques were used to establish any changes of molecular weight in the PLA, theseincluded GPC 
and MALDI-TOF analyses. However, hydrolysis only need to occur at the ester bond connecting the 
peptide-linker to the PLA and it will proves the PLA is unsuitable as the degradable polymeric 
support for the MEPS process. The changes of molecular weight due to disconnecting the ester bond 
at the end terminus of the PLA is too small to be accurately detected or measured by GPC or 
MALDI-TOF. Hence, a different approach was used, starting from attachment of Fmoc-Tyr(tBu)-OH 
onto PLA. The conversion of the attachment was measured by GPC and NMR analysis. The [Fmoc-
Tyr(tBu)]2-PLA product was purified by crystallisation and deprotected using 20%piperidine in DMF 
for 30 minutes. The success of Fmoc- deprotection was confirmed by Kaiser test. The deprotected 
product was analyzed by GPC for the appearance of UV adsorption signal at the retention time of 
PLA starting material. Attachment of tyrosine has the advantage that after deprotection the modified 
PLA is still detectable by UV. Hydrolysis at the PLA terminus will lead to complete disappearance or 
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shifting of the UV signal. Furthermore, the amount of tyrosine attached on the PLA can be estimated 
with 1H-NMR analysis by integration of 1H on the aromatic system of Tyr at 6.9 ppm (d, 4 H) against 
the reference 1H of the PEG200 at 3.6 ppm (t, 4 H).  
GPC result showed UV absorption at 260nm remains on the [H-Tyr(tBu)]2-PLA after deprotection. 
No shifting of retention time or peak broadening was observed to the modified PLA suggesting no 
significant hydrolysis occurs at the terminus of the [H-Tyr(tBu)]2-PLA during deprotection. This was 
also confirmed by 1H-NMR analysis. Integration between reference 1H and aromatic 1H on 
tyrosineestimated 80% attachment of Fmoc-Tyr(tBu)-OH onto PLA, Figure 88. Same amount of 
aromatic 1H was detected remaining on the [H-Tyr(tBu)]2-PLA after deprotection, Figure 89. 
Therefore, it was concluded the PLA is stable in 20% piperidine in DMF for a minimum of 30 
minutes and is feasible to be uses as the degradable polymeric support for the MEPS process. 
 
Figure 88: NMR spectrum of [Fmoc-Tyr(
t
Bu)]2-PLA before deprotection in 20% piperidine in DMF. Integration 
between 
1
H from PEG200 at 3.6 ppm (t, 4 H) and 
1
H on Tyr(
t
Bu) aromatic system at 6.9 (d, 4 H) gave 80% 
attachment of Tyr(
t
Bu) onto PLA 
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 Figure 89: NMR spectrum of [Tyr(
t
Bu)]2-PLA after deprotection in 20% piperidine in DMF. Integration between 
1
H from PEG200 at 3.6 ppm (t, 4 H) and 
1
H on Tyr(
t
Bu) aromatic system at 6.9 (d, 4 H) estimated attachment of 
Tyr(
t
Bu) onto PLA remains at 80% suggesting no hydrolysis occurs to PLA during deprotection. Complete 
disappearance of the Fmoc-group signal indicates total deprotection of Fmoc occurred 
5.3.4 Cross-linked Polyimide Membrane Characterisation 
Further from Chapter 4, the “solvent to co-solvent ratio” strategy was chosen to tailor make a suitable 
cross-linked PI membrane for the MEPS process. This strategy was proven successfully in 
fabricating reproducible membranes with simpler preparation procedure. Based on the results from 
section 4.3.2.3, attempt was made to prepare a more open cross-linked membrane using the 
formulation of 22% weight PI polymer  with the 4:1 DMF to 1,4-dioxane solvent to co-solvent ratio 
system (code 22WP84PP41). The DMF solvent flux given by this membrane was very high reaching 
100 Lm-2h-1 at 5 bar. This was expected, since using such a high ratio of DMF to fabricate PI 
membrane it commonly generates an UF membrane. The high flux from this membrane allows fast 
washing of impurities from the post-reaction mixture and minimises contact time with piperidine and 
is ideal for the MEPS process. The rejection data of this membrane is illustrated in Table 9. The 
rejection of the PEG and PLA polymeric support (Table 9, entry 9 and 10) were 99% and 100% 
respectively. With the attachment of linker onto the PLA support, no loses of the polymeric support 
and peptide-PLA building were expected. A few Fmoc-protected amino acids were chosen to 
PEG  
–CH2− 
Tyr Harom 
characterise the 22WP84PP41 membrane, results from Table 9 (entry 1 to 3) showed the rejections of 
these Fmoc-amino acids were compatible with those obtained from Inopor ZrO2/Al2O3 membrane 
and is possible to remove the Fmoc-amino acid after the coupling reaction by diafiltration. Rejection 
of DIC, HOBt and PyBOP (entry 4 to 6) were estimated to be 6%, 22% and 63% respectively. Again, 
due to the charge and the bulky nature of the PyBOP it was well rejected by the membrane, while the 
small DIC and HOBt were easily permeated through. Negligible rejection of piperidine (entry 7) was 
observed with this open cross-linked PI membrane. The reproducibility of this 22WP84PP41 
membrane was so great it was further developed and up-scaled by MET Ltd and incorporated into 
their DuraMem series. 
Table 9: Rejection data of PLA, PEG, Fmoc-protected amino acids and reagent commonly used in MEPS process 
in DMF solvent collected in batch rejection experiment with 22WP84PP41 polymeric membrane at 5 bar and 20°C 
Entry Compound MW [g.mol-1] Rejection [%] Error [%] 
1 Fmoc-Ala-OH 311 31 15 
2 Fmoc-Lys(Boc)-OH 469 66 12 
3 Fmoc-Tyr(tBu)-OH 460 44 1 
4 DIC 126 6 3 
5 HOBt 135 22 3 
6 PyBOP 520 63 19 
7 Piperidine 85 0.5 12 
8 MeO-PEG5k 5,000 99 8 
9 PL12k 12,000 100 0 
A more open membrane using DMF to 1,4-dioxane ratio of 6:1 was also made. Characterisation of 
this membrane showed permeation of DMF to be approximately 150 – 160 L.m-2.h-1 with 99% 
rejection of MeO-PEG5k and only 30% rejection of Fmoc-Tyr(O
tBu)-OH at 5 bar and 20°C. However, 
this membrane was unsuitable for the MEPS process since its flux deteriorated in 6 – 8 hours under 5 
bar operating pressure, which suggests low mechanical strength. Further investigations were not 
carried out with this membrane.  
In conclusion, the cross-linked 22WP84PP41 membrane showed good permeation flux and 
selectivity between the polymeric support and the post-reaction wastes, such as Fmoc-amino acid and 
coupling reagent. It is a feasible membrane formulation for fabricating cross-linked PI membrane for 
the MEPS process.  
5.3.5 MEPS Process with Poly(lactide) as degradable anchor 
The model penta-peptide H-Tyr-Ala-Tyr-Ala-Tyr-OH was synthesized as an example to prove the 
principle of using degradable polymeric support for the MEPS process. The cross-linked PI 
membrane 22WP84PP41 was used as the separation membrane. The preliminary stability tests 
showed the cross-linked membrane has some stability in 20% piperidine in DMF deprotection 
solution. However, the stability tests were performed under “extreme” conditions and maximum 
exposure time. During the real MEPS process the membrane will spend majority of the time exposes 
to lower than 20% piperidine, as this impurity is easily remove from the filtration system. The high 
permeation flux of 22WP84PP41 membrane will ensure short exposure time to the piperidine, 
therefore longer membrane lifetime is expected. The performance of the membrane will be monitor 
through on-line analysis of permeate from the MEPS process, at any sign of membrane failure, the 
membrane disk can be replaced rapidly. 
The “alanine” strategy (Figure 40) was used to convert the hydroxyl terminal into amino terminal 
before coupling the linker onto the PLA. The attachment of Fmoc-Ala onto PLA was lower than 
previously and only reached 60% after 3 reaction cycles. No further improvement in conversion was 
observed after 5 reaction cycles. The only difference between two experiments was the scale of the 
production and the batches of PLA. The conversion presented in section 5.3.3.2 was for initial 
screening tests and was synthesized in 2 g batch. Due to the large dead-volume of the MEPS 
filtration rig, a much larger quantity of PLA was required in order to operate the MEPS process with 
PLA efficiently and a 10 g batch of [Fmoc-Ala]2-PLA was synthesized. Our experience showed 
scaling-up of the polymer modification reaction is not always straightforward and the conversion to 
the product sometime varies between batchs.  
The reduction in coupling efficiency is possibly caused by the higher molecular weight of 12,000 
g.mol-1 from the second, larger batch of PLA12k when comparied tothe 9,000 g.mol
-1 from the first 
batch of PLA9k. Literature sources pointed out an increase in molecular weight of the polymer would 
results to decreases in its reactivity [67]. The molecular weight of the support should be takes into 
consideration when selecting a suitable polymeric support for the synthesis. 
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MEPS-PL process S2 ( attachement of Fmoc-Tyr( tBu)  onto L-PL12 081203)  
Figure 90: NMR analysis of [Fmoc-Tyr(
t
Bu)-HMPA-Ala]2-PLA peptide building block in DCCl3. Integration 
between 
1
H on PEG adjacent to ester bond and Fmoc-protection group suggests conversion of 35% for the 
attachment of Fmoc- Tyr(
t
Bu)-OH onto [HMPA-Ala]2-PL 
The attachment of the HMPA linker and the first amino acid, Fmoc-Tyr(tBu)-OH were successful 
and the [Fmoc-Tyr(tBu)-HMPA-Ala]2-PLA product was analysed with 
1H-NMR analysis, result is 
illustrated in Figure 90. The conversion to [Fmoc-Tyr(tBu)-HMPA-Ala]2-PLA product was lower 
than expected, this was likely caused by the use of over-sized PLA as the polymeric support.  
The progression of the MEPS process with PLA is illustrated in Table 10. The loading of the HMPA 
linker reached 60% using PyBOP activator. This suggests a HMPA linker is attached onto every 
amino functional group that been converted on the PLA oligomer. However, as the synthesis further 
progressed, results showed rapid decline in coupling efficiency and re-coupling of the Fmoc-amino 
acid showed no further improvement in conversion. This could be due to additional inter- or intra- 
aggregation of PLA-peptide in contrast to the PEG. The actual cause of the reduction in conversion is 
unknown and further investigation is required. However, the Fmoc- deprotection in 20% piperidine in 
DMF was not affected. A possible explanation is the Fmoc-deprotection with 20% piperidine in DMF 
is approximately 40+ times molar equivalent excess. Therefore it forces deprotection to completion, 
while coupling reaction is only using 2 molar equivalent excess hence the concentration driving force 
is much lower in comparison with the deprotection. The MEPS process –with PLA experiment was 
Fmoc 
HMPA 
Lactide H 
PEG  
-CH2- 
PEG  
-CH2- 
Lactide 
–CH3 
Ether 
-CH2- 
Ether 
-CH2- 
terminated since only small amount of dipeptide was synthesized. Precipitation and separation of the 
dipeptide product from scavenger, lactic acid and other side products after cleavage/hydrolysis of 
PLA step would be extremely difficult.  
Table 10: Integrating 
1
H at 3.6 (4H, t) from -CO2-PEG- with 
1
H at 7.7 (4H, d) from Fmoc- group, the conversion of 
each coupling and deprotection was estimated by 
1
H-NMR analysis to monitor the progress of pentapeptide 
synthesis H-Tyr-Ala-Tyr-Ala-Tyr-OH with the MEPS-PL process.  
Steps Conversion (%) Comment 
L 60 Attachment of HMPA linker onto [Ala]2-PLA 
1 35 Attachment of Fmoc-Tyr(tBu)-OH onto [HMPA-Ala]2-PLA 
support (1st amino acid) 
2 100 Deprotection of Fmoc- Tyr(tBu)-OH 
3a 4 Attachment of Fmoc-Ala-OH onto peptide-PLA support 
cycle 1 (2nd amino acid) 
3b 11 Attachment of Fmoc-Ala-OH onto peptide-PLA support 
cycle 2 (2nd amino acid) 
3c 10 Attachment of Fmoc-Ala-OH onto peptide-PLA support 
cycle 3 (2nd amino acid) 
4 100 Deprotection of Fmoc-Ala-OH 
5a 0 Attachment of Fmoc- Tyr(tBu)-OH onto peptide-PLA 
support cycle 1 (3rd amino acid) 
5b 0 Attachment of Fmoc- Tyr(tBu)-OH onto peptide-PLA 
support cycle 2 (3rd amino acid) 
5.4 Conclusion 
In conclusion, the feasibility of replacing PEG as the polymeric support with a degradable polymeric 
support was investigated. This would resolve the problem with PEG contamination in the peptide 
crude product for both LPPS and MEPS processes. Polyester was chosen from a number of possible 
degradable polymers. This was due to its good chemical and mechanical stability, commercially 
availability and well studied chemistry.  
Two polyesters were investigated – the commercially avaliable poly(caprolactone)-diol (PCD) and 
in-house synthesized poly(lactide) (PLA). The product characterisation of PCD revealed it contains a 
wide spread of molecular weight, application of this PCD to the MEPS process would results in 
considerable losses of peptide-building block during the diafiltration. Hydrolysis study of PCD 
suggested, to efficiently hydrolysing PCD under acidic conditions a high water contented acid 
solution is require, which could potentially affects the recovery of peptide crude after the cleavage 
step. Coupling of Fmoc-amino acid onto PCD was successful and demonstrating the possibility of 
growing peptide on the PCD. However, the conversion of the attachment was very low and 
combining the above results, it was concluded PCD is not suitable to be use as the degradable 
polymeric support for the MESP process.  
PLA was also investigated, and because of the high cost and low availability of low molecular weight 
PLA oligomer, PLA used for the investigation was synthesized in our laboratory. A number of 
analytical techniques were employed to characterise the PLA product. By varying the synthesis 
conditions it is possible to prepare PLA with different molecular weight, allowing tailor made PLA 
for the MEPS process. Thus giving more flexibility to the investigation and better chance for the 
success of the MEPS process with degradable support. Hydrolysis study of PLA suggested the 
current cleavage condition of 95% TFA is sufficient to completely hydrolyse PLA with molecular 
weight of 12,000 g.mol-1 within < 24 hours, but the PLA can be completely hydrolysed in 3-4 hours 
with 70% TFA. Attachment of Fmoc-amino acid onto PLA was successful with the conversion of 
attachment reaching 60 - 100% depending on the molecular weight of the PLA. It is as compatible as 
with the PEG as support, demonstrating the viability of growing peptide on PLA. The stability of 
PLA in 20% piperidine in DMF deprotection solution was examined, and results indicated no 
degradation of PLA in the solution for a minimum of 30 minutes, the typical duration of the 
deprotection. These results indicate PLA is a promising degradable polymeric support for the MEPS 
process and the ability of hydrolysing PLA support during the cleavage step has shows great potential 
to improve the purity of peptide crude product. 
Attempt was made to synthesize the penta-peptide H-Tyr-Ala-Tyr-Ala-Tyr-OH as an example to 
demonstrating the use of PLA as degradable polymeric support for the MEPS process. However the 
coupling reaction on the PLA seemed to be challenging, the conversion was relatively low, starting 
from 60% and deteriorating quickly as the number of attaching amino acid increases. Overall the 
synthesis was not successful however the advantages of PLA still make it promising as a degradable 
polymeric support for the MEPS process. We believe after further investigation and optimisation of 
the synthesis procedure (for example optimisation of the molecular weight of PLA, using different 
solvent or reagent for the coupling reaction, etc.) the suggested process could be successful.  
Chapter 6.   
 
Conclusions and Recommendations 
6.1 Conclusion 
In this research project, the feasibility of combining organic solvent nanofiltration with liquid phase 
peptide synthesis process has been demonstrated, and developed the Membrane Enhanced Peptide 
Synthesis process – MEPS process. It is a simple process with the advantages of reaction in 
homogeneous phase but easy inter-step separation, as in heterogeneous synthesis. Advances in 
membrane technology have made this process possible and the membrane separation remains the 
strategic point for the success of the process. Two membranes have been identified as excellent 
candidates for the MEPS process. These are the commercially avaliable Inopor ZrO2/Al2O3 
hydrophobic ceramic membrane and the cross-linked PI membrane, which are made available as the 
DuraMem 1000 membrane by MET Ltd. Two pentapeptides were synthesized as examples for the 
MEPS process. Results showed the yield and the putiry of these peptide products were comparable 
with one synthesized from LPPS and SPPS processes. It offers an alternative route for the synthesis 
of peptide and PEGylated peptide product to the industies.  
The basic principle of the MEPS process has been demonstrated, but for this newly developed 
process to be compatible with other well-developed techniques such as SPPS and LPPS, further 
improvement and optimisation are necessary. The fundamental of membrane fabrication has been 
investigated in an attempt to understand and to manipulate the performance of the polymeric 
membrane. Two techniques have been identified which will allow tailor-made of an open membrane 
(higher MWCO) using the P84 PI solution. Characterisation of these more open membranes shows 
they have great potential to be applied to the MEPS process, and separate the growing peptide 
building block from post-reaction waste during the inter-step separation. One of the techniques, the 
manipulation of “solvent to co-solvent ratio” was further used to fabricate cross-linked polymeric 
membranes for the MEPS process. This improves the supply and reproducibility of the membrane for 
the MEPS process and points towards up scaling of the process.  
Another aspect of improving the MEPS process was to replace the PEG polymeric support with a 
degradable support. The use of PEG support results in a lower overall peptide crude product purity 
due to contamination by PEGylated waste after the final cleavage step. PLA was finally chosen as the 
degradable support for the MEPS process, hydrolysing it during the cleavage step could avoid 
contamination of the peptide product. It has a simple synthesis protocol, good solubility and stability 
during peptide synthesis and the ability to be hydrolysed during cleavage, making it an ideal 
candidate for the task. However, results showed further work are required for this idea as the peptide 
synthesis on PLA was shown to be not as straightforward as expected. The peptide synthesis was 
jeopardised possibly due to steric hindrance effects or peptide aggregation or fall of reactivity of 
peptide-PLA building block. . 
6.2 Recommendation 
Given the MEPS process is a newly developed process, there are a number of recommendations and 
directions for future work that could be carry out to improve this process. These relate to the three 
main chapters of the thesis.  
6.2.1 Membrane Enhance Peptide Synthesis (MEPS) Process 
The main drawbacks of the current MEPS process are: 
1) Low loading of peptide building block on support 
2) Long operation time 
3) The unanswered question of “what are the true potentials and limitations of the MEPS 
process?” 
In order to makes the MEPS process more efficient, the following are recommendation for further 
research. 
6.2.1.1 Use of Dendritic Support 
The disadvantages of using linear MeO-PEG or PLA as the polymer support for the MEPS process 
are their loading and shape. Firstly, these polymer supports only contain 1 (or 2) reactive site(s), 
which limits the loading capacity of the support. To achieve higher productivity, a much higher 
concentration of support is requires. This increases the viscosity of the synthesis solution and affects 
both the reaction and the separation performance; Secondly, linear molecules are often permeated 
easily through NF or OSN membranes and have lower rejection than branched or globular molecules 
due to steric effects. Hence, to increase the production capacity there is a need to improve the loading 
capacity and further minimise steps lost.  
Dendritic polymers are synthetic 3-dimensional macromolecules. They have been an attractive topic 
in recent years due to their multi-properties and multi-application nature [176] - [178]. There are a 
number of publications on using dendrimer as a carrier for metallic catalysts in organic synthesis 
[179] and as drugs/bio-molecules carrier [180] - [182] in medical applications.  
Here I propose to use dendritic polymeric supports instead of linear polymeric supports. Both 
multiple functional sites and steric hindrance should improve the production yield. Furthermore, it is 
possible to engineer the number and position of the functional site on a dendritic molecule. This can 
prevent overcrowding of the growing peptide during the synthesis and eliminating issues such as 
peptide entanglement. The polydispersity of the dendrimer are often unity (Mw/Mn = 1) due to the 
way it been synthesized. This gives a define molecular weight for the support that helps in any 
material balance calculation, analysis and the reaction performance. Since it is possible to engineer 
the dendritic support, we can set some basic criteria for an ideal dendrimer for the MEPS process. 
• Good chemical, thermal and mechanical stability; 
• Globular in shape, this helps in retaining the peptide building block by the membrane, but it 
could also be rigid “hyperbranched” molecule; 
• Containing multiple functional sites on the surface with maximum separation between each 
site, but no more than 8 sites as it may get overcrowded; 
• Easy separation between the support and the peptide product, possibly degradable as PLA 
does and no need for additional processing step; 
• High solubility in most common solvents;  
• Install with reference tags such UV absorption regions or NMR internal referencing parts that 
will ease the analysis.  
A schematic representation of the ideal shape of dendrimer for the MEPS process is illustrated in 
Figure 87, with F symbolize for the functional group where peptide grow. A numberof dendrimers 
have been published in the past few years and several look very promising. These includs the 
poly(benzy-alcohol) based dendrimer [183] or the low molecular weight (3rd generation) 
poly(amidoamine) dendrimer (PAMAM) [184], as shown in Figure 92. Both have great potential to 
be the support for the MEPS process. 
 Figure 91: A schematic representation of the ideal dendrimer for the MEPS process. The directed functional site, 
F, is extended from the dendritic core with a) the ideal 4 reactive sites and b) 8 reactive sites. The shaded area 
representing a reference tags that helps in analysis. 
 
Figure 92: Examples of well published dendrimer, a) poly(benzyl alcohol) dendrimer [183] and b) PAMAM 
dendrimer [184] 
Nevertheless, the use of dendritic polymer as supports is currently constrained by its cost and 
availability. Most of the dendrimers reported were custom made to fit the author’s application and 
purposes. There are a few commercially available dendritic polymer on the market, however they are 
often very expensive and do not necessarily meet the MEPS requirement. For instance, many of the 
commercially available dendrimers have too many functional groups and/or with long linear branches 
pronged from the core similar to a “star shape”. The uses of these dendrimer could result in peptide 
F 
F 
F 
F 
F 
F F 
F 
F F 
F 
a) b) 
F 
a) 
b) 
chain or dendrimer branch entanglement during synthesis, which could affects the coupling reaction 
and reduces the final product purity. 
6.2.1.2 Exploration and Justification of the MEPS Process 
This project has demonstrated the principle of the MEPS process but its true potential and limitation 
are important questions that have to be answered before this technology could emerge as a new 
paradigm to compete with the SPPS process. In case of limitations, the ultimate question needs to 
answer is whether liquid phase synthesis really better than solid phase? The typical length of peptide 
synthesize by SPPS process are 10 – 15 units (but will depends on the peptide sequence), these short 
sequence then couple together by fragment condensation method. Direct synthesis of very long 
peptide sequence with SPPS generally results to entanglement of peptide chain which is undesirable. 
The best way to examine the capability of MEPS and LPPS processes is synthesize a peptide with > 
15 units or a known difficult peptide sequence for the SPPS process. By comparing the yield and 
purity of the final product from both processes and validating whether LPPS is better than SPPS.  
Synthesizing peptide and oligo-nucleotide using the MEPS process are two of the many examples 
that the MEPS process is capable of. The MEPS concept should not be limited to only apply to the 
production of peptide and oligo-nucleotides. In theory the MEPS process can be applies to any 
“sequential synthesis” - Membrane Enhanced Sequential Synthesis (MESS). The idea of “sequential 
synthesis” applies to any product synthesized from multi-step reaction of which each reaction step 
involving repetition of an additional unit. In another words, MESS can also apply to synthesize other 
bio-molecules such as peptide-nucleic acid (PNA) or phosphopeptide (PP). These are relatively new 
class of biomolecules and are gaining attention in the biological and biochemical communities, due to 
their bioactivity and potential in drug discovery [185] - [190].  
The MESS process can also be applies to synthesize synthetic molecules such as dendrimer! The 
synthesis of dendritic polymer is also a classic case of “sequential synthesis”. Their general synthesis 
procedure involves a coupling step of monomer follow by regeneration of functional group on the 
monomer – “one generation”. Just like in peptide synthesis, the dendritic product will be separated 
from its monomer after each coupling steps, and the reagent use to regenerating the functional group 
after each regeneration step. The synthesis of dendrimer was also suffer from separation disadvantage, 
but unlike peptide synthesis it cannot be synthesize by solid phase synthesis and have to depend its 
inter-step separation method on chromatography or crystallisation. The MESS process will provides 
an alternative production procedure for dendrimer and with the inter-step separation no longer 
constrained to chromatography or crystallisation this is expect to have a great impact on the dendritic 
market and will attracting more research and application of dendrimer.  
In general, the MEPS project has great potential beyond peptide and nucleotide synthesis, but more 
exploration with some imagination is needed for this new process to discover its true protential.  
6.2.1.3 Automated Membrane Enhance Peptide Synthesizer 
Both SPPS and LPPS processes have been available as automated systems for many years [191]. In 
particular, SPPS has been commercialised as a versatile laboratory scale machine and applied to 
industrial scale systems [27]. There are many advantages for automating these processes, for instance:  
• Doing manual SPPS or LPPS is time consuming and labour intensive. Automating the 
processes can saves time and labour;  
• These syntheses are “sequential synthesis”, therefore many repeated steps will be performs 
before the final product is obtain and automation will reduce the chance of making human 
errors during the operation;  
• Automation allows faster screening of process parameters and eases the complexity of the 
process optimisation; 
• Transferring the manual MEPS process into an automated MEPS process is the first step for 
up-scaling of the process and moving it towards commercial practise.  
The process flow diagram (PFD) of the automated MEPS is presented in Figure 93. The entire 
process will be control by a “Programmable Logical Controller” (PLC). The require reagents will be 
takes from their reservoirs and feed into the system by an injection pump, P3. The pipe line would 
clean itself after the feeding. The reaction duration and temperature will be pre-set and monitored by 
the PLC. The pressure of the system will be increases to begin the filtration when the reaction is 
completed. Permeate will be collected onto a balance, B1 which measures the weight of permeate and 
communicate this back to the PLC. The flow rate of the fresh solvent feed into the system will be 
adjusts to replace the permeated mass and maintaining a constant volume within the filtration system. 
Once the diafiltration has been completed the next synthesis step will be perform immediately. Pump 
P2 will be activated at the same time and emptying the contents on the balance into a separate waste 
tank. This procedure will be repeated until the require peptide sequence has been synthesized.  
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6.2.2 Membrane Fabrication for MEPS process 
Chapter 4 investigated ways to manipulate the MWCO of the PI membrane and successfully 
fabricates reproducible cross-linked PI membranes for the MEPS process. However, further research 
on the membrane fabrication is essential for the MEPS process development. The unsolved mystery 
of degradation of cross-linked PI membrane in piperidine solution is still a challenge for the long 
term competiveness of the MEPS process. There are two solutions for this problem. It either 
investigating different deprotection reagents for the Fmoc-protection group, or research for a better 
membranes. The membrane option might include new membrane material and new cross-linking 
reagent. The disadvantage of investigating new membrane materials is that not all polymers can be 
fabricate into OSN membranes, only specific types of polymer can be use in fabrication, and the 
outcome of the membrane mostly will not be the same as the proven cross-linked PI membrane. The 
purpose of the cross-linking is to keep the polymer chains in place after phase inversion, therefore 
finding a different way to anchoring these polymer chains will also make the membrane more stable. 
Here, I propose to cross-link the PI membrane using an alkene diamine instead of alkane diamine, 
follow by exposing the membrane to UV radiation to initiating free radical cross-link through the 
C=C bonds. With both physical and chemical structure of the membrane fixed in place, the secondary 
cross-linking serves as further reinforcement to the structure and since free radical polymerisation of 
C=C bond will generate the strong C-C bond it reduce the chance of membrane degradation. Two 
potential candidates for the alkene diamine is illustrate in Figure 94.  
 
H2N
NH2 H2N
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Figure 94: Two potential candidates for secondary cross-linking of PI membrane 
The major drawback of the current MEPS process is its large solvent consumption during the 
diafiltration, therefore ideally incorporating a solvent recovery and recycle system into the MEPS 
process will improve the attractiveness of the process. Furthermore, the solvent recovery system can 
also be applied to SPPS process and further improving the efficiency of the SPPS process. For this 
reason there is a need to develope an OSN membrane with very low MWCO for the solvent recovery 
system. The major challenge for solvent recovery is the removal of piperidine, since the molecular 
weight of the piperidine (MW = 85 g.mol-1) is very similar to DMF solvent (MW = 73 g.mol-1), 
hence using membrane separation will be difficult. Perhaps targeting the basicity of the piperidine 
and neutralising piperidine with a bulky acid then applies OSN would be able to remove this organic 
base and recovering the solvent.   
6.2.3 Degradable Polymeric Support for the MEPS Process 
Chapter 5 has demonstrated the feasibility of using PLA as a degradable polymeric support however 
the synthesis came to a halt after the attachment of the second amino acid and did not make to the 
penta-peptide as hoped for. There are two hypotheses for the sudden decrease in reactivity, 1) the 
growing peptide-PLA building blocks start to entangle, which reduces the accessibility of the reagent 
to the active site; or 2) it reached the maximum molecular length of a polymer chain which it has any 
reactivity and becoming an inert molecule. The use of light scattering techniques could provide 
information on the conformation and orientation of the peptide-PLA building block in DMF solvent, 
and clarify the hypothesis of entanglement during synthesis.  
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Figure 95: Other PLA candidate for the MEPS process with a) glycerol as initiator and b) tri(phenyl) methanol as 
initiator 
The general idea of using a large PLA support is to increases the difference in molecular weight, to 
improve the selectivity between peptide building block and post reaction waste. There are other ways 
to improve the selectivity, such as steric effects. This allows the use of smaller PLA as the degradable 
a) 
b) 
support for the MEPS process without sacrificing reaction kinetics. In-house PLA synthesis provides 
the opportunity to tailor make the PLA to meet MEPS process requirements. Two potential candidate 
of PLA were synthesized for the MEPS process and are shown in Figure 95. GPC and NMR results 
suggest both PLA syntheses were successful but these have not been characterises with the cross-
linked PI membrane due to time limitation. The idea of using glycerol to initiate the PLA synthesis 
instead of PEG is the use of tri-alcohol will generates a hyper-branched molecule, Figure 95 a), 
which will helps in retenting the peptide building block by the membrane. It will also increase the 
loading capacity of the support. Initiation with tri(phenyl) methanol, Figure 95 b), only gives one 
active site per support but the bulky tri(phenyl) substituent acts as a large “anchor” for the support 
which should give better rejection in comparison to a normal linear polymer, and allows lower 
molecular weight of PLA to be use. The aromatic system can also be use as a referencing substituent 
for UV and NMR analysis, which will helps in monitoring and tracking of the synthesis progress.  
Chapter 7.   
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Appendices 
8.2 Table of Amino Acids 
Table 11: 20 natural amino acids and their abbreviations 
Amino Acid Abbreviation Side chain, - R 
Molecular Weight 
(g/mol) 
Alanine 
Ala A 
NH2
CH
C
CH3
OH
O
 
89 
Arginine 
Arg R 
NH2
CH
C
H2
C
OH
O
H2
C
H2
C
H
N C NH2
NH
 
174 
Asparagine 
Asn N 
NH2
CH
C
H2
C
OH
O
C NH2
O
 
132 
Aspartic acid 
Asp D 
NH2
CH
C
H2
C
OH
O
C OH
O
 
133 
Cysteine 
Cys C 
NH2
CH
C
H2
C
OH
O
SH
 
121 
Glutamic acid 
Glu E 
NH2
CH
C
H2
C
OH
O
H2
C C OH
O
 
147 
Glutamine 
Gln Q 
NH2
CH
C
H2
C
OH
O
H2
C C NH2
O
 
146 
Glycine 
Gly G 
NH2
CH
C
H
OH
O
 
75 
Histidine 
His H 
NH2
CH
C
H2
C
OH
O
N
NH
 
155 
Isoleucine 
Ile I 
NH2
CH
C
CH
OH
O CH3
H2
C CH3
 
131 
Leucine 
Leu L 
NH2
CH
C
H2
C
OH
O
CH
CH3
CH3
 
131 
Lysine 
Lys K 
NH2
CH
C
H2
C
OH
O
H2
C
H2
C
H2
C NH2
 
146 
Methionine 
Met M 
NH2
CH
C
H2
C
OH
O
H2
C S CH3
 
149 
Phenylalanine 
Phe F 
NH2
CH
C
H2
C
OH
O
 
165 
Proline 
Pro P 
N
H
C
OH
O
 
115 
Serine 
Ser S 
NH2
CH
C
H2
C
OH
O
OH
 
105 
Threonine 
Thr T 
NH2
CH
C
CH
OH
O OH
CH3
 
119 
Tryptophan 
Trp W 
NH2
CH
C
H2
C
OH
O
NH
 
204 
Tyrosine 
Tyr Y 
NH2
CH
C
H2
C
OH
O
OH
 
181 
Valine 
Val V 
NH2
CH
C
CH
OH
O CH3
CH3
 
117 
8.3 Protocol of Liquid Phase Peptide 
Synthesis 
The LPPS procedure was mainly based on Fischer [87] reported and mainly consists of 4 type of 
reactions, coupling of first amino acid by esterification, chain assembly, Fmoc-deprotection and 
cleavage. 
Coupling of first amino acid. Dissolve a known amount of MeO-PEG support into DCM solvent (20 
mmol.L-1). Pre-activating Fmoc-amino acid, HOBt and DIC (all 2 molar equivalents to support) with 
DIPEA (1 molar equivalent to support) in DMF solvent (40 mmolFmoc-amino acid.L
-1) for 15 minutes 
before mixing with the support solution. Stir the reaction mixture vigorously at room temperature for 
1 hour. Slow addition of diethyl ether into the reaction mixture to precipitating out the peptide 
building block. Re-dissolve peptide building block in ethanol and repeat precipitation and wash with 
diethyl ether 2 times before drying in vacuum. Sample of peptide building block is analysis with 
Kaiser Test for the absence of free amine group. 
Chain assembly and attachment of linker. Dissolve peptide building block into DCM solvent (20 
mmol.L-1). Pre-activating Fmoc-amino acid (or HMPA linker), HOBt and PyBOP (all 2 molar 
equivalents to peptide building block) with DIPEA (1 molar equivalent to peptide building block) in 
DMF solvent (40 mmolFmoc-amino acid.L
-1) for 15 minutes before mixing with the peptide building block 
solution. Stir the reaction mixture vigorously at room temperature for 1 hour. Slow addition of 
diethyl ether into the reaction mixture to precipitating out the peptide building block. Re-dissolve 
peptide building block in ethanol and repeat precipitation and wash with diethyl ether 2 times before 
drying in vacuum. Sample of peptide building block is analysis with Kaiser Test for the absence of 
free amine group. 
Fmoc-deprotection. Dissolve peptide building block into DMF solvent (6 mmol.L-1). Add piperidine 
(20% v/v) into the peptide building block solution and stir at room temperature for 30 minutes before 
precipitating the peptide building block with diethyl ether. Re-dissolve peptide building block in 
ethanol and repeat precipitation and wash with diethyl ether 2 times before drying in vacuum. Sample 
of peptide building block is analysis with Kaiser Test for the presence of free amine group. 
Peptide cleavage. The cleavage solution containing phenol and Water (each 2.5% v/v) in TFA (95% 
v/v) is pre-mixed before using. Dissolve peptide building block in cleavage solution (70 mmol.L-1) 
and stirring solution at room temperature for 3 hours before precipitating the peptide and support 
with diethyl ether. The purity of peptide product is analysis with HPLC and MALDI-Tof to 
determine the molecular weight of the peptide product. 
8.4 Protocol of Solid Phase Peptide 
Synthesis 
The manual SPPS procedure divided into 4 parts, resin preparation, coupling reaction, deprotection 
and cleavage. Resin preparation is essential since solid resin purchased came in a completely dried 
form, it needs to be pre-swell in solvent to expend it matrix before use in the synthesis or it will affect 
the mass transfer during the SPPS reaction. The coupling and deprotection protocol was slightly 
altered to match the LPPS protocol for performance comparison.  
Resin preparation. A known amount of resin (0.1 g) is charge into a polypropylene syringe 
containing a polyethylene frit. 3 times the bed volume of DCM solvent then add into the resin to 
swell the matrix. The swelling takes approximately 30 minutes under continuous shaking condition. 
Upon the completion of the resin preparation, drain-off the DCM solvent and leave in vacuum for 1 
hour to remove DCM residue.  
Coupling procedure. Fmoc-amino acid, HOBt, PyBOP (all 2 molar equivalents) and DIPEA (1 
molar equivalent) are weighted and pre-dissolve into 2 ml of DMF solvent. The amino acid solution 
then mix with the resin and continuously shakes for 1 hour. Drain off the coupling reagent and wash 
the resin with 3 times the bed volume of DMF solvent for 5 times 
Deprotection procedure. Pre-mix 20% (v/v) piperidine in DMF solvent. Add enough deprotection 
reagent to covering the resin and shakes for 30 minutes. Drain off the deprotection reagent and was h 
the resin with 3 times the bed volume of DMF solvent for 5 times. 
Peptide cleavage. The cleavage solution containing phenol and Water (each 2.5% v/v) in TFA (95% 
v/v) is pre-mixed before using. Wash the peptide-resin using methanol with 3 times the bed volume 
and repeating for 3 time follow by DCM wash and diethyl ether wash. Allow the peptide-resin to dry 
then add 2 times the bed volume of cleavage solution into the resin. Shake the system for 3 hours, 
drain off and wash the resin 3 times with cleavage solution. Collect all of the peptide containing 
filtrate solution and precipitating the peptide product with 10 volume of diethyl ether. Dry the peptide 
product in vacuum and analyse the peptide purity with analytical HPLC.  
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Figure 96: Synthesis route of MeO-PEG-NH2 proposed by Pillai et al. [101] 
MeO-PEG-Tosylate synthesis (1). Polyethylene glycol monomethyl ether (MeO-PEG, MW~5000 
gmol-1) was dehydrated in vacuo at 80oC for 4 hours before dissolving in DCM (25 mL per mmol 
MeO-PEG). p-Toluenesulfonyl chloride (46 mmol per mmol MeO-PEG) and pyridine (1.5 mL per 
mmol PEG) were added to the PEG solution, reaction was performed under nitrogen atmosphere and 
continuous stirring for 12 hours. The resulting solution was concentrated in vacuo and the product 
(MeO-PEG-Tos) was precipitated by adding diethyl ether and kept at 4°C for few hours to complete 
the precipitation. The precipitate was filtered and washed with ether, recrystallised with ethanol and 
dried in vacuo. UV analysis was performed by measuring the absorption at 270nm to verify the 
presence of the tosylate group. 
MeO-PEG-Phthalimide synthesis (2). MeO-PEG-Tos and potassium phthalimide (10 mmol per 
mmol MeO-PEG-Tos) were dissolved in DMF (14 mL per mmol MeO-PEG-Tos), and heated under 
reflux and nitrogen atmosphere for 4 hours. Residual solids were removed by filtration, and diethyl 
ether was added to filtrate to precipitate product from the solution. The resulting slurry was kept at 
4°C for few hours to complete the precipitation. The product was filtered and washed with ether, 
followed by digestion with DCM. The insoluble impurities were filtered and MeO-PEG-Phth was 
precipitated from filtrate with ether. The solid product was filtered again, washed with ether and 
dried in vacuo. The appearance of the phthalimide group was verified by UV analysis at 292nm and 
264nm. 
MeO-Amino-PEG synthesis (3). MeO-PEG-Phth and hydrazine hydrate (40 mmol per mmol MeO-
PEG-Phth) were dissolved in ethanol (18.5 mL per mmol MeO-PEG-Phth) and heated under reflux 
for 12 hours. The product mixture was cooled to room temperature before precipitation with diethyl 
ether. The precipitate was filtered and re-dissolved in DCM, the insoluble impurities were filtered 
and MeO-PEG-NH2 product was precipitated from filtrate, washed with diethyl ether, recrystallised 
with ethanol and finally dried in vacuo. The product was analysed with UV analysis for 
disappearance of phthalimide group and Kaiser test to verify the presence of amino group. The 
conversion (~80%) was determined by titration with HCl (aq). 
8.6 Protocol of Methoxy Amino PEG 
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Figure 97: Synthesis route of MeO-PEG-NH2 synthesis by direct coupling method 
Attachment of Fmoc-Ala onto MeO-PEG (4). MeO-PEG was dissolved in DCM (10 ml per mol 
MeO-PEG), while Fmoc-Ala and HOBt (both 2 mol per mol MeO-PEG) were dissolved in DMF (4 
ml per mol MeO-PEG) before mixing the two solutions together. DIC (2 mol per mol MeO-PEG) 
was added afterward and mixed vigorously for 4 hours at 20°C. Solid impurities were filtered and the 
product was precipitated with diethyl ether and dried. The coupling step was repeated 3 times to 
obtain conversion >80%,Figure 98. MeO-PEG-Ala-Fmoc product was recrystallised first from DMF 
by adding diethyl ether followed by recrystallisation with ethanol. The conversion was determined 
with H1-NMR as a ratio between the peaks at 3.4 (s, 3H) for the MeO- group and 1.4 (d, 1H) for Me- 
group of alanine.  
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Figure 98: The reaction conversion for Fmoc-Ala attachment onto MeO-PEG as a function of the number of 
reaction cycles performed. Conversion higher than 80% is achievable after 3 coupling reaction cycles. 
Deprotection of Fmoc-group (5). Standard 20% v/v piperidine/DMF solution was used to remove 
Fmoc-protecting group from (4). After deprotection the product was precipitated and washed with 
diethyl ether, recrystallised with ethanol and dried in vacuo. H1-NMR was used to verify the 
disappearance of Fmoc-group at 7.2 (t, 2H), 7.3 (t, 2H), 7.5 (d, 2H) and 7.7 (d, 2H). Kaiser test was 
used to confirm the presence of amino functional group. 
8.7 Protocol of Poly(Lactide) Synthesis 
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Figure 99: Poly(lactide) synthesis with tin (II) ethylhexanoate (Sn(Oct)2) as catalysis, PEG200 as initiator and 
lactide as monomer. Polymerisation was carried out at 140°C under continuous stirring and nitrogen inert 
atmosphere for 72 hours. 
Stainless steel reactor was dried in oven at 100°C for 2 follow by purge with argon gas throughout 
the preparation. Poly(ethylene glycol) with mean molecular weight of 200 g.mol-1 (PEG200) was dried 
in vacuum at 60°C for 30 min before uses as the initiator for the ring-opening polymerisation reaction. 
The amount of initiator require for the synthesis was calculated base on Equation 13, with [Lact]0 and 
[OH] are concentration or mole of starting lactide and hydroxyl functional group, respectively. MLact 
is the molecular weight of lactide and xPLA is the molar conversion. The pre-dried PEG200 was first 
added into the reactor. Tin(II) ethylhexanoate (also known as Stannous octoate, Sn(Oct)2) was taken 
directly from the argon gas blanketed container and mixed with the PEG200. Lactide (also known as 
3,4-dimethyl-1,4-diane-2,5-dione) was freeze dried before added into the reactor. The reactor was 
continuously purging with slow flowing argon gas for 2 minutes before closing to ensure moisture 
content within the reactor is minimum. The whole system was heated to 140°C and kept at this 
temperature for 72 hours. The reactor was cooled to room temperature before opening and 
chloroform was added to dissolve the PLA product. Diethyl ether (or methanol or hexane) was added 
to precipitate out and wash the PLA product. Gummy like PLA oligomer product was dried in 
vacuum for minimum of 3 days before GPC and NMR analysis were performed. 
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Equation 13 
